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Clinical Features and Prognosis of Chinese Childhood
Pulmonary Arterial Hypertension-related Gene Mutation
Carriers
Z Xu, H Gu, H Zhang
Beijing Anzhen Hospital, Capital Medical University, China
Background: Since identiﬁcation of the BMPR2 gene in families
affected by PAH, mutations in several other genes have been discovered. The impact of these genes on the clinical phenotype are not yet
fully understood, especially in childhood.
Methods: 114 consecutive patients with IPAH/HPAH whose diagnostic
age <18 years were included. Gene sequencing used NGS-based targeted penal. Clinical characteristics and outcomes were collected in all
patients. Results: Thirty-one BMPR2, nine ALK1 and 33 other PAHrelated gene mutation carriers were detected in this cohort. The median
age at diagnosis of PAH was 5.9 (3.4, 10.3) years. Fifty PAH-related gene
mutations were identiﬁed in 33 patients, including seven mutations in
NOTCH3, six mutations in CPS1, ﬁve mutations each in TBX4, ABCA3
and KCNK3, four mutations each in SMAD9 and EIF2AK4, three in
GDF2, two mutations each in TBS1, ENG and NOTCH1, one each in
ABCD4, ATP13A3, ARHGAP31, CAV1 and HTR2B. 64 patients (46 mutation carriers) underwent cardiac catheterization examinations, with
acute vasodilator testing performed simultaneously. BMPR2 mutation
carriers demonstrated the highest pulmonary vascular resistance index
(p¼0.037) and responded poorly to vasodilator (24.0 to 25.5 WU*m2,
p¼0.785). Other three cohorts all responded to vasodilator, with mutation noncarriers experiencing the greatest decline (16.2 to 9.6 WU*m2,
p¼0.045). Over all 5-year survival for all patients was 65.6%. Five-year
survival was lower in ALK1 mutation carriers than mutation noncarriers
(0% vs 73.7%, HR 48.1, p¼0.062) and was similar with BMPR2 mutation
carriers (0% vs 32.4%, HR 1.1, p¼0.891). Other PAH-related gene mutation carriers had a tendency to have better outcome than mutation
noncarriers (5-year survival rate 95.5%, HR 0.33, p¼0.131).
Conclusions: Chinese pediatric IPAH/HPAH patients with a ALK1 or
BMPR2 mutations demonstrated worst clinical outcomes. Other PAHrelated gene mutation carriers and mutation noncarriers were more
responsive to PAH speciﬁc therapies. It is important to consider
aggressive treatment for pediatric IPAH/HPAH patients.
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Utility of a Modiﬁed Vascular Corrosion Casting
Technique in the Diagnosis of Fetal Total Anomalous
Pulmonary Venous Connection
J Zhang 1, 2, H Guo 1, Y Wang 1

1

Xiangyang No.1 People's Hospital, Hubei University of Medicine
Xiangyang, Key Laboratory of Maternal-Fetal Medicine in Fetal Heart
Diseases, Hubei, Xiangyang, China

2

Background: This study investigated the characteristics and accuracy
of prenatal ultrasound in the diagnosis of fetal total anomalous pulmonary venous connection (TAPVC).
Methods: We retrospectively identiﬁed patients hospitalized from May
2015 to May 2020 at our Maternal–Fetal Medicine Center who were
reported to have TAPVC prenatally. Pre- and postnatal medical records, including results obtained by ultrasound, postpartum echocardiography and computed tomography angiography, as well as
anatomic and cardiovascular casting ﬁndings were reviewed and
analyzed.
Results: Of the 20 fetuses with a prenatal diagnosis of TAPVC, 80% (16/
20) had intra- or extracardiac malformations. The TAPVC types were
supracardiac (n¼8), cardiac (n¼6), infracardiac (n¼4), and mixed
(n¼2). The diagnosis of 1 case each of supracardiac and cardiac TAPVC
was modiﬁed to partial anomalous pulmonary venous connection;
additionally, 4 malformations were missed and 2 were misdiagnosed.
Conclusion: Prenatal ultrasound can be used to accurately diagnose
most types of fetal TAPVC. By analyzing the characteristics of echocardiography, the speciﬁc types of fetal TAPVC can be distinguished.
Postpartum cardiovascular casts can accurately depict the branch
structure of the heart's larger vessels, and may be used as a clinical
assessment and teaching method in complex cardiac malformations.
32

Value of Color Doppler Ultrasound in the Diagnosis of
Prenatal Pulmonary Sequestration
H Guo
Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang,
China
Background: To analysis the ultrasonic manifestations of fetal pulmonary sequestration(PS) and investigate the diagnosis value of Color
Doppler ultrasound for the fetal PS.
Methods: A Voluson E8 three-dimensional color Doppler ultrasonic
apparatus was used to screen fetus abnormality in approximately 1,500
pregnant women in metaphase and terminal period A fetal fourchamber view, sagittal section of thorax, and coronal section were used
to thoroughly observe the shape and size of fetal lung tissue and their
surrounding tissue, to check whether there are abnormal echo, and
observe the shape, size, blood supply type and whether combined with
other deformities.
Results: Three cases of fetal PS was detected in a total of 1,500 cases. In
the three case, one was extralobar PS combined with diaphragmatic
hernia, one was extralobar PS combined with Type II congenital cystic
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Methods: We retrospectively identiﬁed patients with a fetal diagnosis
of severe congenital heart defects referred to our Maternal-Fetal
Medicine center from 2013 to 2018 and selected those who had postnatal conﬁrmation of cardiovascular anatomy. Prenatal and postnatal
medical records, including echocardiographic reports and cardiovascular casts, were reviewed and cardiac abnormalities were compared
and analyzed.
Results: The fetal cardiovascular casts showed that all of thirty-ﬁve
cases of induced labors were conﬁrmed to have complex cardiac
malformations. Ninety cardiovascular malformations were demonstrated on casts, sixty-nine cardiovascular malformations were found
on prenatal echocardiography. Twenty-one fetal cardiovascular malformations were misdiagnosed and missed diagnosed by prenatal ultrasound. Among them, seven cardiovascular malformations were
misdiagnosed and fourteen cardiovascular malformations were
missed diagnosed.
Conclusion: Our study shows that fetal echocardiography may
misdiagnose and missed diagnose of abnormal DA, vascular deformities and other complex cardiac malformations. The cast specimens of fetal hearts and great vessels can visually display fetal cardiac
malformations and abnormalities of macrovascular and its branches.
Prenatal understanding of such malformations may help to improve
prenatal diagnosis.

adenomatoid, and the other was intralobar PS; two of them located in
right pleural, one of the in the left pleueal. In the three of them, two
accompany with the heart compressed and shift. The blood supply of
two were originate from descending aorta, the other was from branch
of aortic arch. All three pregnant patients under went induced labor
and PS diagnosis of their fetuses was conﬁrmed by autopsies and
pathological examinations.
Conclusion: Color Doppler ultrasound can serve as an effective tool for
prenatal diagnosis of PS. It can provides important reference value For
clinical in early diagnosis and treatment of fetal PS.
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Study of Cystic Volume Ratio in Prenatal Assessment the
Prognosis of Fetal Pulmonary Sequestrations
T Xu
Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang,
China
Background: To evaluate the prognostic risk of pulmonary sequestration (PS) by measuring cystic volume ratio (CVR) value in fetal
congenital sequestration (PS).
Methods: 88 cases of fetal PS diagnosed by prenatal ultrasound in
Xiangyang No.1 People's Hospital from March 2010 to June 2017 were
measured of the fetal CVR, their clinical and outcomes were observed.
According to the prenatal ultrasound CVR value, 49 fetuses diagnosed
with pulmonary sequestration (PS) were divided into 2 groups, group 1:
CVR ≥.6, group 2: CVR<1.6. To compare the incidence rate of fetal edema,
respiratory distress symptoms and survival rate between the two groups.
Single and multiple Logistic regression analysis were made to evaluate
the risk factors of the fetal pulmonary sequestration. Correlation was
used to evaluate the relationship between CVR and fetal prognosis.
Results: Of the 88 fetuses, 62 cases of PS (ILS) type (70.45%, 62/88, 19
cases of PS (ELS) type I (21.59%, 19/88 and 7 cases of PS (ELS) type II
(10.20%, 7/88), 81 cases (93.88%, 81/88) born alive, 5 case (CVR ≥1.6)
(7.95%, 5/88) of induced abortion, and 2 cases (CVR ≥1.6) (4.08%, 2/88)
of stillbirths. In 24 group 1 (CVR
≥1.6) cases, 44 cases born alive, the incidence rate of newborn respiratory distress was 100%(36/44), fetal edema was 88.64% (39/44). In 44
cases of the group 2 (CVR<1.6), 3 cases (6.82%, 3/44) were diagnosed
with newborn respiratory distress, 3 cases (6.82%, 3/44) were diagnosed with fetal edema, and the rate of live birth was 100%. There was
statistical signiﬁcant difference between the PS with CVR <1.6 and that
with CVR ≥1.6 in the incidence rate of fetal edema, postpartum respiratory symptoms and survival rate. CVR is a risk factor for pulmonary
sequestration and is associated with fetal prognosis.
Conclusion: CVR in second-trimester of pregnancy is an effective
index to evaluate the prognosis of PS fetal. CVR ≥1.6 was associated
with an increased risk of fetal edema, infant respiratory distress and
intrauterine or postnatal death.
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The Sonograms and Autopsy Data of 3 Cases of Fetal
Right Atrial Isomerism and Literature Analysis
Y Wang
Xiangyang No.1 People's Hospital, Hubei University of Medicine,
Xiangyang, China
Aims: Analysis sonograms feature of cardiovascular malformation and
its associated anomalies in fetus with right atrial isomerism.
Methods: The sonograms and autopsy data of 3 cases found in 256
pregnant women and 676 cases found in literature with right atrial
isomerism which conﬁrmed by angiocardiography, autopsy, and surgical operation were analyzed retrospectively.
Results: In our 3 cases, the stomach and gallbladder were all located on
the right side, asplenia in 2 cases, and the other was located in the right
side. They were trilobites lung (asymmetric), and both sides were the
right auricle (asymmetric). Associated anomalies included right valve
atresia, single ventricle, single atrium, complete atrioventricular
atrioventricular septal defect, double outlet of right ventricular, right
aortic arch, pulmonary artery stenosis, total anomalous pulmonary
venous connections, etc. According to the literature, the rate of right
and left atrial isomerism was 2.5:1 (524:209), the age of children were
from 0 to 15 years. The main cardiovascular abnormalities included
anomalous pulmonary venous connections (57.6%), single ventricle
(64.8%), single atrium (21.5%), endocardial cushion defect (37.8%),
double superior vena cava (24.9%), double outlet of right ventricular
(24.2%), pulmonary artery stenosis (33.9%), pulmonary atresia (19.7%),
VSD, right aortic arch, PDA, and left superior vena cava, etc. In 284
cases, The median of liver (97%), asplenia (91.1%), abdominal aorta
and inferior vena cava located in the same side of spine (93.6%),
bilateral trilobites lung (87.9%), bilateral right bronchial (100%), were
the main abnormalities Outside the heart.
Conclusion: Right atrial isomerism was combined complex cardiac
anomalies, short-term and long-term prognosis were not optimistic.
They always accompanied the median of liver, asplenia, abdominal
aorta and inferior vena cava located in the same side of spine,
anomalous pulmonary venous connection, etc. Prenatal ultrasound
was effective method for diagnosis of the fetus with right atrial
isomerism.
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Description of Misdiagnosis and Missed Diagnosis
of Fetal Complex Heart Malformations by Fetal
Echocardiography Combined With Cardiovascular Cast
Y Wang
Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang,
China
Background: We compared fetal echocardiography with cardiovascular casts and analyzed the causes of missed diagnosis and missed
diagnosis of fetal cardiac malformations.

2
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Results: This study conﬁrmed that the indicators of RV development
in fetuses with PA/IVS improved continuously after FPV was performed under ultrasound guidance. Compared with those before
FPV, the Z- score of TV in 5 fetuses with continued pregnancy
decreased signiﬁcantly at 2 and 6 weeks after FPV, while the ratio of
TV/MV and RV/LV increased signiﬁcantly (P<0.05), and massive
tricuspid regurgitation improved signiﬁcantly at 6 weeks after FPV
(P<0.05).
Compared with 6-month-old and 2-year-old, the diameter of TV
increased most rapidly in 1-year-old, and the Z-score of TV increased
most signiﬁcantly (P¼0.002; P¼0.064), compared with those at 6
months old and 2 years old, the diameter of TV increased most rapidly
at the age of 1 year (P¼0.002; P¼0.102), and the Z-score of TV also
increased most signiﬁcantly. There was no signiﬁcant difference in the
growth rate and Z-score of right ventricule among different periods
(P<0.05), but the growth rate of right ventricule at 6 months old was the
fastest compared with that at 1 year old (P¼0.009), and there was no
signiﬁcant difference at 2 years old (P¼0.497). Bradycardia was found
to be the chief complication of FPV (4/7, 57.12%) procedures. All the 4
fetuses were punctured in the right atrium and injected with
epinephrine or atropine, and the fetal heart rate returned to normal.
Conclusion: The study offers clinically signiﬁcant insights into postnatal RV development following FPV for PA/IVS and shows that timely
detection and correct treatment are crucial for ensuring the success of
FPV.
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Efﬁcacy and Safety of Subcutaneous Treprostinil
Infusions in the Treatment of Pediatric Patients With
Severe IPAH
J Peng, Q Li, C Zhang, Z Xu, H Zhang, H Gu
Beijing Anzhen Hospital, Capital Medical University, Beijing, China
Background: Treprostinil, a prostacyclin analogue, is effective for the
treatment of pulmonary arterial hypertension(PAH). However, information is scarce regarding treprostinil for treatment of severe pediatric
idiopathic PAH (IPAH). The aim of this study was to examine the efﬁcacy and safety of subcutaneous treprostinil in this setting.
Materials and Methods: A retrospective study was for 16 patients
(under 18 years of age) with a diagnosis of IPAH admitted to Department of Pediatric Cardiology of Beijing Anzhen Hospital between May
2018 and December 2020. All the patients were arranged to receive
baseline cardiac catheterization. Clinical status, laboratory tests,
echocardiography, and adverse reactions were evaluated.
Results: Advanced IPAH patients with NYHA FC III or IV disease
(n¼16, age 9.13±4.57 years, 10 females) received treprostinil, 9 (56.25%)
patients had a history of syncope. The right atrial pressure was
(11.00±4.77) mmHg, mean pulmonary artery pressure was
(82.27±12.37) mmHg, mean aortic pressure (80.93±17.31) mmHg, pulmonary vascular resistance index (PVRI) was (23.69±6.77) wood⋅m2,
acute pulmonary vasodilation test(AVT) was negative. The interval
between the initiation of treprostinil and the ﬁrst comprehensive
follow-up assessment was (68±34) days. The mean ﬁnal dose achieved
was 20 ng/kg/min with a range of 10- 22.5 ng/kg/min. The heart
function was improved obviously (15 with NYHA FC II and 1 with
NYHA FC III), BNP from 380.06±353.38 to 134.93±97.72 ng/L. Echocardiography showed main pulmonary artery diameter decreased
from 29.88±6.46 to 27.50±4.15 mm, tricuspid regurgitant pressure
gradient from 88.00±19.09 to 73.50±19.48 mmHg, main pulmonary artery diameter /aortic dimension ratio from 1.62±0.47 to 1.32±0.22, right
ventricular anteroposterior diameter / left ventricular end diastolic
dimension ratio from 0.94±0.56 to 0.65±0.32 (all p<0.05). In the ﬁrst 2-5
days subcutaneous treprostinil, there were 2 (12.50%) patients had the
initial pain subsides, 3 (18.75%) headache and 2 (12.50%) ﬂushing.
None stopped treatment because of intolerable.
Conclusions: Subcutaneous treprostinil infusion is an effective therapy
without serious side effects in children with severe IPAH.
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Aortic Arch Reconstruction in Infants and Young
Children
X Li
Children's Hospital, Soochow University, Suzhou, China
Background: The aim of this study was to review the surgical outcomes
of aortic arch reconstruction in infants and young children with aortic
arch anomalies.
Methods: Thirty-ﬁve consecutive patients with aortic arch anomalies
undergoing aortic arch reconstruction between 2017 and 2020 were
retrospectively reviewed. The aortic arch anatomy was either coarctation (CoA) with or without arch hypoplasia (n¼29) or interruption
(IAA, n¼6). Repair techniques were designed according to individual
anatomy based on the preoperative images and operatives ﬁndings.
Aortic arch reconstruction was performed by end-to-end anastomosis
(n¼3), extended end-to-end anastomosis (n¼16), end-to-side anastomosis (n¼5). Patch augmentation was performed in 11 cases. Nine
patients underwent left posterolateral thoracotomy, while 26 underwent median sternotomy, cardiopulmonary bypass (CPB) and circulatory arrest, of which continuous antegrade cerebral perfusion
(CACP) were performed in 19 patients.
Results: There were 22 male and 13 female. Median age at operation
was 38 days (3 days - 6 years). Twenty-six were neonates. Median body
weight were 4 kg (1.9-14.5 kg). Concomitant lesions include ventricular
septal defects (VSD, n¼15), left ventricular outﬂow tract obstruction
(LVOTO, n¼5) and other complex lesions (n¼10). Median circulatory
arrest and CACP time were 51 minutes (5-164 minutes) and 46 minutes
(25-104 minutes), respectively. Median postoperative ICU stay was 8
days (1-26 days). Four patients had delayed sternal closure and 2 patients required peritoneal dialysis. There were two in-hospital deaths
(mortality 5.7%). One neonate with ﬁfth arch coarctation underwent
emergency operation at day 3 after birth. He died from postoperative
heart failure. Another 2-month-old baby with IAA/VSD/LVOTO died
of pulmonary hypertensive crisis. Median follow-up was 18 months (138 months). Re-CoA occurred in 4 patients, one of which was treated
successfully by balloon dilatation at postoperative 5 months. Another
three were still closely followed up. One patient with CoA and double
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Fetal Pulmonary Valvuloplasty of Pulmonary Atresia
Associated With Intact Ventricular Septum With
Hypoplastic Right Heart: Mid- term Follow-up Results
G Luo, S Pan
Qingdao Women and Children's Hospital, Qingdao University, Qingdao,
China
Background: The goal of FPV is to decompress the hypertensive RV,
which can improve fetal circulation with the growth of the TV and RV,
making them amendable to biventricular repair postnatally. In the
past ten years, there has been preliminary development of fetal
cardiac interventions in China. However, there is little experience in
the indications, technical procedures, and management of complications of FPV.
Methods: This study conﬁrmed that the indicators of RV development
in fetuses with PA/IVS improved continuously after FPV was performed under ultrasound guidance. Compared to intrauterine RV
development, the tricuspid valve continues to develop rapidly after
birth, while RV development is relatively slow. Bradycardia was found
to be the chief complication of FPV.
3
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dyssynchrony indices were assessed by speckle tracking and tissue
doppler echocardiography.
Results: Upon pacing interruption, LV global systolic longitudinal
(p¼0.002) and circumferential (p¼0.026) strain, early diastolic strain rate
(p¼0.013), and mitral annular early diastolic velocity (p¼0.011) increased
signiﬁcantly. The LV systolic and diastolic dyssynchrony indices
normalized for RR interval decreased signiﬁcantly from 1.40±0.42 to
0.97±0.29 (p<0.001) and 0.59±0.32 to 0.30±0.10 (p¼0.001), respectively.
This was accompanied by signiﬁcant increase in LV early diastolic IVPG
from 0.19±0.08 mmHg/cm to 0.58±0.02 mmHg/cm (p<0.001). Log LV
IVPG was found to correlate negatively with normalized LV systolic (r¼0.42, p¼0.007) and diastolic dyssynchrony (r¼-0.47, p¼0.002) indices.
Multivariate analysis showed that age at study, gender, age at pacemaker implantation, and pacing mode were not signiﬁcant determinants of LV IVPG at baseline or during pacing interruptions.
Conclusion: Temporary interruption of RV pacing in children and
young adults with heart block acutely improves LV early diastolic
IVPG coupled with improvement in synchronicity of systolic contraction and diastolic relaxation.

outlet right ventricle (DORV) undergoing total correction in neonate
developed LVOTO and was re-operated successfully at postoperative
11 months.
Conclusion: Management of aortic arch anomalies in infants and
young children is challenging. Satisfactory results can be achieved
when individualized arch reconstruction technique is applied.
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Cardiopulmonary Exercise Test is an Important
Assessment Tool in Grown-up Congenital Heart Disease
(GUCH)
PC Chow
Hong Kong Children's Hospital, Hong Kong SAR
Background and objectives: There is increasing number of grown-up
patients with congenital heart disease (GUCH) worldwide. Functional
assessment is important to guide the management of these patients.
While many guidelines stratiﬁed the management according to functional class, however, functional class may not be objectively adequate
to determine the capacity of GUCH patients.
Methods: Parameters, including percent of predicted maximum oxygen consumption (Percent mVO2), exercise duration (ex time), ventilation CO2 production slope (VE/VCO2), of cardiopulmonary exercise
test (CPET) of 53 Chinese GUCH patients (27 male) were retrieved and
were compared among different functional classes based on New York
Heart Association functional class (NYHA) and Warnes-Somerville
Ability Index (WSAI), and among different level of complexity, and
illness severity. The comparison was made between CPET results and
quality of life (QOL) assessment (SF36-PCS and SF36-MCS).
Results: Percent mVO2 is lower in NYHA 3 than NYHA 1 (p<0.05) but
the difference between that of NYHA 1 and 2 and between NYHA 2
and 3 were insigniﬁcant. WSAI 2 has lower percent mVO2 than WSAI
1 (p<0.01). CPET parameters showed no difference among different
complexity levels. Greater illness severity had incrementally lower
percent mVO2 and higher VE/VCO2 slope (both p<0.001). Percent
mVO2 was moderately correlated with SF36-PCS and SF36-MCS
respectively (both r¼0.33, p<0.05).
Conclusions: Functional class, complexity and QOL scores are not
adequate to stratify patients with different level of cardiopulmonary
capacity. Management of GUCH patients should rely on objective
assessment using CPET.
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Effectiveness of the Transition Care Program on
Enhancing Knowledge Level Among Adolescents With
Moderate to Complex Congenital Heart Disease in Hong
Kong - Preliminary Experience
PC Chow, RHS Chen, SY Leung, KNL Ho, KS Lun
Hong Kong Children's Hospital, Hong Kong SAR
Background: Most children born with congenital heart disease (CHD)
can reach adulthood. However, they may still develop various medical
problems and need life-long follow-up care. It is essential to transfer
them to adult car settings when they grow up to ensure continuity of
care. With various differences between paediatric and adult care settings, Transition Care Program is developed for adolescents with moderate to complex CHD to enhance their knowledge on CHD and selfmanagement skills which facilitate them to manage their care in adultoriented health care settings in future. We aimed to evaluate the effectiveness of the Transition Care Program on enhancing the knowledge of
CHD and related issues in adolescents with moderate or complex CHD;
and to assess satisfaction level of the patients and their parents.
Methodology: Adolescents aged 15-18 years with moderate to complex
CHD were recruited into the Transition Care Program. Their knowledge of CHD were assessed by Congenital Heart Disease SelfAssessment Questionnaire (CHD-SAQ). Education and counselling
were provided according to their response in questionnaires. Followup sessions were provided to re-assess their knowledge and recognition of the self- management related to their CHD. Results before and
after the transition care were compared using paired t tests or
McNemar's chi-square test where appropriate to evaluate the effectiveness of the program on enhancing adolescents' knowledge of CHD
and related issues. Satisfaction level of adolescents and their parents
towards the Program are assessed by questionnaire survey.
Results & Outcomes: From July 2018 to October 2020, 52 transition
sessions were conducted for 35 adolescents. Seventeen adolescents
completed 2 sessions. After the second session, the proportion of "fully
correct" in 'name of heart defects' was increased by 17.6 percentage
points (pp) (p¼0.03), 25pp on 'name of cardiac surgeries/interventions'
(p¼0.05), and 12.5pp on 'knowledge'. There is insigniﬁcant increase in
number of respondents recognizing shortness of breath (88.2% vs
82.4%), decreased exercise tolerance (88.2% vs 82.4%) and palpitation
(76.5% vs 64.7%) as symptoms of deterioration. Mean composite score
of knowledge on endocarditis prophylaxis was improved by 63%
(p¼0.006). Adolescents girls showed increased recognition of their
pregnancy risk (from 27.3% to 63.6%, p¼0.13). Both adolescents and

135

Interruption of Right Ventricular Pacing Improves Left
Ventricular Diastolic Intraventricular Pressure Gradient
and Synchronous Relaxation
KL Chan 1, SY Kwok 1, VWY Li 2, EKF So 2, W Chuan 2,
YF Cheung 1, 2
1
Hong Kong Children's Hospital
2
Department of Paediatrics and Adolescent Medicine The University of
Hong Kong, Hong Kong SAR
Background: Right ventricular (RV) pacing is associated with left
ventricular (LV) diastolic dysfunction. We sought to determine the
effects of temporary interruption of RV pacing on LV early diastolic
intraventricular pressure gradient (IVPG) at isovolumic relaxation and
LV mechanics and dyssynchrony in children and young adults with
heart block.
Methods: 20 patients aged 20.3±9.0 who had undergone RV pacing for
heart block for at least 6 months were studied before and after interruption of RV pacing for 5 minutes. The Left ventricular IVPG was
assessed by vector ﬂow mapping while LV mechanics and
4
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Background: We reported a newborn with Calmodulin-related long
QT syndrome (CALM-LQTS) whose refractory atrioventricular block
converted to 1:1 AV conduction after intravenous lignocaine and
calcium.
Case: The post-natal ECG of a newborn with antenatal bradycardia
and intermittent 2:1 atrioventricular block (AVB) showed sinus
bradycardia, markedly prolonged QT interval, long isoelectric ST
segment and late- peaking T waves. Isoprenaline infusion did not
improve conduction abnormalities. Since the T wave morphology was
suggestive of LQT3, a bolus of lignocaine followed by infusion was
given, with conversion to transient 1:1 conduction and improvement in
metabolic acidosis (Fig 1b). However, 2:1 AVB recurred, therefore an
epicardial dual-chamber pacemaker was implanted. During VVI pacing, there was intermittent 1:1 AV conduction without and with
aberrancy followed with VVI paced beat in a trigeminal pattern. Serum
ionized calcium was <1 mmol/L, therefore intravenous (IV) calcium
bolus was given. Within a few minutes, there was 1:1 conduction with
left bundle branch pattern.
Subsequent AAI pacing had sustained 1:1 conduction. Ionised calcium
level was maintained ~1.3 mmol/L. Oral propranolol and mexiletine
were started. Genetic test revealed a novel likely pathogenic heterozygous missense variation in exon six of the CALM2 gene NM_001305624.1:c.532G>C p.(Asp178His).
Decision-making: Intravenous lignocaine and calcium was used to
terminate refractory atrioventricular block in a newborn with
Calmodulin-related long QT syndrome.
Conclusion: This report demonstrated the potential of using intravenous lignocaine and calcium to treat AV block in CALM-LQTS.

their parents showed overall satisfaction about the program (mean
satisfaction score 4.27/5 among adolescents and 4.65/5 among parents
respectively).
Conclusion: The structured transition care program helped improve
the knowledge of CHD and related issues among adolescents with
moderate to complex CHD, and achieved overall satisfaction from
patients and their parents.
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Left Buddle Branch Pacing in Paediatric Centre - Initial
Experience in Hong Kong
SY Kwok 1, KL Chan 1, NL Ho 1, J Hai 2, TC Yung 1, S Tsao 1
1
Cardiology Centre, Department of Paediatrics and Adolescent Medicine,
Hong Kong Children's Hospital
2
Division of Cardiology, Department of Medicine, Queen Mary Hospital,
University of Hong Kong, Hong Kong SAR
Background: Physiological pacing, left bundle branch pacing (LBBP) in
particular, has been increasingly used as a contemporary pacing
technique. Paediatric data is scarce.
Methods: Retrospective review of all patients who attempted physiological pacing was conducted, in our only tertiary Paediatric cardiac
centre in Hong Kong.
Results: Four patients were identiﬁed. Their demographics and clinical
details were shown in table. They were all indicated for implantation of
a new transvenous ventricular lead. LBBP was attempted, with the use
of Medtronic SelectSecure 3830 pacing lead coupled with C315 HIS
sheath.
LBBP can be successfully performed in three out of four patients. Their
acute implantation parameters were shown in table. The QRS duration
shortened after the change to LBBP system (from 172.3 ms to 92.7 ms,
p¼0.028). Echocardiogram demonstrated signiﬁcant improvement in
left ventricular synchronous contraction. Subsequent follow-up
showed stable pacing lead parameters, with a mean pacing threshold
of 1.04 +/- 0.44 V@0.4 ms.For the 4-year-old girl who failed to implant
the LBBP lead, trans- esophageal echocardiography (TEE) showed the
interventricular septum (IVS) was measured 5.4 mm in diastole. LBB
could be captured with good sensing and pacing parameters (Impedance 725 ohm, sensing threshold 21 mV, pacing threshold 1.0V@0.5
ms). 12-lead electrocardiogram showed non-selective LBBP with QRS
duration of 110 ms and LV activation time of 70 ms. TEE conﬁrmed the
lead tip was embedded inside the IVS and angiogram suggested the
lead tip was 5.2 mm inside the septum. However, dislodgement of lead
was encountered during the subsequent ﬁxation procedure. Despite
further attempts of successful relocation of LBB pacing lead, the
septum was unable to hold the engaged screwed lead with easy
dislodgement. Therefore, LBBP was changed to conventional right
ventricular apical pacing, with no complication.
Conclusion: LBBP can be successfully applied in paediatric patients
but appeared limited by the septal strength with relatively thin IVS in
very young child.
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Prenatal Ultrasound Combined With Cardiovascular
Casts Diagnose Symmetrically Complex Cardiac
Malformations in Two Fetuses
J Zhang
Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang,
China
Background: Dextrocardia with a ductus arteriosus (DA) malformation
is extremely rare. Here, we present a case of dextrocardia complicated
with a right DA that is circuitously connecting the pulmonary artery
and the right brachiocephalic artery. Coincidentally, the deformities of
this fetus are almost symmetrical with those in another fetus, which is
astonishing and meaningful. Dextrocardia is rare, complicated, and
not well understood. In this report, we carefully compared prenatal
echocardiographic images and cardiovascular casts from two fetuses.
Our report of these cases may provide new insights for cardiologists to
better understand dextrocardia and its associated malformations.
Case: A 28-year-old primigravida woman and a 25-year-old pregnant
woman (gravida 2, para 1) were referred to our maternal-fetal medical
center at gestational weeks of 23±3 weeks and 25±6 weeks, respectively, for suspected fetal heart defects. Prenatal ultrasound revealed
mirror symmetry in the hearts of each fetus. Fetal echocardiography in
the ﬁrst baby showed dextrocardia, situs solitus of the atria, an Lventricular loop, a ventricular septal defect, a double outlet of the right
ventricle (anatomic right ventricle), an L-mal/transposition of the great
arteries with pulmonary stenosis, a right DA in which the DA circuitously connects to the pulmonary artery and the right brachiocephalic
artery. The second fetus demonstrated levocardia, situs solitus, a Dventricular loop, a ventricular septal defect, a double outlet of the right
ventricle with pulmonary stenosis, a right aortic arch with mirrorimage branching, and a left DA in which the DA circuitously connected
to the left pulmonary artery and the left brachiocephalic artery. Each
fetus died in utero, one as a result of an umbilical cord knot at the
gestational age of 25±3 weeks and the other as a result of placenta
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Novel Use of Lignocaine and Calcium in Refractory
Atrioventricular Block in Newborn With Calmodulinrelated Long QT Syndrome
CKY Mak, SY Kwok 1, PC Chow 1, TC Yung 1, C Mak 1, KC Leung 1,
S Tsao 1
1
Hong Kong Children's Hospital
2
Queen Mary Hospital, Hong Kong SAR
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Background: Chronic pulmonary regurgitation (PR) in post-operative
native right ventricular outﬂow tract (nRVOT) is one of the largest
burdens on adult congenital heart disease service. Percutaneous pulmonary valve implantation (PPVI) with self-expandable valves for
dysfunctional nRVOT is a promising strategy under investigation. This
pilot study describes the feasibility of a novel self-expandable valve
with a trileaﬂet porcine pericardial tissue valve for PPVI.
Methods: This is a pilot study assessing the safety and efﬁcacy of PPVI
using the PT Valve (Med-Zenith, Beijing). Five patients who fulﬁlls
conventional criteria for pulmonary valve replacement was enrolled
with baseline cardiac MRI and ECG-gated CT performed. Two out of 5
patients were selected as pilot patients to receive the study valve after
screening, while the intention was to recruit 15 patients. CT dataset of
the RVOT were analyzed in a core lab with perimeter assessment of the
potential valve landing zone at 6 levels to determine an appropriate
valve size. Virtual simulation and trial implantation on patient speciﬁc
3D models were used to conﬁrm the suitability of the chosen valve size.
The baseline patient characteristics, procedural details, immediate
procedural success, and post-procedural acute results were
documented.
Results: Both patients were graded to have severe PR (PR fraction 44%
and 29%) with dilated right ventricle (RVEDV: 164 and 157 ml/m2); the
second patient also has signiﬁcant right ventricular (RV) dysfunction
(RVEF 20%). The procedures were performed under general anaesthesia in a biplane cardiac catheterization lab. The age at procedure
was 36 and 42-year-old respectively. Both procedures were performed
via right femoral venous access, with left femoral venous access for
angiography during valve implantation. PT valves (size 3626 and 4626)
were successfully implanted in both patients without procedural
complications. In the second patient, the distal ﬂare of the valve was
partially folded during deployment, which did not require intervention as it did not affect valve function. Procedural time was 79 and 117
minutes. Post- procedural course was unremarkable other than lowgrade fever for 3 days in the second patient with no evidence of
infection. Post procedural follow-up showed excellent valve function
and decreasing right ventricular dilatation at 1 month post procedure.
Conclusion: This pilot feasibility study on the Med-Zenith PT valve for
treatment of dysfunctional nRVOT has demonstrated good acute result
with no major adverse events. Expansion of the study and further
follow up will allow better understanding on the medium-term efﬁcacy
of the device.

previa at the gestational age of 26±2 weeks. Both families voluntarily
donated specimens to our maternal-fetal medical center. A subsequent
anatomic and cardiovascular cast for each fetus conﬁrmed the prenatal
diagnoses.
Decision-making: Dextrocardia almost inevitably is combined with
other cardiac malformations; these typically include ventricular or
atrial septal defect, pulmonary stenosis, congenitally corrected transposition of the great arteries, and hypoplasia of the pulmonary artery.
However, dextrocardia with a DA malformation is rare.
Conclusion: Fetal cardiovascular casting is a technique that can
perfectly show the microscopic deformities of a fetal cardiovascular
system, making it a good educational tool for students of congenital
heart diseases.
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Two Cases of Paediatric Cardiac Tumour With Different
Outcome
DWY Mak, YM Fu, NC Fong
Department of Paediatrics & Adolescent Medicine, Princess Margaret
Hospital, Hong Kong SAR
Background: Primary cardiac tumours are rare in paediatric population with a reported prevalence of <0.1% to 0.28%. Majority are benign
tumours and rhabdomyoma is the most common primary cardiac
tumour in childhood. They can be clinically asymptomatic but at the
other end of the spectrum, they can cause life-threatening arrhythmia,
obstruction and functional impairment; depending on the size,
numbers and location.
Case: Two newborns with incidental ﬁnding of heart murmur were
found to have cardiac tumours on echocardiogram. Case one had a
solitary lesion eventually diagnosed as cardiac ﬁbroma with speciﬁc
ﬁndings in magnetic resonance imaging (MRI); there were no associated complications. The lesion was left unresected as there was a
considerable chance of damaging the mitral valve with surgery. Case
two with multiple lesions was compatible with cardiac rhabdomyomas; and Wolff- Parkinson-White (WPW) syndrome was found on
electrocardiogram (ECG). The patient developed further clinical features of tuberous sclerosis complex (TSC) in infancy. Following the
well reported natural history, the cardiac lesions progressively
regressed with complete resolution of the rhabdomyomas as well as
the WPW around the age of two; during which he was put on everolimus for cortical tubers and recurrent seizures (after one years old).
Decision-making: Different types of primary cardiac tumours can
usually be differentiated by their clinical characteristics without going
into histopathology. MRI and relevant genetic studies are helpful tools.
Surgical resection, either total or subtotal, is the treatment of choice for
cardiac ﬁbroma. The risk of ventricular arrhythmia is high if left
unresected. The use of the inhibitor of mammalian target of rapamycin
(mTOR inhibitor) in case two may have hastened the resolution of the
cardiac rhabdomyomas.
Conclusion: Different types of primary cardiac tumours in children are
associated with different outcomes. The use of mTOR inhibitor in
symptomatic TSC-associated rhabdomyomas is currently under further
clinical studies; hopefully will be the next FDA approved indication.

CLINICAL CARDIOLOGY CASE ABSTRACTS
6

Cardiac Manifestation of Multisystem Inﬂammatory
Syndrome in a COVID-19 Patient
SY Au
Queen Elizabeth Hospital, Hong Kong SAR
Background: In April 2020, a cluster of COVID-19 children developed
hyperinﬂammatory shock similar to atypical Kawasaki disease in the
United Kingdom, and the condition was later termed multisystem
inﬂammatory syndrome in children (MIS-C). A few case reports
described similar syndrome in young adults, and now termed MIS in
adult (MIS- A). A man recently recovered from acute COVID-19 presented with possible MIS-A with cardiac involvement is presented.
Case: A 52-year-old man with good past health presented with cough,
dyspnea, and loose stool for 6 days. COVID-19 PCR was positive. He
required up to 2 L/min O2. He was given antiviral and anti-inﬂammatory medication. SAR-CoV-2 IgG was positive on day 9 of hospitalization and was discharged home on day 13.
He presented to the hospital again in 1 week after discharge (25 days
from symptom onset) with fever without localizing sign. Initial blood
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Prospective, Single Arm, Single-center Pilot Study on the
Safety and Efﬁcacy of the Sterile Transcatheter Pulmonary
Valve and Delivery System
RHS Chen, PC Chow, KS Lun, AKT Chau
Hong Kong Children's Hospital, Hong Kong SAR
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hyperthyroidism, coronary angiography could not be performed with
iodine contrast medium, gadolinium contrast medium and IVUS were
selected to exclude STEMI. Combined with the results of echocardiography and the patient's history, stress cardiomyopathy was
diagnosed.
Conclusion: The characteristics of this case are: 1. Patients with hyperthyroidism can choose gadolinium contrast medium; 2. Female's
stress, ST elevation, troponin elevation, we could not only consider
STEMI, but also consider stress cardiomyopathy.

test, CXR and vital signs were all unremarkable. Repeated SAR-CoV-2
RNA RT-PCR was negative.
On day 5 of this second admission, his condition deteriorated with
hypotension and respiratory distress. He developed rash and
conjunctivitis. Blood test showed neutrophilia, deranged liver and
renal function and increased inﬂammatory markers. (CRP 304 mg/L,
Procalcitonin 8.89 ng/mL, ferritin 154848 pmol/L). His TropI was
elevated to 1425 ng/L. ECG showed sinus rhythm with poor R wave
progression. Repeated CXR showed new cardiomegaly.
The patient was transferred to ICU on day 5. Echocardiography
showed impaired biventricular function with LVEF around 30%, with
global hypokinesia.
On day 6, coronary angiography revealed distal LAD CTO. There was
no coronary aneurysm. PCI was not proceeded in view of active
inﬂammation. Endomyocardial biopsy revealed hemorrhage and acute
inﬂammatory exudate but negative for SAR-CoV RT-PCR. The skin
rash was also biopsied and revealed mild mononuclear and lymphoplkasmacytic perivascular inﬁltrate in the dermis.
In view of possible MIS-A, he was given IV hydrocortisone, high dose
IVIG, hemodialysis with EMiC2 ﬁlter for clearance of cytokines.
His condition improved with inotropes weaned off on day 8 and
extubated on day 10. Repeated echocardiography on day 10 showed
that the LVEF improved to 50%, and the RV systolic function also
improved. The inﬂammatory markers also lowered dramatically. The
patient was discharged on day 19.
Decision making: Cardiac manifestation of COVID-19 can be related
to coronary thrombosis, myocarditis or hyperinﬂammation as in MISA. Echocardiography, coronary angiography and endomyocardial biopsy would guide appropriate treatment.
Conclusion: The cardiac involvement in COVID-19 MIS-A can be
rapidly reversible.
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Failing Right Ventricle Following Inferior STEMI - Use of
Impella RP Guided by Invasive Hemodynamic
Assessment
JYK Yeung, MKY Lee
Queen Elizabeth Hospital, Hong Kong SAR
Background: Acute myocardial infarction (AMI) complicating with
cardiogenic shock (CS) is associated with high mortality approaching
50%. Right ventricular (RV) ischemia following acute occlusion of right
coronary artery (RCA) causes depressed RV function and compromised left ventricular preload. Here, we described our ﬁrst Impella RP
use in a patient with RV failure following inferior STEMI and acute
stent thrombosis.
Case: A 70-year-old gentlemen presented to us with sudden onset of
chest pain with hypotension. ECG showed inferior ST elevation with
complete heart block. Cath lab was activated and primary PCI was
performed. Transvenous pacing was inserted. Angiography showed
acute proximal RCA occlusion. IVUS-guided PCI to RCA was performed with restoration of TIMI 3 ﬂow. Blood pressure was stabilized
with inotrope. However, he had subsequent rapidly downhill course
in CCU with recurrent chest pain, persistent CS and intercurrent
ventricular tachycardia and ventricular ﬁbrillation. Echocardiography
showed impaired LVEF 40-45%, dilated RV with reduced systolic
function. Intra-aortic balloon pump (IABP) was inserted. Repeated
angiography showed acute RCA stent thrombosis. Thrombectomy
was performed to restore coronary ﬂow. OCT showed heavy
thrombus burden but no obvious mechanical factors of early stent
failure. Coronary ﬂow was further optimized with Penumbra and
AngioJet. Unfortunately, he developed refractory CS despite volume
expansion, vasopressor support and IABP, and required escalation of
mechanical circulatory support (MCS) device. Swan-Ganz catheter
revealed a RV-dominant CS (PAPi 0.5, RA pressure 16 mmHg and
PCWP 12 mmHg). Impella RP was inserted for RV unloading. There
was signiﬁcant improvement after placement of Impella RP and
vasopressor demand was reduced. Impella RP and IABP were weaned
off on Day 6 and 7 respectively. He was discharged after a course of
rehabilitation.
Decision-making: Regardless of a lack of beneﬁt in routine use of
pulmonary artery catheter (PAC) in heart failure, growing evidence
supports the early invasive hemodynamic assessment in CS. PAC
could identify the CS phenotype and guide the escalation of medical
and device-based therapies. Our case demonstrated the use of invasive
hemodynamics to reveal a predominantly RV failure, and therefore
unload the failing RV with Impella RP.
Conclusion: Our case outlines the importance of invasive hemodynamic assessment to guide device selection. We presented our ﬁrst
experience of Impella RP as a salvage therapy in a predominant
RV failure following inferior STEMI and acute stent thrombosis.
With the evolving availability and growing experience in various
MCS devices, we aim to improve the outcomes of patients with AMI
and CS.
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Diagnosis and Treatment of an 89 Year Old Woman With
ST Segment Elevation, Fracture and Hyperthyroidism
R Wang
Wuxi No. 2 People's Hospital, Nanjing Medical University, Wuxi, China
Background: An 89 year old woman was hospitalized in orthopedics
department due to left intertrochanteric fracture with ST segment
elevation and hyperthyroidism. Gadolinium contrast medium and
IVUS were selected to complete CAG and diagnosis.
Case: A female, 89 years old, 45 kg, was admitted to orthopedics
department for "swelling and pain of left hip caused by trauma
for 1 day". Left hip X-ray showed: left intertrochanteric fracture,
with a history of hypertension, denied diabetes and heart disease
history.
Physical examination showed no abnormality. ECG: V2-6 ST segment
elevation 0.2-0.5 mv. Troponin I: 10.569 ng / ml.
Thyroid function: TSH 0.000 mIU / L↓, FT3 5.34 pmol/l, FT4 35.53 pmol/l↑.
Diagnosis:
1. Coronary artery disease
Acute anterior myocardial infarction Cardiac function I (Killip grade)
2. Left intertrochanteric fracture Coronary angiography by gadolinium
contrast medium 80 ml and IVUS examination: LM no abnormality,
LAD proximal 50% calciﬁed stenosis, middle myocardial bridge, diagonal branch proximal 50% calciﬁed stenosis, LCX distal 66%
stenosis.
Echocardiography showed that the apical beat was weakened.
Diagnosis: Stress cardiomyopathy (Takotsubo syndrome)
Decision-making: It looked like STEMI from patient's ECG and
troponin, but she had no signiﬁcant chest pain. Because of
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arrhythmias, sudden cardiac death and RV failure. However, preferential LV involvement is being increasingly recognized and presents
unique challenges in diagnosis.
Case: A 45-year-old man presented with recurrent ventricular tachycardia (VT). Four years prior, he received an implantable cardioverterdeﬁbrillator (ICD) for VT. He subsequently underwent repeated
ablation for outﬂow tract VT without success. He continued to experience episodes of VT and ICD shocks despite being on bisoprolol.
Cardiac magnetic resonance imaging (CMR) prior to ICD implantation
reported mild left inferolateral hypokinesia but no evidence of RV
dysfunction.
Decision making: Review of CMR showed intramyocardial fatty
inﬁltrate in inferior septum and inferolateral wall, although RV size
and systolic function was normal. The VT had an inferior axis and left
bundle-branch block morphology. Signal averaged ECG was positive.
The patient met 1 major and 2 minor criteria and a diagnosis of ARVC
was established four years after presentation.
Preferential LV involvement has been described and increasingly
recognized in ARVC. Some consider it as a separate entity and named
"arrhythmogenic left ventricular cardiomyopathy" (ALVC). In the
absence of RV involvement, ECG ﬁndings such as T wave inversion in
V1-3 and epsilon waves may not be apparent. Similarly, the current
imaging criteria, designed to capture RV dysfunction and dilation, may
not be applicable. Establishing the diagnosis can be challenging
especially in the early course of the disease.
Conclusion: Preferential LV involvement can be seen in ARVC and
may predate RV dysfunction.
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The Danger of DDDR
S Ching, ATK Lau, CS Yue
United Christian Hospital, Hong Kong SAR
Background: The bradycardia programming of implantable cardioverter-deﬁbrillators (ICD) deserves no less attention than antitachycardia therapies. We present a case in which DDDR pacing
triggered ventricular tachycardia (VT).
Case: A 70-year-old man presented with his ﬁrst discharge since implantation of a dual-chamber single-coil ICD for primary prevention
for ischemic cardiomyopathy three years ago. He has a history of sick
sinus syndrome. He was brisk walking and felt a shock without loss of
consciousness. ECG showed sinus rhythm and evidence of prior
anterior myocardial infarction. Device interrogation showed stable
lead parameters; other settings are shown in the Table. An episode of
VT was retrieved that corresponded to his symptom. A programming
change was then made.
Decision making: Figure shows the onset of the VT episode. The patient
was in sinus tachycardia that is faster than the maximum tracking rate.
Some of the A signals were functionally undersensed (blue arrows)
because they fell into the post-ventricular atrial refractory period
(PVARP). PVARP can be inferred from the device setting by subtracting
AV delay from maximum tracking cycle length yielding 270ms for
paced AV and 300ms for sensed AV, respectively. Sensor-driven atrial
pacing occurred at the maximum tracking rate as indicated by SIR
marker. Functional atrial loss of capture (LOC) was noted due to
competitive atrial pacing. At the beat marked by blue asterisk, the
intrinsic V signal coincided with atrial pacing falling into the post-atrial
pacing ventricular blanking period (PAVB) and was not sensed.
Following a 300 ms AV delay, ventricular pacing was delivered landing
on the T wave but hits the relative refractory period and did not capture.
Ventricular LOC was recognized by the device and a remedial spike
was delivered, capturing the ventricle but initiated monomorphic VT.
The beat that follows is a fusion beat. The VT was unresponsive to antitachycardia pacing and was only terminated with a shock. The ICD was
programmed from DDDR to DDI to minimize V wave undersensing.
Conclusion: Appropriate choice of bradycardia programming in ICD is
important to avoid V wave undersensing and device-related arrhythmia.
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Hemopericardium
After
Myocardial
Infarction
Complicated With Left VVentricular Aneurysm - Is It
Rupture?
CK Wong
Princess Margaret Hospital, Hong Kong SAR
Background: In a patient with hemopericardium after myocardial
infarction (MI) complicated with left ventricular (LV) aneurysm, how
could we deﬁnitely rule out concealed rupture, which requires emergency open repair?
Case: A 67-year-old man with hypertension and diabetes presented to
the emergency department with on-and-off chest pain starting 4 days
prior to admission. ECG showed ST-elevation over anterolateral and
inferior leads. Emergency coronary angiogram showed culprit total
occlusion of distal left circumﬂex artery (LCX); the LCX was stented
with 3 drug-eluting stents. Post-PCI, patient developed recurrent fevers, dyspnea, and atrial ﬁbrillation with rapid ventricular rate, and
was treated with intravenous antibiotics, amiodarone, and parenteral
anticoagulation. On day 10, bedside echocardiogram noted 3 cm-thick
pericardial effusion with tamponade features. Urgent pericardiocentesis yielded bloody pericardial ﬂuid. Serial echocardiogram showed
interval reduction in pericardial effusion, and a small (1 x 1 cm) outpouch at the apico- lateral LV wall, corresponding to the location of MI.
This patient remained stable with defervescence and decreasing
pericardial drain output. Contrast echocardiogram, left ventricular
cine-angiogram, computed tomography (CT) of the heart, and magnetic resonance imaging (MRI) were performed.
Decision-making: Should we send this patient to cardiothoracic surgery for suspected concealed rupture?
Conclusion: Multimodality imaging of post-MI LV aneurysm is of
paramount importance, particularly when hemopericardium is present. The decision of whether to proceed to further imaging tests depends on the acuity of presentation, the institutional availability of
each imaging test, and the clinical probability of LV rupture.

Table
A sense
V sense
A threshold
V threshold
Auto-capture
A impedance
V impedance
Shock impedance
Mode/ rate
Paced AV delay
Sensed AV delay
Anti-tachycardia therapy

2.2 mV
6.8 mV
0.5V@0.4 ms
0.75@0.4 ms
On
450 ohm
540 ohm
68 ohm
DDDR (base rate 45 bpm, max track rate 105 bpm)
300 ms
275 ms
VT: ATP x 3 then shock
VF: ATP during change then shock
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When the Right Meets the Left
S Ching, CS Yue, TS Chung
United Christian Hospital, Hong Kong SAR
Background: Arrhythmogenic right ventricular cardiomyopathy
(ARVC) classically involves the right ventricle (RV) resulting in
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degeneration and focal calciﬁcation with no evidence of infective
endocarditis. He made satisfactory recovery. CT aortogram one year
post-operatively showed residual aortic dissection distal to the origin
of the left subclavian artery to 8th thoracic vertebra level with no
progression. TTE showed good function of prosthetic aortic valve.
Conclusion: Progressive aortic root dilation, albeit the progression
being rate, appeared preceding aortic dissection in repaired TOF and
warrants regular monitoring for potential aortic dissection.
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Acute Pericarditis - A Cause Not to Be Forgotten
W Ho, TM Mok, IP Sam, YM Fan, M Evora
Centro Hospitalar Conde de S~ao Januario, Macao SAR
Background: A 26-year-old man presented to the A&E department
with a 2-week history of fever and cough and new onset of chest pain
and dyspnea for 5 days. He came from Myanmar and started working
in Macau as security since 1 year ago.
Case: Temperature at arrival was 39"C and tachycardia (HR 123 bpm)
was recorded at triage. ECG showed sinus tachycardia with diffuse
mild ST segment elevation. CXR revealed a mass like image in left
upper lung. Further Chest CT scan found multiple bulky lymphadenopathies with abscess formation in mediastinum, left supra-clavicular
and axillar region. The biggest one measuring about 7.8x4.7x4.5 cm
located in the para-aortic region. Moderate amount of pericardial
effusion was noted.
Decision-making: Diagnostic pericardiocentesis was performed and
blood tests for auto-immune diseases, tumor markers and infection
study including HIV antibodies were done. GeneXpert assays for
mycobacterium tuberculosis (mTb) from pericardial ﬂuid was reported
positive within 48 hours. HIV antibodies was reported positive 4 days
later. Lymph node biopsy revealed granulomatous lymphadenitis with
presence of acid-fast bacilli. Anti-Tb treatment with isoniazid,
rifampin, pyrazinamide, ethambutal and levoﬂoxacin were started.
Prednisolone (1 mg/kg) together with ibuprofen and colchicine were
also prescribed for prevention of constrictive pericarditis. Control
echocardiography 1 week after steroid treatment revealed thickened
pericardium with worrying sign of future constriction.
Conclusion: Tuberculous infection is no longer an uncommon cause
for acute pericarditis in the era of HIV. The role of steroid in the prevention of constrictive pericarditis is still inconclusive.
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Post Infarct Left Ventricular Aneurysm Presented With
Malignant Arrhythmia: Management Decisions and
Endocardial Scar Resection
ATC Chang, JYK Ho, K Lim, JWY Chan, SCY Chow, MWT Kwok,
RHL Wong
Division of Cardiothoracic Surgery, Department of Surgery, Prince of Wales
Hospital, Hong Kong SAR
Background: Post infarct left ventricular (LV) pseudoaneurysm is lethal, caused by the mechanical and functional complications including
malignant arrhythmia caused by the endocardial scar tissue. We reported a case of post infarct LV apical aneurysm presented with malignant ventricular tachycardia (VT). Management decisions pathway
and on table decisions of surgical aneurysmectomy with endocardial
scar resections are discussed.
Case: A 76-year-old lady with no family history of sudden death was
admitted for palpitation and chest discomfort for 2 days. Non-sustained ventricular tachycardia was noted on presenting electrocardiogram (ECG) with elevated troponin. Echocardiography and
computed tomography revealed a large LV apical aneurysm of 3.8cm
with a narrow neck. Coronary angiogram showed a signiﬁcant 70%
stenosis over the distal left anterior descending artery.
The non-sustained VT was recurrent, electrical cardioversions and
amiodarone infusion were attempted to stabilize her status. However,
suspected a large scar tissue load, the hemodynamic signiﬁcant nonsustained VT was not completely controlled; hence an intra-aortic
balloon pump (IABP) was inserted and emergency surgery was
offered. Intra-operatively, the LV aneurysm was identiﬁed and resected together with scarred endocardium under cardiopulmonary
bypass. Defect was repaired with bovine pericardium. The postoperative recovery included continuous inpatient telemetry monitoring showed no single recurrence of arrhythmias. Reassessment CT
showed no residual LV aneurysm. Discharged on post-op day 8 with
the follow-up ECG in sinus rhythm.
Decision-making: Left ventricular aneurysm is a mechanical complication from myocardial infarction associated with arrhythmia. The
decision making based on early diagnosis, workup and stabilization for
surgical repair. The communication between medical and surgical
teams shed light on decision makings in these cases.
The acute presentation of post infarct pseudoaneurysm, size of the
aneurysm and the presence of recurrent non-sustained VT are the
major clinical determinants. Survival is better with surgical treatment
in large LV aneurysm with less recurrence of mechanical and functional complications.
Another crucial decision was on endocardial scar resection, which
aimed at eliminating the arrhythmogenic foci and consequently to
lessen the recurrent arrhythmias. The intraoperative decision to resect
till normal myocardium was reﬂected a correct decision with the patient having no recurrence of VT.
Conclusion: In conclusion, acute post infarct LV aneurysm carries
signiﬁcant risk of fatal complications. Emergency operation should be
offered with endocardial resection to lower post-operative recurrence
of arrhythmias and might prevent the need for implantable cardioverter deﬁbrillator.
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Aortic Dissection in a Chinese Patient 31 Years After
Surgical Repair of Tetralogy of Fallot (TOF)
PC Chow, BA Rocha, TWK Au, TC Yung
Hong Kong Children's Hospital, Hong Kong SAR
Background: There has been increasing concern of aortic involvement
on long-term follow-up of various congenital heart diseases especially
tetralogy of Fallot. Serious complication of aortic dissection can
develop, although the prevalence is estimated to be low.
Case: A male patient with surgical repair of TOF at 4 years-old remained
asymptomatic on follow-up. Serial CMRI as part of follow-up protocol,
at 29 years-old and 32 years-old respectively, revealed mild dilation of
right ventricle, satisfactory right ventricular function, mild pulmonary
regurgitation, but mild interval growth of aortic root dilation from 4.8 cm
to 5.1 cm. Losartan was started, but he defaulted follow-up and stopped
losartan. He returned to follow-up at 35 years-old and reported intermittent chest discomfort for few months. BP was normal (114/64
mmHg). TTE showed markedly dilated aortic root (7.96 cm) with a ﬂaplike structure. Urgent CT aortogram revealed aortic dissection extending from ascending aorta just distal to the aortic valve to the descending
thoracic aorta at the level of 9th thoracic vertebra. He showed no feature
of Marfan syndrome and negative family history of aortic dissection.
Decision-making: Bentall operation was urgently performed. Intraoperatively, a dissecting ascending aortic aneurysm with a tear just
above the non-coronary cusp commissure was found. Histology
showed the dissection ﬂap involving the outer third of the aortic wall
and small pools of mucin within the elastic lamina, compatible with
cystic medial degeneration. Histology of aortic valve showed myxoid
9
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Hispanic colleague. Trypanosoma cruzi antibody was ordered and
returned positive a few weeks after our patient was discharged. On an
outpatient follow-up visit with cardiology a nuclear stress test was
successfully performed which conﬁrmed the presence of a myocardial
scar involving the basal and inferolateral walls consistent with Chagas
cardiomyopathy. He was referred to infectious diseases specialist who
decided against anti-parasitic therapy after weighing beneﬁts and
risks. Patient continues to be treated for heart failure according to
standard guideline and is currently under consideration for implantable cardioverter deﬁbrillator (ICD) and pacemaker to prevent sudden
cardiac death.
Conclusion: This case underscores the importance of taking into
consideration patient's immigration background in approaching diseases with unusual presentations. In addition, cardiac or gastrointestinal symptoms in a patient from Latin America should prompt
consideration of chronic Chagas disease.
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Rare Presentation of Ball Valve Thrombus in Right
Atrium
A Kumar 1, P Zare 2, P Vaideeswar 2
1
Seth GSMC and KEM Hospital
2
Department of Pathology (Cardiovascular & Thoracic Division), Seth GS
Medical College & KEM Hospital, Mumbai, India
Background: Cardiac thrombi are mostly seen on the left side of the
heart. In a setting of rheumatic heart disease, it assumes a ball valve
conﬁguration in the left atrium. Such a thrombus is a rare occurrence
in the right atrium (RA).
Case: A 32-year-old female, 3 months post-partum came to our tertiary
care center with the chief complaints of left lower limb swelling since a
month and acute-onset dyspnea NYHA class III since 1 day. Imaging
studies revealed deep vein thrombosis (DVT) of external iliac, femoral
and popliteal veins and pulmonary thrombo-embolism with ball valve
thrombus in RA. A bad past obstetric history and positive anti-cardiolipin antibody (IgM titer 32.3) hinted towards a possibility of antiphospholipid antibody syndrome.
Decision making: Pulmonary thrombo-embolectomy was performed
by median sternotomy and cardiopulmonary bypass. A right atriotomy
revealed a 2.8 cm, pebble-shaped, smooth-surfaced, white, free
ﬂoating thrombus and an irregular 1.5 cm thrombus attached to the
chordae of the septal tricuspid leaﬂet (causing mild tricuspid regurgitation). Histo- pathological examination conﬁrmed an organized
thrombus with focal calciﬁcation. An infra-renal inferior vena caval
(IVC) ﬁlter was inserted. She had an uneventful recovery and was
advised follow-up in a rheumatological clinic.
Conclusion: Ball valve thrombus occurring in RA is an exception. Our
patient underwent surgical thrombo-embolectomy with good surgical
outcome with IVC ﬁlter insertion and appropriate anti-coagulation.
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An Unusual Left-ventricular Mass
J Fang
Queen Mary Hospital, Hong Kong SAR
We present a case of culture-negative infective endocarditis presenting
as a left ventricular mass. A 52-year-old man presented with acute
onset right lower limb weakness for 2 days. He was afebrile Physical
examination was unremarkable except for reduced power 4/5 in the
right lower lip. There was no murmur audible on auscultation. The
magnetic resonance imaging of the brain revealed multiple infarcts. A
workup for cardioembolic stroke was performed. An electrocardiogram showed sinus rhythm. An echocardiogram showed a 2.8 cm mass
in the left ventricle attached to the inferior wall and trivial mitral
regurgitation. Six sets of blood culture were negative. Serology for
Coxiella Bartonella chair related. Immune markers were negative. The
mass was excised to prevent further embolization. Pathology revealed
microabscess formation and inﬂammation. Tissue culture was negative. Polymerase chain reaction on the tissue was positive for Streptococcus. The patient completed 6 weeks of antibiotics. The case
highlights an atypical presentation of infective endocarditis and the
need of a high index of suspicion.
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An Unexpected
Cardiomyopathy

Cause

of

Heart

Failure:

Chagas

J Chang, M Yu, G Zou, W Perdomo, K Lin, J Burdowski
Danbury Hospital, Danbury, United States
Background: Chagas cardiomyopathy is a classic ﬁnding of advanced
Chagas disease due to chronic infection by the protozoan parasite
Trypanosoma cruzi and can result in progressive heart failure, arrhythmias, and sudden cardiac death caused by destruction of the
heart muscle and its nervous system.
Case: An 83-year-old male who recently emigrated from Ecuador to
the U.S. came to the emergency room because of worsening shortness
of breath for 2 weeks. He has no signiﬁcant medical history in the past.
A diagnosis of new-onset heart failure was made and treatment with
diuretics was initiated. Initial electrocardiogram (ECG) revealed
frequent premature ventricular contractions and bifascicular block
with right bundle branch block and left anterior fascicular block.
Echocardiogram showed ejection fraction (EF) of 25-30%, global left
ventricular dysfunction, and interventricular septal motion that was
consistent with conduction abnormality. Additional studies to evaluate
for ischemic cardiomyopathy including nuclear stress test and cardiac
catheterization could not be performed at the time as patient was very
restless and unable to lay still. He subsequently developed supraventricular tachycardia (SVT) and had to be placed on high-dose betablocker. Also, a restrictive diet had to be introduced because of
frequent aspiration episodes. Eventually he was discharged on medications for heart failure and rate-control.
Decision-making: Given his strange symptoms and recent immigration history, we decided to test for Chagas disease on the advice of a
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A Case of Coronary Artery Perforation During PCI in a
Post CABG Patient, A Devastating Complication
A Ali
Metro Hospital, India
Background: A patient undergoing coronary angioplasty with a history
of coronary artery bypass surgery is very vulnerable to mortality if the
coronary artery gets perforated. These patients can develop localized
pericardial effusion which may be very difﬁcult to tap.
Case: A 65-year-old Asian man presented with new-onset angina. He
underwent CABG three years back by putting LIMA to LAD and SVG
to PDA grafts. The patient's electrocardiogram revealed T wave
inversion in inferior leads. An echocardiogram showed inferior wall
hypokinesia with an ejection fraction of 45%. Coronary angiogram
revealed patent LIMA to LAD and occluded SVG to PDA graft. LCX
had proximal CTO, RCA revealed signiﬁcant proximal stenosis. PTCA
to proximal RCA was done successfully.
Decision making: PTCA to LCX was done by antegrade wire escalation
technique by putting one DES. After post dilatation of stent, the patient
had ELLIS class III perforation. Immediately perforation was sealed by
10
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balloon inﬂation and pericardiocentesis was performed due to hemodynamic compromise. We tried to place one covered stent but it
was not able to cross the lesion. Then we used guidezilla to cross the
covered stent but unfortunately, it was also not going in LCX. Then we
used balloon-assisted advancement of guidezilla (telescoping method)
in LCX and successfully placed a covered stent to seal the perforation
with the acceptable distal ﬂow.
Conclusion: Coronary artery perforation is a very rare but catastrophic
complication during angioplasty. Patients with a history of bypass
surgery can develop localized tamponade due to adhesions. In the case
of coronary perforation, impending cardiac tamponade requires rapid
and accurate measures by the interventionist, at the risk of emergency
surgery or death of the patient. In this case, patient developed coronary
perforation after post dilatation of stent, which was successfully treated
by putting covered stent with the help of guide catheter extension.

NQ Wu, YG Sui, YL Xu, J Qian
Department of Cardiology, Fuwai Hospital, Peking Union College, Beijing,
China
Background: Coronary rotation is very effective to facilitate the procedure of coronary calciﬁcation lesion intervention. However, in some
condition, the procedure is not very smooth even after coronary
rotation.
Case: A 68-year-old man was admitted to Fuwai Hospital with
paroxysmal chest discomfort for 3 years. Coronary angiography was
performed for him to show that distal left anterior descending (LAD)
total occlusion with severe calciﬁcation of proximal LAD. 7F EBU3.5
guiding was engaged to the ostial of left main (LM), fortunately soft
wire passed through the total occlusion of LAD. We used post-dilation
balloon to dilate the lesions including distal and proximal parts,
however, the balloon couldn’t expand fully at the site of severe calciﬁcation, and coronary dissection was found in the middle of LAD.
Coronary rotation was performed by using 1.5 burr for 10 rounds. Two
stents were implanted from the distal to proximal of LAD with Firebird2 2.5*13 mm and Firebird2 3.0*26 mm.Unfortunately, maximal
lumen area (MLA) of the most stenosis part of the proximal stent was
only 2.51 mm2.
Decision-making: We tried to settle it by tolerated-high pressure
balloon dilation on the site of insufﬁcient expanded stent, however we
failed. So we chose excimer laser ablation for severe calciﬁcation
lesion, MLA of most stenosis part of the stent became 4.77 mm2.
Conclusion: Excimer laser is a good choice to treat stent insufﬁcient
expansion at the site of severe coronary calciﬁcation after coronary
rotation.
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A Tough One to Crack
JCY Lee
Grantham Hospital, Hong Kong SAR
Background: Our patient is a 75 year-old lady from Grantham Hospital, who has a history of DM, hyperlipidaemia and ischaemic cardiomyopathy (LVEF 35%). She is known to have triple vessel disease,
with multiple PCIs done before. She presents to us for persistent
angina after a recent PCI attempt. We present a case of Impellaassisted PCI with atherectomy to an un-dilatable ISR lesion.
Case history: Our patient has a long history of CAD. PCI was done to
LAD and LCX in 2000, and repeated to LAD, RCA in 2007. PCI was
done again in 2009 and 2019 to RCA ISR. She was also found to have a
LCX-OM1 CTO in 2019, which was successfully re-vascularised. Most
recently, she had an episode of NSTEMI in August 2020. The coronary
angiogram showed mild dLM stenosis, mLAD 80% calciﬁed ISR, LCX
patent stents, and a long diffuse 50% RCA ISR. PCI was targeted towards the mLAD ISR. However, the lesion was un-dilatable despite
high pressured OPN balloon inﬂation and Shockwave treatment, so
much so that we could not pass an IVUS. Hence, we decided that
stenting was not suitable, and proceeded with DCB to the lesion. The
ﬁnal angiogram showed a residual 50% mLAD ISR.
During follow up, the patient complained of having persistent angina,
requiring regular TNG. She refused CABG after discussion. In view of her
poor LVEF and anticipated difﬁcult procedure, we decided to perform a
complex, high risk PCI with atherectomy under Impella support.
Decision making: During the procedure, we ﬁrst set up the Impella
device, and proceeded to lesion preparation. Since the patient had
already failed balloon-based atherectomy and also Shockwave therapy,
we decided to prepare the mLAD ISR using Diamondback device.
Although it was successful, during subsequent balloon pre-dilation, the
patient developed severe hypotension and required resuscitation. After
stabilisation, the lesion was stented with a DES. During post-dilation,
the patient developed severe hypotension again, which resolved after
reperfusion. IVUS showed excellent results. In view of unstable haemodynamics, we decided to conclude the procedure at that point.
Conclusion: This case illustrates the importance of mechanical circulatory support in high risk patients, such as those with poor LV function, multi-vessel disease or difﬁcult coronary anatomy. It also
highlights the need for out-of-the-box thinking and off-label use of
newer technologies in difﬁcult ISR lesions.
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Multimodality Imaging To Guide Transcatheter Edge-toedge Repair in a Patient With Severe Symptomatic
Atrial Functional Mitral and Tricuspid Regurgitation
EKY Chan, SCC Lam, YM Lam
Queen Mary Hospital, Hong Kong SAR
Background: Transcatheter edge-to-edge repair is proven to confer
survival beneﬁts in patients with severe functional mitral regurgitation
secondary to LV dysfunction despite medical therapy. It is recently
proven to be feasible in patients with severe functional tricuspid
regurgitation.
Case: We described a successful percutaneous repair in an 81-year-old
patient with atrial ﬁbrillation, gross bi-atrial enlargement (LA area 58.0
cm2 and RA area 75.3 cm2), severe symptomatic atrial functional mitral
and tricuspid regurgitation due to dilated mitral and tricuspid annuli.
The patient had been repeatedly admitted for acute pulmonary edema,
ascites and limb edema, signifying biventricular heart failure despite
best medical therapy. Echocardiogram showed severe (4+) MR and TR
with systolic ﬂow reversal in pulmonary and hepatic veins. After heart
team discussion, she was brought to the cath lab.
Decision-making: Under TEE guidance, two MitraClip devices (NTW
and NTR) were deployed in the medial (A3-P3) and central (A2-P2)
scallops with MR reduction to 1+. The same delivery system was used
in the TV using a "miskey" technique. However, due to grossly
enlarged atria, the TV was in the far-ﬁeld rendering TEE image quality
unsatisfactory. Transthoracic echocardiogram yielded better imaging
quality of TV but failed to produce excellent grasping view of the
anteroseptal commissure. Eventually clipping of TV anterior & septal
leaﬂets was performed with an XTW device under intracardiac echocardiogram and ﬂuoroscopic guidance, reducing TR to 2+. She remains
in NYHA class 1.
Conclusion: Multimodality imaging is essential in contemporary
structural heart interventions.
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How to Treat Stent Insufﬁcient Expansion at the Site of
Severe Coronary Calciﬁcation After Coronary Rotation?
Excimer Laser Ablation is a Good Choice
11
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strategies, retrograde ablation and wire bias for instance, are necessary
in such condition to avoid severe complication and improve outcome.
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Acute Stent Thrombosis
K Dinsi
Hospital Queen Elizabeth 2, Kota Kinabalu, Malaysia
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Novel Management for Coronary Perforation During
Chronic Total Occlusion Percutaneous Coronary
Intervention

A 59 years old gentleman, non-smoker admitted for non-ST elevation
Myocardial Infarction.Coronary angiogram shows dual vessel disease
with LAD eccentric 50% ostial disease and midsegment 90%tandem
lesions involving Diagonal 1 which was directly stented and The LMSLAD bifurcation was also treated with a stent (T-stenting). Patient was
well throughout admission and discharged well with triple therapy
(Started on Warfarin as developed paroxysmal Atrial Fibrillation in
ward) with plan for surveillance coronary angiography in 6 months.
However patient developed recurrent chest pain 10 days after
discharge and presented with acute anterolateral Myocardial Infarction and rushed to the Intervention Cardiac Lab (ICL) for primary PCI.
Intra-procedure noted large thrombus in distal LAD stent as evidence
of acute stent thrombosis. Proceeded with thromboaspiration with
Export Advanced Aspiration catheter which was successful and distal
LAD subsequently treated with drug eluting balloon. This case served
as a good and typical case presentation of acute stent thrombosis and
should be swiftly recognized as one of the major complications after
coronary angioplasty that demanded urgent cardiology intervention.

NCY Mui, STS Chung
United Christian Hospital, Hong Kong SAR
Background: Mr Hung was arranged for elective coronary angiogram
due to recent non-ST elevation myocardial infarction with reduced
LVEF.
Case: He was a 70-year-old ex-smoker with hypertension, diabetes and
hypercholesterolaemia. Echocardiography showed LVEF 45% with left
ventricular anterolateral hypokinesia. Coronary angiogram showed
right- side dominance, proximal LAD CTO with retrograde collateral
ﬂow from RCA via septal branches. Proximal LCX and RCA were
mildly stenosed. The CTO segment was calciﬁed and >20 mm long (JCTO score: 2). Seven French EBU 3.5 and 6 French AL 0.75 guiding
catheters via bilateral femoral arteries were used. Unsuccessful antegrade approach by UB3, Gaia ﬁrst and Conquest Pro wires with
Turnpike microcatheter, followed by retrograde approach by Sion wire
with Caravel microcatheter. Subsequent antegrade angiogram showed
type 3 coronary perforation via subintimal space created by antegrade
wires. The perforation was failed to be closed by intermittent prolonged low pressure inﬂation of 1.25 mm semi-compliant balloon. A 5
mm Vicryl absorbable braided suture was advanced through Turnpike
and deployed before
perforation by UB3 wire. Coronary angiogram 1-2 minutes after suture
deployment showed successful closure of perforation. Pericardiocentesis was performed for impending cardiac tamponade. Vital
signs were all along stable, pericardial drain was removed on postprocedure day 2 and patient was discharged on day 5.
Decision-making: The mechanism of type 3 coronary perforation
proximal to CTO is similar to type 5 perforation. Suture is readily
available at extremely low cost; it's easily prepared, handled and
administered compared with autologous fat or blood clot. The CTO
anatomy is least affected by absorbable suture, hence facilitating
subsequent reattempt intervention, compared with covered stent or
coil embolization.
Conclusion: Absorbable suture embolization provides a perfect option
for managing coronary perforation proximal to CTO lesion, due to its
unique properties and the special coronary anatomy.
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Orbital Atherectomy for Calciﬁed Ostial Lesion
NCY Mui
Catheterization Laboratory, United Christian Hospital, Hong Kong SAR
Background: Mr Yu was admitted for elective coronary angiogram for
stable angina with suspected 3-vessels disease by CTCA.
Case: He was a 76-year-old gentleman, who was an ex-smoker with
hypertension, diabetes and hypercholesterolaemia. Echocardiography
was unremarkable.
Coronary angiogram showed right-side dominance, mild left coronary
disease, heavily calciﬁed ostial right coronary critical stenosis. 6 Fr JR 4
guiding and NS runthrough were used. IVUS advancement was failed
initially, hence ostial lesion was predilated with 2.5 mm semicompliant balloon. IVUS showed diffuse eccentric calciﬁcation with 2
mm thick calciﬁed nodule and ostial MLD was 2 mm. Ostial vessel size
was 5 mm, distal reference size 4.5 mm.
Orbital atherectomy at low then high speed, in 8 runs totally, was
performed in retrograde fashion, afterwards with the aid of disengaged and caudally displaced JR guiding to achieve wire-bias inferiorly. Type 3 dissection was noticed at ostium. Further predilatation
with 4.0 non- compliant balloon. Ostial-to-proximal RCA was stented
with 4.0x33 mm DES, which was postdilated with 4.0 mm and 4.5 mm
non-compliant balloons. Final angiogram showed satisfactory result
with completely sealed off dissection.
Decision-making: Orbital atherectomy was chosen because outcome
of balloon angioplasty is unlikely satisfactory, the maximum rotational
burr size was only 1.5 mm in the laboratory, and eccentricity and
calciﬁed nodule predicted unfavourable outcome and perforation for
rotational atherectomy. Retrograde atherectomy avoided unconstrained orbit resulting in severe ostial injury. Absent pitch change
after only 1-2 runs during coaxial and superior alignment of JR guiding
indicated inferior eccentricity of the calciﬁed nodule, inferiorly-biased
orbital atherectomy resulted in excellent calciﬁed nodule ablation.
Regular angiogram or intracoronary imaging is necessary in between
orbital atherectomy, especially for ostial lesion, to prevent tragedy.
Conclusion: Orbital atherectomy generates satisfactory outcome for
ostial lesion with heavy calciﬁcation and calciﬁed nodule. Speciﬁc
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His Bundle Pacing is a Feasible and Physiologic
Alternative in Patients With Congenitally Corrected
Transposition of Great Arteries
MH Ho, YW Cheng, TC So, CY Wong, CL Fu, KC Chan, SF Chui,
CF Tsang, YH Fong, MH Wong, CS Chiang, CB Ho, PH Lee,
C Leung, YK Yeung, MY Chim, KY Lee
Queen Elizabeth Hospital, Hong Kong SAR
Background: Complete heart block is prevalent among patients with
congenitally corrected transposition of great arteries (CCTGA). However, the optimal pacing strategy in this group of patients remained
unknown.
Case: A 65-year-old man with CCTGA and situs solitus had history of
atrial septal defect and ventricular septal defect repair and pulmonary
valvotomy done in 1976. He had long-standing complete heart block
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Case: The patient was an 87-year-old woman with diabetes mellitus,
hypertension, atrial ﬁbrillation (AF) on reduced dose ApixabanTM and
chronic kidney disease, who presented with sudden chest pain and an
electrocardiogram (ECG) showing posterior STEMI. She was in
cardiogenic shock requiring inotrope and temporary transvenous
pacing support. Baseline clotting parameters were normal. Echocardiogram showed dilated right ventricle, fair left ventricular systolic
function and moderate functional mitral regurgitation.
Urgent coronary angiography showed saddle thrombus in distal LM
and total thrombotic occlusion of left circumﬂex artery (LCX) with
TIMI-0 ﬂow. The left anterior descending artery (LAD) had a proximal
thrombus with TIMI-3 ﬂow. The rest of LAD and right coronary artery
had mild disease. Mechanical thrombectomy via LCX wire with
PenumbraTM catheter was attempted and met with resistance and the
patient developed pulseless electrical activity arrest. Angiogram
showed clot plowing effect to LAD with reduced ﬂow. Thrombusaspiration to LAD was performed with ExportTM catheter and there
was return of spontaneous circulation. Ping Pong guiding technique
was adopted to protect the LAD with another wire. Intravascular ultrasound (IVUS) to LAD showed ostial LCX clot protruding into distal
LM and ostial LAD and no dissection and minimal plaque burden over
LAD. Multiple passes of thrombectomy resulted in repeated clot
dislodgement to LAD with subsequent blood pressure drop, while the
thrombus reduction in ostial LCX remained angiographically
insigniﬁcant.
Decision-making: We thought PenumbraTM catheter was the most
powerful thrombectomy device and considered options of simple
ballooning or direct stenting. However, the attempt of balloon dilatation of ostial LCX resulted in another blood pressure drop.
We ﬁnally decided to switched to Pronto V4TM thrombus aspiration
system, which is a simple extraction catheter allowing manual suction.
Pronto catheter was advanced through LAD and successfully removed
ostial LCX and ostial LAD clots with TIMI-3 ﬂow achieved in both
vessels. IVUS showed no signiﬁcant lesion in distal LM, ostial LAD and
LCX, conﬁrming a thromboembolic event.
Conclusion: Simple manual clot aspiration may be a good option for
selected patient. The ability to continuously reﬂect and explore
possible options with an open mind is the key for a successful intervention.

but refused permanent pacing previously. Patient developed dyspnea
and decreased exercise tolerance 6 months ago. Cardiac MRI showed
CCTGA without residual ASD or VSD, with right ventricular ejection
fraction 54% and right ventricular end diastolic volume index 167 ml/
m2. Coronary angiogram showed no signiﬁcant coronary artery disease. ECG revealed junctional escape rhythm at 44 beats per minute.
Patient ﬁnally agreed for pacemaker implantation.
Decision-making: We proceeded to permanent pacemaker implantation with left cephalic cut-down approach. Intra-operatively, patient
was noted to have atrial ﬁbrillation. Cardiac monitor guided selective
His bundle pacing was successfully performed. The paced QRS
duration was the same as preoperative intrinsic QRS. The threshold of
His lead was 0.5V at 0.4 millisecond postoperatively and remained the
same 5 months post implantation. NYHA class was improved.
Conclusion: His bundle pacing in patient with CCTGA and chronotropic incompetence is feasible without electroanatomical mapping
system.
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Retrieval of Dislodged Stent During Bifurcation Stenting
in a Calciﬁed Lesion
D Tiwari
Metro Hospital, Jabalpur, India
Background: Complications during percutaneous coronary interventions in a calciﬁed bifurcation lesions are high including stent
dislodgement but successful retrieval and completion of procedure is
satisfying.
Case: 66 years, gentleman, hypertensive, had h/o ACS 4 months back,
coronary angiography revealed critical LAD and LCx-OM bifurcation
lesions with calciﬁcation. In view of persistent symptoms and no willingness for CABG, PCI planned. PCI to LAD done uneventfully. During
LCx-OM bifurcation PCI, stent bed prepared with sequential pre-dilatation by different sized balloons with the help of Guidezilla guide
extension catheter (6F, 120cm, Boston Scientiﬁc). During stent (3x24 mm
Ultimaster DES, Terumo) delivery, the stent got dislodged. Fortunately
some part of dislodged stent remained inside the Guidezilla.
Decision-making: Another 0.014" coronary guidewire put across the
deﬂated dislodged stent and then anchored by the 2x12 mm semi
compliant balloon inside the guide extension catheter and whole assembly including the guiding catheter (7F' Extra Back Up) pulled out.
Subsequently successful bifurcation PCI done using two Abluminus
DES (Concept medical) 3.0x16 mm in LCx to OM and 2.75x12 mm in
LCx with T and Protrusion (TAP) technique. Final kissing balloon and
proximal optimization done with good end results.
Conclusion: Complications are the part and parcel of the cardiac interventions but one should know how to bailout. Use of guide extension catheter makes the things simple and should be used frequently if
required.
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When a Coronary Hardware Became an Innovator in
Peripheral Intervention - Failed AV Fistula Successfully
Treated With OPN NC Balloon in a Fibrotic Lesion
M Sudhakar Rao, R Padmakumar
Kasturba Medical College, Manipal, India
Background: We describe a novel technique where a coronary hardware OPN NC balloon has been used in venous interventions like
arterio- venous(AV) ﬁstuloplasty to break the ﬁbrotic lesion and led to
successful intervention.
Case: 62 year old male known diabetic and chronic kidney disease
(CKD) on maintainance hemodialysis came with inadequate ﬂow
during dialysis and loss of thrill. Fistulogram after initial Doppler
revealed signiﬁcant stenosis at right brachiocephalic ﬁstula at anastomotic site. The stenosis was initially dilated with low pressure 6*40
balloon which did not yield at anastomotic site. Subsequently 5*40
high pressure Bard balloon at 30 ATM, 6* 40 high pressure Mustang
balloon at 20 ATM and 8*40 high pressure Mustang balloon at 22 ATM
were used to dilate the lesion but did not yield. We tried to break the
ﬁbrotic lesion with high pressure OPN NC 3*10 at 36 ATM following
which 8* 40 Mustang yielded at 22 ATM. A good ﬁstula ﬂow and
palpable thrill was achieved.
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Back to Basic
J Shek, YH Tang, HC Yuen, PT Tsui
Princess Margaret Hospital, Hong Kong SAR
Background: Though not recommended routinely in primary percutaneous coronary intervention (PCI), thrombus aspiration might be a
cornerstone treatment for patient's survival. We report a case in which
very difﬁcult intracoronary thrombectomy was successful for STsegment elevation myocardial infarction (STEMI) due to a huge
intracoronary saddle embolus in distal left main (LM).
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Decision making: As both low and high pressure balloons failed to
open the lesion, we thought of using coronary hardwares which
are traditionally used for ﬁbrotic and calciﬁed lesions. Initially we
tried to open the lesion with 4 mm non compliance balloon at
high pressures however it did not yield the ﬁbrotic lesion. So a 3 mm
OPN NC was used which broke the ﬁbrotic lesion at 36 ATM
following which a 8 mm high pressure balloon successfully opened
the lesion.
Conclusion: Fibrotic and calciﬁed lesions in peripheral interventions
are difﬁcult to treat and not many devices are currently available for
the same. AV Fistula remains an important access in management of
patients with CKD and every attempt should be made to keep it patent.
Here we describe one such case where a coronary hardware was used
to manage ﬁbrotic lesion in a highly stenotic AV ﬁstula. This marks an
innovation and remains the ﬁrst documented case in literature where
an OPN NC balloon was used for managing a ﬁbrotic lesion in a peripheral intervention. This case opens the ways for its use in future
management of such cases.
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A Case of Left Main Trifurcation PCI Loaded With
Complications
K Mahajan
Indira Gandhi Medical College, Shimla, India
Background: Left main trifurcation PCI is a complex procedure which
needs to be done with great caution and expertise.
Methods: A 58 years old male presented to us with class 3 exertion
angina and was taken up for coronary angiogram which revealed
critical disease of ostial LMCA, and 70% stenosis of ostioproximal LCX.
LAD and rams were normal. Plan was to do LMCA-LCX Stenting
(provisional Stenting approach).
Decision-making: Immediately after Stenting from LMCA to LCX,
after adequate bed preparation, we realised that there is a new stenosis
distal to stent. On IVUS it revealed a stent edge dissection with
intramural hematoma. So another stent was deployed distally. After
that the Ramus got severely pinched, which needed to be dilated.
However, at this momental hardware came out. That was a tricky situation as we were not able to re-engage the guiding catheter because
of excessive postal protrusion of left main stent. We decided to crush
the ostial part of stent and then proceeded with wires in all three
branches. Then Stenting to Ramus was done using TAP technique,
followed by triple kissing inﬂation. This was followed by another
LMCA stent across the uncovered LMCA ostium.
Conclusion: This case was full of complications at all steps. While
attempting such complex cases, interventional radiologist should
anticipate all possible complications and must be well versed with
handling them. Intravascular imaging is of paramount importance.
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Complete Surgical Removal of a Left Atrial Appendage
Occlusion Device Complicated by Persistent Device Related Thrombosis
S Chow 1, J Ho 1, K So 2, G Cheung 2, E Wu 2, R Wong 1
1
Division of Cardiothoracic Surgery, Department of Surgery
2
Division of Cardiology, Department of Medicine, The Chinese University
of Hong Kong, Prince of Wales Hospital, Hong Kong SAR
Background: Surgical removal of a left atrial appendage occlusion
(LAAO) device complicated by device related thrombosis (DRT) is
rare, and complete removal of the device can be difﬁcult. We present a
patient with progressive DRT of the AMPLATZER™ Amulet™ device
which required removal with open heart surgery.
Case: The patient was a 76 year old lady with a history of non-valvular
atrial ﬁbrillation and ischemic stroke. The CHA2DS2-VASc score was 7
and she was started on warfarin. Subsequently she was diagnosed with
idiopathic thrombocytopenic purpura and was offered percutaneous
LAAO. The Amulet™ device was implanted successfully and she was
discharged with aspirin and clopidogrel. Routine transesophageal
echo 2 months post procedure found a 3x1.9 cm thrombus attached to
the disc of the device. The thrombus persisted for 3 years despite
adequate anticoagulation with warfarin and aspirin, and progressively
enlarged after substituting warfarin with dabigatran. Open surgical
removal of the thrombus via median sternotomy was performed.
Intraoperatively, immature thrombus was removed from the disc of
the Amulet™ device and complete removal of the device was smooth.
The left atrial appendage was closed externally by a surgical clip. The
patient recovered uneventfully and was discharged 7 days post
operation.
Decision-making: The progressive nature of the thrombus warranted
exclusion of the LAAO device from the left atrium. This could be
achieved either by complete extraction of the device or by covering the
disc with a pericardial patch. Signiﬁcant left atrial injury and left
circumﬂex artery compromise could occur with forceful removal of the
disc and lobe of a fully endothelialized device. In our patient, the
endothelialization was incomplete and removal of the device was
surprisingly smooth. To prevent future left atrial appendage clot formation, an external surgical clip was implanted with excellent sealing
of the appendage.
Conclusion: Persistent DRT of LAAO device despite adequate anticoagulation and antiplatelet therapy is an indication for surgical
intervention. Complete removal of the device is possible in cases with
incomplete device endothelialization.
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Percutaneous Coronary Intervention in a Distal Left Main
Bifurcation (Medina 1,1,1) Disease - Provisional Versus
Dedicated Two-stent Approach?
K Mahajan, N Ganju, A Gupta, V Verma
Indira Gandhi Medical College, Shimla, India
Background: Provisional cross over Stenting is the preferred approach
in majority of bifurcation lesions. In distal left main bifurcation lesions,
choosing the right approach is of paramount importance. Recent trials
have shown superiority of 2-stent techniques in complex bifurcation
lesions. Severity of stenosis in the side branch and the length of disease
in side branch are the major criteria while assessing the complexity of
bifurcation lesions.
Methods: A 53-year-old male presented with ST elevation myocardial
infarction and was subjected to rescue PCI after failed thrombolysis.
On coronary angiography, he had distal left main coronary artery
(LMCA) bifurcation disease (Medina 1,1,1) with nearly 95% stenosis of
distal LMCA and ostial left anterior descending artery (LAD). Left
circumﬂex (LCX) also showed 90% stenosis but lesion was very focal
and limited to 1-2 mm from the ostium.
Decision Making: Keeping in mind the focal nature of disease in the
side branch, patient was treated with LMCA-LAD Stenting using
provisional cross over approach. Proximal optimisation (POT) was
done followed by kissing balloon inﬂation and repeat POT. Final optical coherence tomography scan showed an optimal result.
Conclusion: Recent data have shown that upfront 2-stent strategy is
better when length of disease in side branch is more than 10 mm. This
case was very intriguing since the side branch ostium showed critically
stenosis but the length of disease was very focal. Provisional approach
was used which proved to be a good choice and once again highlighted
the usefulness of "keep it simple and safe" principle.
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more common in surgical AVR. The decision of proceeding to AVR in
supravalvular aortic stenosis and the subsequent PPM managements
requires regular review and surveillance. The heart team approach in
managing this group of patients is pivotal.
Surgical decision of a concomitant anterior and posterior root annular
enlargement is crucial to reconstruct a neo-annulus for a suitable size
prosthesis to prevent PPM. Root enlargement techniques are important to be developed and maintained for patients with small aortic root
and unusual anatomy.
Conclusion: In patients undergoing surgical aortic valve replacement,
aortic root enlargement should be considered in small or hypoplastic
aortic roots to avoid patient prosthesis mismatch. A combination of
techniques as opposed to a single technique, is safe, and can be utilised
to improve success rate of suitably sized prosthesis implantation.
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To Ro or Not to Ro
YH Cheng 1, YH Chan 2
1
Pok Oi Hospital
2
CU Medical Center, Hong Kong SAR
Background: Calcium is one of the major obstacles in modern day
percutaneous coronary intervention. Adequate preparation of lesion is
necessary for good stent expansion.
Case: Here we present a case with calciﬁed vessel with severe stenosis
detected on both coronary angiogram as well as OCT. Calcium
modiﬁed technique was used to well prepare the lesion.
Decision-making: Instead of tradition scoring balloon or rotablator, we
decided to use Diamondback 360 coronary orbital atherectomy system.
Rather than using the device for several runs, we polished the lesion
extensively for best debulking. Various methods of calcium modiﬁcation techniques will be discussed with pros and cons explained.
Conclusion: Nowadays, more advanced equipment is available to
cardiologists and we need to learn the role of each and when to use
them in speciﬁc situation in order to achieve best patient outcome.
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Rapid Deployment Prosthetic Valve in Minimally
Invasive Cardiac Surgery for Aortic Regurgitation: A
Novel Technique
MKH Wong, DTL Chan, TWK Au
Queen Mary Hospital, Hong Kong SAR
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Background: Minimally Invasive Cardiac Surgery (MICS) via hemisternotomy has been well established in its beneﬁts compared to full
median sternotomy. The development of rapid deployment prosthetic
valves has allowed cardiac surgeons to shorten cross clamp times,
bypass times and further improve clinical outcomes. However, these
valves are designed for patients with aortic stenosis to anchor the valve
within the aortic annulus.
Case: We present a 67-year-old man with severe aortic regurgitation
and atrial ﬁbrillation with tachy-brady syndrome. We performed aortic
valve replacement with a rapid deployment Intuity valve and left atrial
appendage occlusion with Atriclip via hemi-sternotomy, using a novel
surgical technique.
Decision making: The patient was a young and ﬁt gentleman who
preferred a MICS aortic valve replacement. Myocardial protection and
suture placement are key considerations in aortic regurgitation during
MICS. We opted for rapid deployment valve to further improve on the
beneﬁts of MICS.
Conclusion: We present a ﬁrst-in-man novel modiﬁed surgical technique for rapid deployment Intuity Valve in MICS approach.

Patient Prosthesis Mismatch: Re-operative Aortic Root
Enlargement by Combined Konno and Manougian
Enlargement
ICH Siu, K Lim, JYK Ho, SCY Chow, MWT Kwok, RHL Wong
Division of Cardiothoracic Surgery, Department of Surgery, Prince of Wales
Hospital, Hong Kong SAR
Background: We describe a case of a re-operative combined root
enlargement and aortic valve replacement, for a patient with severe
patient prosthesis mismatch (PPM) following aortic valve replacement
(AVR).
Case: A 44-year-old lady with history of diabetes mellitus and hypertension presented with heart failure and angina. Echocardiography
showed progression of a known supravalvular aortic stenosis. First
operation with supravalvular patch aortoplasty was performed, noting
a small native sinotubular junction with hypoplastic non-coronary
cusp. Mean gradient remained elevated after aortoplasty, signifying
native valvular stenosis. Mechanical valve replacement was performed, requiring a concomitant posterior aortic root enlargement
(Nick's technique) using pericardial patch. However, only a size 16
valve could be implanted with reduced gradient.
Patient initially remained asymptomatic, but recurrence of heart failure symptoms with progressively elevated trans-prosthetic gradient
occurred 6 months post operation. In view of clinically signiﬁcant PPM,
re- operation with combined posterior and anterior annular enlargement was performed.
The size 16 aortic valve was explanted. A repeated posterior annular
enlargement by Manougian technique was performed, with a pericardial patch. The posterior enlargement was deemed inadequate for
root enlargement treating PPM. Further enlargement was achieved via
an anterior approach (Konno-Rastan procedure). The anterior portion
of the aortic annulus was incised towards the inter-ventricular septum
and the right ventricular outﬂow tract. The annulus was reconstructed
with pericardial patch.
The reconstruction allowed for a size 22 mechanical valve, and pericardial patch reconstruction of the aortic sinus, sinotubular junction
and right ventricular outﬂow tract was completed. Postoperative
trans-oesophageal echocardiography showed a mean gradient of
2 mmHg.
Decision-making: In the era of trans-catheter aortic valve implantation
for aortic stenosis, special anatomical considerations are becoming
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New Device for Mechanical Thrombectomy for Patient
With Submassive Pulmonary Embolism
CLH Ng
Princess Margaret Hospital, Hong Kong SAR
Background: Catheter directed mechanical thrombectomy for patient
with submassive pulmonary embolism is still controversial. This case
was presented to illustrate using a new device i.e. Penumbra Indigo
system Catheter and Separator is safe and effective for management of
patient with submassive pulmonary embolism.
Case: A 54-year-old lady with past history of diabetes mellitus and
hyperlipidemia was clinically admitted to neurosurgical unit for left
cerebellopontine angle tumor. Operation was done on 17/5/2021. On
post operation day 8, she developed hypotension and desaturation.
ECG showed new S1Q3T3 pattern and D dimer was elevated to ~6000
ng/ml. Urgent CT thorax showed ﬁlling defect in main pulmonary
arteries and mild right heart ventricle with straightening of inter
ventricular septum suggestive of right heart strain. Patient was treated
as submassive pulmonary embolism with enoxaparin given.
15
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RCA where the wire inadvertently entered subintimal space in proximal RCA, had subintimal tracking with dissection re-entry into the
true lumen and reaching PL branch. Predilation and stenting of the
lesion without awareness of the subintimal nature of the wire led to
spiral dissection distal to stent. Further stenting at matched size led to
Ellis 3 perforation. The complication was managed by placement of 2
cover stents and prolonged balloon inﬂation with heparin reversal. A
review of the IVUS showed the subintimal nature of the wire. The
patient eventually had TIMI 3 ﬂow to both PDA and PL and no further
bleeding with pericardiocentesis was performed on-table with 500 ml
aspirated. It is always important to pay attention to the position and the
coures the wire position. Intravascular imaging can provide crucial
information even in emergency setting.
Guiding: 6Fr JR4 Sion: Sion Blue
Thrombus aspiration: Penumbra x 2 passes Predilation: 3.0x15
Stent: p-mRCA 4.0x38 DES, 4.0x22 DES
Cover stent: 4.5x20 Papyrus, 3.5x15 papyrus
Posdilation / balloon tamponade: 4.0/15 NC balloon, 4.0/38 stent
balloon. Max postdilate at 18atm
Imaging: IVUS
Medication: Heparin, Eptiﬁbitide, Protamine.

Decision-making: As her hemodynamics was borderline and she had
contraindication to thrombolytic, we offered mechanical thrombectomy in cardiac cath laboratory. Urgent pulmonary angiogram showed
big clots over right distal pulmonary artery and multiple small clots
over left distal pulmonary artery. Mechanical thrombectomy was done
via Penumbra indigo system CAT8 and SEP8 repeatedly. Large
amount of clots were aspirated and right lung perfusion improved.
Patient recovered well afterwards.
Conclusion: Indigo aspiration system was effective and safe device for
mechanical thrombectomy for patient with submassive pulmonary
embolism.
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Running Out of Options! Hybrid Percutaneous
Pulmonary Valve Implantation With Surgical Right
Ventricular Outﬂow Tract Plication
RHS Chen 1, AKT Chau 1, T Au 2, KS Lun 1, N Yam 2
1
Hong Kong Children's Hospital
2
Queen Mary Hospital, Hong Kong SAR
Background: Patients with dysfunctional right ventricular outﬂow tract
(RVOT) late after surgical repair of congenital heart disease are occasionally poor candidates for surgical or transcatheter pulmonary valve
replacement. We describe a hybrid approach to render the dysfunctional RVOT manageable in a patient with complex comorbidities
using currently available equipment.
Case: A twenty-year-old male, with tetralogy of Fallot (TOF) and
oesophageal atresia, had pre-sternal gastric pull-through at birth and
subsequently TOF total repair via right thoracotomy. He suffers from
thoracic scoliosis, severe restrictive lung disease and DiGeorge syndrome. Chronic severe pulmonary regurgitation with right ventricular
dilatation and dysfunction has qualiﬁed him for pulmonary valve
replacement. However, the pre-sternal gastric conduit and comorbidities has rendered open heart surgery very risky, while the pyramidal shaped RVOT has made percutaneous pulmonary valve
implantation (PPVI) relatively contraindicated. It was hence decided
that the patient should undergo a hybrid intervention with RVOT
plication to create a tubular landing zone for percutaneous PPVI.
Decision-making: Procedure was performed in a single-plane ﬂuoroscopy hybrid theatre under general anaesthesia. Decision was made
for left anterior thoracotomy for RVOT plication to avoid jeopardizing
the vasculature of the gastric conduit. Right femoral venous access was
used for PPVI, right internal jugular vein for angiogram and left groin
prepared for partial cardiopulmonary bypass to reduce tension at the
RVOT during plication. Staged RVOT plication was performed with
radio-opaque liga-clips used as markers for potential landing zone.
Repeated balloon interrogation of the plicated RVOT was performed to
determine the adequacy of plication. A self-expandable valve (P28-20
Venus P valve, Venus Medtech, Shengzhen, China) was implanted
successfully via the transfemoral route. A single stay-suture was used
to improve stability of the valve at the RVOT. The procedure yielded
excellent result with marked improvement in right ventricular
dimension at 1-year follow up.
Conclusion: Hybrid PPVI has made management of high risk patient
possible who otherwise would have minimal treatment options.

ABSTRACTS: ADULT CONGENITAL HEART DISEASE
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Survival of Chinese Patients With Pulmonary Arterial
Hypertension Associated With Congenital Heart Disease
in the Modern Treatment Era - A Single Center
Experience
Z Xu, H Zhang, C Zhang, Q Li, H Gu
Beijing Anzhen Hospital, Capital Medical University, China
Background: In 2020, as some of the PAH-speciﬁc drugs are covered by
medical insurance, the choice and efﬁcacy of patient treatment will
surely be greatly improved.
Methods: A retrospective cohort study was undertaken in 525
consecutive patients diagnosed pulmonary arterial hypertension
associated with congenital heart disease (PAH-CHD) between 2007
and 2019. Patients from at least 27 regions in China were referred to
our center. A contemporary group of idiopathic PAH/familial PAH
patients was utilized for comparison. Their baseline clinical data of
demographic, clinical manifestations, auxiliary examination, and right
heart catheterization were collected.
Results: Of 525 patients, 249 had Eisenmenger syndrome; 43 had PAH
associated with prevalent systemic-to-pulmonary shunts; 48 were
diagnosed with PAH with small/coincidental defect; and 185 had PAH
after defect correction. The median age at diagnosis was 20.7 (11.2, 30.3)
years. Children (<18 years) accounted for 43.8%, women accounted for
68.8%. The median follow-up time was 4.5 years. 180 patients had PAH
symptoms at diagnosis, and 350 (84.3%) patients received PAH targeted medication at the last follow-up, including 141 with irregular
medication. Because of ﬁnancial constraints, 78 patients were NYHA
III-IV at diagnosis but none of them accepted initiation of i.v./s.c.
prostanoids. At the last follow-up, only 1.7% (6 cases) (NYHA FC at the
ﬁrst visit were II) received continuous subcutaneous prostanoids for
more than 3 months. 47 patients (9.0%) died, and heart failure was the
most common cause of death (27.7%). Survival rates of end-point- free
events at 1, 3, 5 and 10 years after diagnosis of PAH patients were
98.0%, 95.4%, 89.9%, and 84.4%, respectively; there were statistically
signiﬁcant differences in survival among the subgroups (Log-rank
p¼0.016). NYHA cardiac function was grade III and IV, frequently
occurrences syncope occurred and only one-time syncope at diagnosis
are independent risk factors for lung transplantation or death. Cox
multivariate analysis showed that NYHA cardiac function deterioration, occurrence/worsening of ≥ 2 PAH symptoms, PAH-related
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An Unusual Perforation in VF Arrest
JX Fang
Queen Mary Hospital, Hong Kong SAR
We present a case of a 65 year-old man with VF arrest with bystander
CPR followed by ECMO ECPR-guided primary PCI to an occluded
16
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hospitalization and syncope has a high predictive value for lung
transplantation or death. The survival of the 41 IPAH/HPAH patients
with PAH related gene mutations appeared to be worse when
compared with the PAH-CHD subgroups.
Conclusion: The overall long-term prognosis of CHD-PAH patients in
this study is relatively good, and the survival status of patients in each
subgroup is signiﬁcantly different. Earlier use of PAH targeted combination therapy and improved compliance with PAH-speciﬁc therapy
are expected to improve the prognosis of patients with CHD- PAH.

The Institute of Cardiovascular Diseases, Tianjin University, Tianjin,
China
3
Department of Pharmacology, Hebei University of Chinese Medicine,
Shijiazhuang, Hebei, China
4
Drug Research and Development Center, Wannan Medical College, Wuhu,
Anhui, China
5
Department of Surgery, Oregon Health and Science University, Portland,
United States
Objectives: Post-translational modiﬁcation of protein is closely related
to its function and crotonylation is a novel protein modiﬁcation
regulated by SIRT1. Little is known regarding the effect of SIRT1 on
Cav1.2 protein crotonylation modiﬁcation and whether Cav1.2 protein
crotonylation modiﬁcation is involved in Cav1.2 channel dysfunction.
Methods: Cre-Loxp technology was used to generate conditional cardiac knockout SIRT1 mice (SIRT1 KO). L-type calcium channel current
(ICa) was recorded through patch clamp technique. Immunoprecipitation and western blot were performed to examine the crotonylation
of Cav1.2 and Cav1.2 protein expression.
Results: In SIRT1 KO cardiomyocytes Cav1.2 channel protein was
signiﬁcantly crotonylated compared to WT and SIRT1ﬂ/ﬂ mice. SIRT1
KO reduced ICa in a voltage-dependent manner, and ICa in SIRT1 KO
was signiﬁcantly down-regulated compared to WT and SIRT1ﬂ/ﬂ mice
(-3.57±0.29 pA/pF vs. -5.89± 0.32 pA/pF and -5.71±0.26 pA/pF,
p<0.001). However, SIRT1 KO did not affect Cav1.2 channel electrophysiological property with the V1/2 of activation in WT, SIRT1ﬂ/ﬂ,
and SIRT1 KO of -14.74±0.64, -15.36±1.02, and -17.17±0.89 mV,
respectively. Similarly, the V1/2 of inactivation in WT, SIRT1ﬂ/ﬂ, and
SIRT1 KO were - 27.09±0.67, -26.50±1.03, and -28.12±0.90 mV, respectively; In addition, the τ of recovery from inactivation in WT, SIRT1ﬂ/ﬂ.
and SIRT1 KO were 221.36±9.57, 213.62±6.98, and 211.01±9.04 ms,
respectively.
Conclusion: Conditional cardiac knockout SIRT1 down-regulates ICa
through upregulating the crotonylation modiﬁcation of Cav1.2 channel
protein. However, there is no effect on Cav1.2 channel electrophysiological property.
This work was supported by the National Natural Science Foundation
of China [81870288]; the Non-proﬁt Central Research Institute Fund of
Chinese Academy of Medical Sciences [2020-PT310-007 & 2018TX31002];
Tianjin Science and Technology Project [18PTZWHZ00060].
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Quality of Life, Psychological Resilience, Personality
Traits, and Illness Perception Among 1,028 Grown-up
Congenital Heart (GUCH patients) in a Tertiary Centre
PC Chow
Hong Kong Children's Hospital, Hong Kong SAR
Background: Studies suggested heterogeneity of physical and psychosocial predictors on quality of life (QOL) among patients with
congenital heart diseases. This cross-sectional study aimed to examine
the relationships of QOL, resilience, personality traits, illness
perception, and clinical data of grown-up congenital heart (GUCH)
patients in a tertiary centre.
Methods: One thousand and twenty-eight GUCH patients (male ¼530)
attending Adult Congenital Heart Disease Clinic in Queen Mary Hospital were invited to complete the self-administered questionnaires,
including: 36-items Short Form Health Survey version 2 (SF36), satisfaction with life scale (SWLS), Connor-Davidson Resilience Scale
(RISC), Hospital Anxiety and Depression Scales (HADS), and NEO Five
Factor Inventory (NEOFFI-3), Brief Illness Perception Questionnaire
(BIPQ). Clinical information (disease complexity and illness severity),
and functional status (New York Heart Association (NYHA) class and
Warnes-Somerville Ability Index (WSAI)) of the patient were retrieved
from the clinical record. Predictors of SWLS, SF36-PCS (physical
component summary) and SF36-MCS (mental component summary)
were assessed by correlation analysis and multivariate regression.
Results: Nine hundred and ninety-six patients ﬁlled the questionnaires,
and data was complete for analysis in 973 patients. Greater disease
severity was associated with lower QOL scores respectively (p<0.01).
Worse functional class was associated with lower QOL scores (p<0.01).
QOL scores were correlated with RISC, HADS, NEO-FFI-3, and illness
perception respectively (all p<0.001). In multivariate regression, WSAI,
RISC, and illness perception (consequences, treatment control, and
identity) were predictors of SF36-PCS respectively (all p<0.05). RISC,
neuroticism, anxiety and depression, and illness perception (concern
and emotion) were predictors of SF36-MCS respectively (all p<0.05).
RISC, anxiety and depression, illness perception (consequences), and
extraversion were predictors of SWLS respectively (all p<0.05).
Conclusion: QOL among GUCH patients was associated with both
physical and psychological attributes. Resilience and illness perception
appeared having a role and might be the potential targets of intervention.
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Quantitative Proteomics Proﬁling of Lysine 2hydroxyisobutyrylation in Right Atrial Appendage From
Rheumatic Heart Valve Disease Patients
HT Hou 1, 2, HX Chen 1, 2, Q Yang 1, 2, GW He 1, 2, 3, 4
1
Center for Basic Medical Research & Department of Cardiovascular
Surgery, TEDA International Cardiovascular Hospital, Chinese Academy of
Medical Sciences & Peking Union Medical College, Tianjin, China
2
The Institute of Cardiovascular Diseases, Tianjin University, Tianjin,
China
3
Drug Research and Development Center, Wannan Medical College, Wuhu,
Anhui, China
4
Department of Surgery, Oregon Health and Science University, Portland,
United States

ABSTRACTS: ARRHYTHMIA AND ELECTROPHYSIOLOGY
57

SIRT1
Regulated
Post-translational
Crotonylation
Modiﬁcation: A Novel Regulation of Cav1.2 Channel in
Murine Myocytes

Purpose: Histone lysine (K) 2-hydroxyisobutyrylation (hib) is a novel
post-translational modiﬁcation (PTM). The biological signiﬁcance of
Khib in the mechanism of atrial ﬁbrillation (AF) in rheumatic heart
valve disease remains largely unknown. We explored the role of Khib
in AF by comparing Khib in right atrial appendages of rheumatic heart
valve disease patients with AF and sinus rhythm (SR).
Methods: A total of 4 acylation types (acetylation, succinylation, crotonylation, and Khib) were screened in right atrial appendages form 5

XC Wang 1, 2, 3, Q Yang 1, 2, 3, GW He 1, 2, 3, 4, 5
1
Center for Basic Medical Research & Department of Cardiovascular
Surgery, TEDA International Cardiovascular Hospital, Chinese Academy of
Medical Sciences & Peking Union Medical College, Tianjin, China
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Conclusions: Opportunistic AF screening may be considered in the
Chinese population at a younger age below 65 years. Although diagnostic yield of AF is lower in this age group, a signiﬁcant number of
these patients are at risk of stroke and warrant treatment with OAC.

AF and 5 SR patients who underwent heart valve replacement. Tandem Mass Tag proteomics method was used to identify the protein
proﬁles and Khib sites. Bioinformatic tools, including Gene Ontology,
Kyoto Encyclopedia of Genes and Genomes, and protein-protein
interaction, were also used to explore the biological function between
AF and SR.
Results: A total of 448 proteins based on 3,234 peptides and 2,217 Khib
sites were identiﬁed. After setting the quantiﬁcation ratio >1.20 and
<0.83, 35 and 48 proteins were classiﬁed as upregulation and downregulation respectively in AF patients compared to SR. Moreover, 124
and 67 sites exhibited upregulated and downregulated Khib. Bioinformatic analysis demonstrated that proteins with Khib were
signiﬁcantly enriched in different biological approach, such as cysteine
and methionine metabolism, cGMP-PKG signaling pathway, and
glucose-responsive energy metabolism including galactose metabolism, fructose and mannose metabolism, amino sugar and nucleotide sugar metabolism, and starch and sucrose metabolism.
Conclusions: The present study for the ﬁrst time revealed larger
number of differentially expressed proteins with Khib sites in AF patients with rheumatic valve disease that are involved in diverse cellular
processes including energy metabolism. The study suggests that
glycolysis/ gluconeogenesis may be regulated by these Khib sites,
resulting low level production of energy that could lead to AF. Further
studies are warranted to reveal the precise role of these Khib sites and
PTM in the mechanism of AF.
This work was supported by the National Natural Science Foundation
of China [81870288]; the Non-proﬁt Central Research Institute Fund of
Chinese Academy of Medical Sciences [2020-PT310-007 &
2019XK310001 & 2018TX31002]
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Clinical Predictors of Coronary Calcium Score in a Local
Hospital
S Ching, YW Li, TS Chung, CS Yue
United Christian Hospital, Hong Kong SAR
Background: Cardiac computed tomography is being increasingly
utilized in the management of acute or chronic chest pain. Despite
advances in technology, coronary calciﬁcation remains a major cause
of non-diagnostic studies.
Methods: This is a retrospective observational study of all patients that
underwent CTA and coronary calcium scoring (CAC) at United
Christian Hospital from January 2016 to September 2020. Clinical and
laboratory data were retrieved for each patient regarding age, date of
CTA, gender, coronary calcium score, creatinine, urine albumincreatinine ratio, number of hypertension and diabetic drugs, insulin
prescription, hemoglobin A1c, major adverse cardiovascular events
and escalation in hypertensive or diabetic treatment. We developed a
CAC score, based on patient demographic and clinical information,
that correlates with the probability of encountering coronary calcium
score of greater than 400.
Results: We showed that age, male gender, the number of hypertensive and diabetes medications, kidney function and albuminuria are
independent predictors of high coronary calcium score. A CAC score is
derived to predict the likelihood of CAC greater than 400. The score
comprises age, gender, number of hypertension and diabetes treatment, presence of albuminuria and creatinine more than 100 umol/L,
with different weights assigned to each variable. It is a weighted sum of
the variables with higher scores indicating increasing likelihood of
high CAC. The score is positively correlated with CAC (p<0.01, r¼0.48)
and has a ROC area of 0.81 (p<0.01) for CAC greater than 400. At a cutoff of 2.5, the sensitivity is 64.84% (CI 54.61%-73.86%) and speciﬁcity
79.8% (CI 76.89%-82.43%).
In addition, we are the ﬁrst to report that high CAC is associated with
renal deterioration in chronic kidney disease (CKD) stage 1-2 patients,
as well as escalation in hypertension or diabetes medication, opening a
new avenue for risk stratiﬁcation in CKD and chronic disease patients.
Conclusion: We report for the ﬁrst time in the literature the derivation
of a novel score that predicts the likelihood of high CAC based on
demographic and clinical information with good accuracy.
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Yield and Stroke Risk of Atrial Fibrillation Detected by
Single Timepoint Hand-held ECG Screening in a
Younger Chinese Population Aged 55-64
W Sun, B Yan
The Chinese University of Hong Kong, Hong Kong SAR
Background: Current guidelines recommend opportunistic screening
for atrial ﬁbrillation (AF) in people aged ≥65 years. However, the age
threshold for AF screening is uncertain, given the higher reported risk
of ischemic stroke in Asian patients <65 years. This study aimed to
evaluate the yield of opportunistic AF screening in a Chinese population aged 55-64 during outpatient clinic visits, the risk of stroke of
screen- detected AF, and to compare the yield of single timepoint
screening with that observed in patients aged ≥65 years.
Methods: Consecutive patients aged >55 years attending medical
outpatient clinics underwent AF screening using a handheld singlelead ECG device (AliveCor) from Dec 2014 to Dec 2017. Diagnostic
yield was deﬁned by detection of new AF.
Results: Of 15,898 subjects screened, 3,926 (24.7%) were aged 55-64
years and 8.6% (n¼338/3,926) had known AF. In the remaining 3,588
patients without AF, the yield of new AF at initial screening was 0.8%
(n¼28/3,588) in the younger age group, compared to 2.3% (n¼223/
9,736) in those aged ≥65 years (p<0.01). Mean age for newly diagnosed
AF was 60.8±2.5 years for those aged ≥55 <65, and mean CHA2DS2VASc score was 1.9±1.4. In just over one third of the patients (n¼10/28)
with screen-detected new AF, there was a class 1 indication for oral
anticoagulation (OAC, i.e., CHA2DS2-VASc ≥3 in female or ≥2 in male).
Oral anticoagulant was taken by 36% (n¼10/28) patients with AF and
80% (n¼8/10) with a class 1 indication for OAC. At a median follow-up
duration of 1.8(IQR¼1.5-3.3) years, 7% (n¼2/28) AF patients experienced ischemic stroke, both with a Class 1 indication for OAC but
neither was on OAC at time of stroke.
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Association of Pulmonary Hypertension With Subsequent
Risks of Adverse Renal Outcomes in Patients With Type 2
Diabetes Mellitus
MZ Wu, YJ Yu, QW Ren, HF Tse, KH Yiu
The University of Hong Kong, Hong Kong SAR
Background: Diabetic nephropathy is a major complication which
contributes to the end-stage renal disease and renal deaths in patients
with type 2 diabetes mellitus (T2DM). The aim of our study was to
investigate the role of pulmonary hypertension (PHT) in the development of adverse renal outcomes in patients with T2DM.
Methods: A total of 1279 diabetic patients (mean age 67±13 years;
women, 45.4%) were recruited. Pulmonary artery systolic pressure
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and TAM. ('p'<0.01). TAM/TAPSE, RVMPI, PVR were found to be
strong predictors of severe PH. ('p'<0.01)
Conclusion: Tricuspid annular motion / Tricuspid annular plane systolic excursion, Right ventricular myocardial performance index, Pulmonary vascular resistance (PVR) are strong predictors of severity of
PH and correlate with each other signiﬁcantly reﬂecting RV dysfunction and the prognosis.

(PASP) was estimated by transthoracic echocardiography at baseline.
Adverse renal outcomes were deﬁned as a composite endpoint of a
sustained 40% decline in eGFR, end-stage renal disease requiring
renal replacement therapy, kidney transplantation or renal deaths.
Cox regression hazard model was used to assess the association between PHT and incident adverse renal outcomes.
Results: Patients were divided into three groups based on their baseline PASP as follow: no PHT (PASP¼28 mmHg; n¼971, 75.9%), mild
PHT (PASP¼39 mmHg; n¼248, 19.4%) and signiﬁcant PHT (PASP¼60
mmHg; n¼60, 4.7%). A total of 336 adverse renal outcomes occurred
during a median follow-up of 55 months, Crude incidence of renal
outcome was highest in those with signiﬁcant PHT (45.0%), followed
by mild PHT (33.9%) and no PHT (23.2%). Kaplan-Meier survival curve
demonstrated that patients with signiﬁcant PHT had highest risk of
adverse renal outcomes. Multivariate cox regression, after adjustment
with age, gender, smoking, hypertension, hyperlipidemia and HbA1c
level, revealed that both mild PHT (HR¼1.53, 95%CI 1.18, 2.00, P<0.01)
and signiﬁcant PHT (HR¼2.04, 95%CI 1.35, 3.09, P<0.01) were independently associated with the incident adverse renal outcomes.
Conclusion: The presence of PHT was independently associated with
adverse renal outcomes in patients with T2DM. Monitoring of PASP by
echocardiography may be of clinical relevance in identifying those
who are at risk of diabetic nephropathy.
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Prognostic Value of Pre-operative Left Atrial Strain on
All-cause Mortality in Patients Who Received Aortic
Valve Replacement for Severe Aortic Stenosis
LH Tsui, KH Yiu, HF Tse, YK Tse, YS Yeung
Division of Cardiology, Department of Medicine, The University of Hong
Kong, Hong Kong SAR
Background: Severe aortic stenosis (AS) is the most common primary
valvular heart disease, treatable only by aortic valve replacement
(AVR). Literatures have shown that impaired left atrial (LA) function is
frequent in patients with severe AS. However, predictive value of preoperative LA function on post-operative all-cause mortality is uncertain. The purpose of our study was to evaluate the prognostic value of
pre- operative LA strain on all-cause mortality in patients with severe
AS undergoing AVR.
Methods: A total of 105 patients (age 65±9.1 years, 57% men) with severe AS were assessed using speckle-tracking echocardiography preoperatively. Patients with underlying lung disease and cancer were
excluded. Peak Atrial Longitudinal Strain (PALS) was measured as a
surrogate of LA function. Patients were subsequently stratiﬁed into
low (n¼53) and high (n¼52) PALS by the median. Patients were followed up until death. Data on mortality was obtained from Clinical
Management System under the Hospital Authority. The association
between LA function and all-cause mortality was evaluated by Cox
Proportional Hazards analysis.
Results: Patients were followed up for a median period of 3.96±2.43
years during which 15 patients died. Lower PALS, indicative of LA
dysfunction was associated with higher risks of all-cause mortality
(HR, 0.25; 95% CI 0.07-0.93, p¼0.04). The association between PALS
with all-cause mortality remained signiﬁcant after adjustment for age
and EuroSCORE II.
Conclusion: LA dysfunction, measured by PALS is associated with a
higher risk of all-cause mortality in patients with severe AS undergoing AVR, independently of age and EuroSCORE II. Evaluation of LA
function by assessing speckle tracking derived PALS may aid in
prognostication for patients undergoing AVR.
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Assessment of Right Ventricular Systolic Function in
Patients with Pulmonary Hypertension
SG Pawar 1, A Mulay 2
1
Bharati Vidyapeeth Medical College Hospital and Research Center
2
N M WADIA institute of cardiology, Pune, India
Introduction: The right ventricle (RV) is structurally complex chamber
of the heart. However, its functional assessment has remained an
elusive clinical challenge.
Objective: The pulmonary hypertension was categorized by clinical
examination and by echocardiography. Another was to study the
utility of echocardiographic indices of right ventricular systolic function and their correlation with the severity of pulmonary hypertension.
Methodology: 120 patients were selected with symptoms and clinical
signs suggestive of PH were studied using echocardiography. Patients
were divided into three groups according to the RVSP calculated from
Tricuspid regurgitation (TR) jet velocity using Bernoulli formula. RA
(major and minor) dimensions, RV dimensions (basal, mid-cavity and
longitudinal), RV free wall thickness (RVFWT), RVOT proximal and
distal diameters (RVOTDP and RVOTDD), RV area [end-diastolic
(RVEDA) and end-systolic area (RVESA] and volumes [end diastolic
volume (RVEDV) and end systolic volume (RVESV)] and RV ejection
fraction method, were measured. Tricuspid annular motion (TAM /
TAPSE) was measured with the help of 2DE and M-mode. Using
Doppler, RV myocardial performance index (RVMPI) and pulmonary
vascular resistance (PVR) were calculated. RV fractional area change
(RVFAC) was indirectly calculated from RVEDA and RVESA. The
correlation of these parameters with the severity of PH, RV systolic
function and with each other was studied.
Result: Patients with low TAM/TAPSE in MILD and SEVERE group
had mean of 1.4 cm and 1.1 cm respectively ('p'<0.001). TAM/TAPSE
value had signiﬁcant correlation with severity of PH, RVMPI and PVR
(Pearson's correlation at <0.01). Mean of abnormal RVMPI was 0.5 in
MILD PH as compared to 1.1 in SEVERE PH ('p'<0.001). PVR was
elevated (i.e. >1.5 woods units) in 16 (40 %) patients with MILD PH and
38 (95 %) patients with SEVERE PH ('p'<0.001) with a mean value of 1.7
and 3.08 for these groups respectively. A signiﬁcant correlation of
mean values of PVR was observed with the severity of PH ('p'<0.001)
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A Novel Cardiac Resynchronization Implantation
Approach Under Electrocardiographic Imaging Guidance
With Physiological Pacing Options for Better
Resynchronization in Non-left Bundle Branch Block
Patients - A Pilot Study
CK Au, CP Chan, YS Chan, PY Yan
Division of Cardiology, Department of Medicine and Therapeutics, Prince of
Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR
Background: The response rate of CRT in non-left bundle branch
patients (non-LBBB) patients is low. A novel Electrocardiographic
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Imaging (ECGi) guided CRT implantation method was studied in
non-LBBB patients.
Methods: Twenty-one consecutive patients with left ventricular ejection fraction (LVEF) ≤ 35%, QRS duration ≥120 ms and non-LBBB
morphology (13 RBBB and 8 IVCD) were recruited. During CRT implantation, right ventricular, coronary sinus, His-bundle and/or left
bundle branch leads were inserted. A 252-electrode vest (CardioInsight, Medtronic) was worn by the patient during the procedure to
measure the total activation time (TAT) when different pacing combinations of biventricular pacing (BVP), His-bundle pacing (HBP) and/
or left bundle branch pacing (LBBP) were tested. The combination that
resulted in the shortest TAT would be chosen. Clinical response was
deﬁned by ≥1 NYHA class improvement and echocardiographic
response by LV end- systolic volume reduction ≥15% and/or LVEF
improvement ≥10% at 6-month follow-up.
Results: Final pacing conﬁguration involved HBP in 38%, LBBP in 33%,
BVP in 15% and RV or LV pacing alone in 15% of patients. Mean QRS
duration shortened from 164±18 ms to 132±19 ms and LVEF improved
from 26±6% to 34±12% (both p<0.01). NYHA class improved from
3.1±0.5 to 2.0±0.6 (p<0.01). Clinical and echocardiographic response
rates were 71% and 62%, respectively. Two patients died of decompensated heart failure. One patient had CIED infection requiring device removal. Current approach resulted in better electrical
resynchronization when compared to BVP, as mean TAT (59 ms vs 88
ms) was signiﬁcantly lower and TAT reduction (37% vs 7%) was
signiﬁcantly greater with ﬁnal pacing-conﬁguration compared to BVP,
respectively (both p<0.01).
Conclusion: ECGi guided CRT implantation in non-LBBB patients is
feasible and may associate with better resynchronization results.
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Effectiveness of Smartphone Apps in Promoting Zerotime Exercise and Fitness in Patients With Coronary
Heart Disease: A Pilot Randomized Controlled Trial
NPT Chan 1, AYK Lai 2, HK Choy 3, DYT Cheung 2, ANT Wan 4,
YK Lau 5, CY Yung 5, VYH Cheng 6, TH Lam 2
1
The Open University of Hong Kong, Hong Kong SAR
2
The University of Hong Kong, Hong Kong SAR
3
Poznon University of Medical Sciences, Poland, United States
4
Aberdeen Kai-fong Welfare Association Social Service Centre, Hong Kong
SAR
5
Ruttonjee & Tang Shiu Kin Hospitals, Hong Kong SAR
6
Pok Oi Hospital, Hong Kong SAR
Background: Physical inactivity is an important risk factor of coronary
heart disease (CHD). Physical activity adherence was promoted by
starting from ZTEx with the support of a ZTEx smartphone app and
WhatsApp anti-inertia reminder (AIR). Zero-time exercise (ZTEx )
refers to the integration of simple strength- and stamina-enhancing PA
into daily life, which can be done anytime, anywhere and by anyone.
Objective: To examine the feasibility of using ZTEx smartphone app
and WhatsApp AIR to promote PA adherence in patients with CHD.
Methods: Study design and setting: A pilot randomized (1:1) control
parallel trial with quantitative and qualitative evaluation at week 12.
Intervention: The intervention group (EXP) (n¼70) received a 10minute individual education session on ZTEx, ZTEx App and WhatsApp AIR for behavior change. The control group (CON) (n¼69)
received WhatsApp messages on food choice.
Main outcomes and measures: Linear mixed models were used to
examine the difference in PA and walking steps between 2 groups,
adjusted for age, sex and baseline values. PA level was measured by
the International Physical Activity Questionnaire Short Form for all
participants at baseline and week 12. The 12-week daily steps was
measured by Fitbit in 25 participants in each group. Intention-to-treat
analysis was conducted.
Results: 139 patients with CHD (male: 71%, mean age 59.8±6.6 years)
were recruited from 3 Cardiology Specialty Out-patient Clinics. At
week 12, the EXP had signiﬁcantly higher proportion of patients
engaged in moderate PA (difference: 23.7%, p<0.05), spent signiﬁcantly
more walking time (mean difference: 176 minutes, p<0.05, Cohen's d:
0.40) than the CON. Among the Fitbit users, the EXP had more walking
steps/day than the CON (mean difference: 2137, p¼0.079). In the
walking time of all patients, the interaction of group and Fitbit use
(interaction term: Group x Fitbit) was signiﬁcant (p¼<0.001). Subgroup
analysis showed that patients of the EXP with Fitbit use had signiﬁcant
higher walking time than the EXP without Fitbit use (ES: 0.56, p<0.05)
and the CON without Fitbit use (ES: 0.81, p<0.05).
The qualitative feedback from 20 patients (n¼10 from each group)
reported that they did not have the habit of using e-diary in the ZTEx
App. However, they appreciated the WhatsApp AIR, which enhanced
their intention of doing ZTEx and PA.
Conclusions: The digital ZTEx intervention was feasible to promote PA
in patients with CHD with preliminary evidence in increasing PA. The
AIR were well-accepted by the patients, but not the ZTEx App.
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Reduced Inspiratory Muscle Strength Increases
Pneumonia in Patients with Acute Myocardial Infarction
YH Liu, YN Dai, PC He, N Tan, JY Chen, L Guo, Z Liu, HM Zhan
Guangdong Provincial People's Hospital, China
Background: Inspiratory muscle strength is associated with pneumonia in patients after surgery or those with subacute stroke. However, inspiratory muscle strength in patients with acute myocardial
infarction (AMI) has not been studied.
Methods: Patients with AMI were consecutively enrolled from March
2019 to September 2019. Measurements of maximal inspiratory pressure (MIP) were used to estimate inspiratory muscle strength and
mostly were taken within 24 hr after culprit-vessel revascularization.
Patients were divided into 3 groups by MIP tertile (T1: <56.1 cm H2O,
n¼88; T2: 56.1-84.9 cm H2O, n ¼ 88; T3: >84.9 cm H2O, n¼89). The
primary endpoint was in-hospital pneumonia.
Results: Among 265 enrolled patients, pneumonia developed in 26
(10%). The rates of pneumonia were decreased from MIP T1 to T3 (T1:
17%, T2: 10%, T3: 2%, P¼0.004). In-hospital all-cause mortality and
major adverse cardiovascular events (MACEs) did not differ between
groups. Multivariate logistic regression conﬁrmed increased MIP
associated with reduced risk of pneumonia (odds ratio 0.78, 95%
conﬁdence interval 0.65-0.94, P¼0.008). Receiver operating characteristic curve analysis indicated that MIP had good performance for
predicting in-hospital pneumonia, with an area under the curve of 0.72
(95% conﬁdence interval 0.64-0.81, P<0.001).
Conclusions: The risk of pneumonia but not in-hospital mortality and
MACEs was increased in AMI patients with inspiratory muscle
weakness. Future study focused on training inspiratory muscle may be
helpful.
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Cardiac Rehabilitation Tools in a Pocket! - Initiation of
Telehealth in a Regional Hospital
WK Choi, YW Leung, KY Kwan, CM Yeung, KS Li, J Sit, A Tong,
WY Chu, YB Ng, CS Yue
Cardiac Rehabilitation Team, United Christian Hospital, Hong Kong SAR
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corresponding stent length. Risk factors associated with new onset
conduction disturbances, deﬁned as the occurrence of bundle branch
block or complete heart block, were analyzed.
Results: Operative mortality was 3.3%. Two patients (5.9%) had
moderate PVL by the third month of follow-up. Two patients (6.7%)
had pacemakers preoperatively and were excluded from the subsequent analysis. New onset conduction disturbances occurred in 4 of
the remaining 28 patients (14.3%). This included two cases of persistent
left bundle branch block and two cases of permanent pacemaker implantation due to complete heart block. Univariate analysis identiﬁed
over-sizing of the native LVOT by 5 mm or more as a signiﬁcant risk
factor associated with conduction disturbance.
Conclusion: During INTUITY vale implantation, in addition to the
aortic annulus, the landing site of the sub-annular stent within the
native LVOT should also be sized pre-bypass. Over-sizing the native
LVOT by 5 mm or more is associated with an increased risk of new
onset conduction disturbances and should be avoided.

Background: Cardiac rehabilitation (CR) is the core component to
reduce mortality rate for cardiac patients. In the era of COVID-19
pandemic, the comprehensive CR services in terms of education and
exercise classes are suspended. An online education program came
into play to reduce the risk of myocardial infarction.
Objective: To enhance patients' knowledge and care in coronary artery
disease. To increase patient's conﬁdence in risk factor modiﬁcation.
Methodology: Telehealth for CR was newly initiated in United
Christian Hospital during pandemic in 2020. Twenty patients were
recruited for CR online program after revascularization from
December 2020 to April 2021. The program was still in progress.
Pamphlets with Quick Response (QR) codes of 4 educational videos
prepared by nurses, clinical psychologist (CP), occupational therapist
(OT), physiotherapist (PT) and social worker from health resource
centre (HRCSW) were distributed to the participants. They were
instructed to view 4 educational videos within 2 weeks via QR codes
and completed the post-video questionnaires with 4 questions using eform accordingly. The participants would receive tele-consultation
before and after the program. Patient satisfaction survey was conducted by the end of tele-consultation.
Outcomes: 90% of participants completed the post-video questionnaires, 5% of them was illiterate and 5 % of them were not familiar with
smart technology. Average score of questionnaires related to different
disciplinary was as follows, nursing: 89.6/100, OT: 75/100, CP: 77.8/100,
PT: 81.3/100 and HRCSW: 95.8/100. The results indicated a positive
learning experience of participants through online program.
Overall patient satisfaction of the online program was 4.75 using 5point scale. The rating for enhancing participants’ knowledge and care
about coronary artery disease was 4.5. The rating of conﬁdence
empowerment in risk factor modiﬁcation was 4.58. The length of the
program was appropriate with rating at 4.5.
The average reduction in low-density lipoprotein cholesterol (LDL-C),
high-density lipoprotein cholesterol (HDL-C) and triglyceride (TG)
within 3 months was 1.08 mmol/L, 0.16 mmol/L and 1.23 mmol/L
respectively.
Conclusion: The goals of the online program are achieved. Online
education program is an effective and alternative learning tool for
cardiac patients in the era of COVID-19 pandemic.
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Cardioplegic Protection of Cardiac and Endothelial
Functions During Ischemia/Reperfusion: Comparison of
Three Methods
HM Xue 1, 2, 3, HT Hou 1, 2, SF Wang 1, 2, S Guo 1, 2, Q Yang 1, 2,
GW He 1, 2, 4, 5
1
Center for Basic Medical Research & Department of Cardiovascular
Surgery, TEDA International Cardiovascular Hospital, Chinese Academy of
Medical Sciences & Peking Union Medical College, Tianjin, China
2
The Institute of Cardiovascular Diseases, Tianjin University, Tianjin,
China
3
Department of Physiology, Hebei Medical University, Shijiazhuang, Hebei,
China
4
Drug Research and Development Center, Wannan Medical College, Wuhu,
Anhui, China
5
Department of Surgery, Oregon Health and Science University, Portland,
United States
Purpose: This study was aimed to compare the protective effect of del
Nido (DNC), Histidine-tryptophan-ketoglutarate (HTK) and cold
blood cardioplegia (BC) followed by HTK on cardiac and endothelial
function in ischemia/reperfusion (I/R) rat model.
Methods: Sixty male Wistar rats were randomly allocated into ﬁve
groups: Control, I/R group, DNC group, HTK group, and BC+HTK
group. Rat hearts were conducted with or without 120-min global
ischemia at 4oC followed by 90-min reperfusion with 37oC KrebsHenseleit buffer. Hemodynamic parameters were continuously
recorded. The isometric study of the left anterior descending artery
was determined in myograph. The protein expression of cardiac
Troponin T (cTnT), creatine kinase MB (CKMB) was measured by
western blotting.
Results: The diastolic function after 120-min ischemia and 90-min
reperfusion was preserved better in the DNC group with lower
LVEDP, and better +dp/ dtmax and -dp/dtmax. Whereas the endothelial-dependent vasorelaxation was signiﬁcantly improved by HTK
or BC+HTK administration. The upregulated protein expression of
cTnT and CKMB was suppressed by all the three cardioplegias.
Conclusions: DNC shows a better recovery in diastolic function,
whereas HTK or BC+HTK exerts better protection in coronary endothelial function. All these three cardioplegias could ameliorate the
myocardium injury at the protein level.
This work was supported by the National Natural Science Foundation
of China [81870227 & 81870288].
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Peri-Procedural Trans-esophageal Echocardiographic
Guidance During Edwards INTUITY Valve Implantation
K Lim, YK Ho, SCY Chow, T Fujikawa, RHL Wong
Prince of Wales Hospital, Hong Kong SAR
Background: The Edwards INTUITY rapid deployment valve was
anchored on the left ventricular outﬂow tract (LVOT) by radial force
akin to transcatheter balloon-expandable valves. This design feature
facilitates minimally invasive and complex procedures but comes at
the price of compressing the atrioventricular conduction bundle and
potential requirement for pacemaker implantation.
Methods: A retrospective observational study was conducted on 30
consecutive patients who received the INTUITY valve at our institution
from August 2018 to January 2021. Demographical, clinical and echocardiographic parameters were collected for 90 days postoperatively.
We performed retrospective virtual sizing of the native LVOT at the
landing site of the sub-annular stent. A line was drawn from the inner
edge of the septal endocardium to the inner edge of the anterior mitral
leaﬂet in mid-systole, parallel to the aortic annulus, 6 mm to 8 mm
apical to the aortic annulus depending on the valve size and the
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patients had moderate hypothermic circulatory arrest (mean arrest
time of 56 min) and mean selective antegrade cerebral perfusion time
of 55 min during the aortic surgery.
Conclusion: Acute type A aortic dissection as a lethal disease holds
true, in particular with malperfusion syndrome. Contemporary outcomes showed improving surgical outcome worldwide with aortic
specialists. Local experience offers insights on the understanding of
the disease and technical considerations.

60

Current Study on Risk Factors for Development of Acute
Renal Failure Requiring Dialysis in Patients Undergoing
Coronary Artery Bypass Grafting Surgery
JY Zhou 1, 2, Q Yang 1, 2, GW He 1, 2, 3, 4
1
Center for Basic Medical Research & Department of Cardiovascular
Surgery, TEDA International Cardiovascular Hospital, Chinese Academy Of
Medical Sciences & Peking Union Medical College, Tianjin, China
2
The Institute of Cardiovascular Diseases, Tianjin University, Tianjin,
China
3
Drug Research and Development Center, Wannan Medical College, Wuhu,
Anhui, China
4
Department of Surgery, Oregon Health and Science University, Portland,
United States
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Post-infarct Ventricular Septal Rupture Repair - A Review
of 16 Cases in 8 Years
JWY Chan, JYK Ho, SCY Chow, MWT Kwok, RHL Wong
Division of Cardiothoracic Surgery, Department of Surgery, Prince of Wales
Hospital, the Chinese University of Hong Kong, Hong Kong SAR

Purpose: Acute renal failure (ARF) is one of the major complications
after coronary artery bypass grafting (CABG) surgery. Dialysis is an
effective treatment of ARF after CABG surgery. Due to technical evolution, risk factors may change from time to time. This study was
aimed to investigate the risk factors for ARF in the current era.
Methods: Five thousand and seventy-seven consecutive patients who
underwent CABG from April 2012 to November 2019 were analyzed
retrospectively. The patients were divided into ARF group requiring
dialysis (n¼53, 1.04%) and non-ARF group (n¼5,024, 98.96%) according
to whether ARF occurred post-operatively requiring dialysis. Univariate analysis was performed to ﬁnd possible factors associated with
ARF. Any variables that had trends to be associated with ARF (p<0.1)
were included in stepwise multiple logistic regression analysis.
Results: Cardiopulmonary bypass (CPB) time (113.2 49.8 vs.
227.3129.8 min, p¼0.006), application of intra-aortic balloon pump
(IABP, p¼0.000), and preoperative ejection fraction (EF, 62.56.4 vs.
52.75  12.8, p¼0.000) are independent risk factors for development of
ARF requiring dialysis in patients undergoing CABG Surgery.
Conclusions: Our study identiﬁed risk factors for development of ARF
in the current era. The study suggests that efforts should be made to
shorten CPB time and that renal protection should be enhanced in
patients with low ejection fraction and insertion of IABP.
Tianjin Science and Technology Project [18PTZWHZ00060]; TEDA
International Cardiovascular Hospital Internal Grant [2020-TD-010].

Background: Ventricular septal rupture (VSR) is a rare but devastating
complication after myocardial infarction, with historical operative
mortality up to 52.5% if percutaneous closure is not feasible. Numerous
surgical techniques have been described to minimize fatal post-operative complications including bleeding, patch dehiscence and ventricular dysfunction. A novel technique of double-patch repair with infarct
exclusion has been developed recently with promising results.
Methods: All cases of post-infarct VSR repair between January 2013
and April 2021 were reviewed. Primary outcome was operative mortality. Baseline characteristics, intra-operative ﬁndings and postoperative outcomes were reported.
Results: 16 cases of VSR repair were performed in the past 8 years.
Average patient age was 68 years old (range 56-79), with equal sex
distribution. All VSR occurred after STEMI, with 62.5% having delayed
presentation. The majority (64.3%) involved LAD territory, leading to
apical or anteroseptal VSR. Average size of VSR was 1.8 cm, ranging
from 1-4 cm. 78.6% required pre-operative intra-aortic balloon pump
support, while 7.1% required ECMO support. 87.5% were repaired
through left ventriculotomy, and 25% required concomitant CABG.
The ﬁrst 10 cases (cohort 1) were treated with single patch VSR repair
and direct primary closure of ventriculotomy, while the latest 6 cases
(cohort 2) were repaired with double- patch for the VSR and infarct
exclusion technique for ventriculotomy. 30-day mortality of cohort 1
was 50% while that of cohort 2 was 0%. Causes of death in cohort 1
included 3 cases of ventricular failure, 1 case of bleeding and 1 case of
ischemic bowel related to inotropic use. There is a trend towards
survival when delayed repair (>7 days between diagnosis of VSR and
surgery) was feasible. Among patients repaired with double patch
technique, post- operative echocardiogram showed no shunt in 50%
and trivial 1-3 mm shunt in the rest. None required additional intervention or was readmitted for congestive heart failure or hemolysis.
Mean post-operative length of stay was 12.7 days.
Conclusion: Post-infarct VSR carries a 31.3% risk of operative mortality
in our series, but the novel technique of double-patch infarct-exclusion
was able to minimize our recent operative mortality to 0% by providing
secure hemostasis and preventing patch dehiscence. Delayed surgery,
if haemodynamically feasible, may confer survival advantage due to
ﬁbrosis of infarcted myocardium allowing more durable repair.
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Contemporary Outcomes of Acute Type A Aortic
Dissection in Hong Kong: Review From a Single Institute
JYK Ho, K Lim, JWY Chan, SCY Chow, MWT Kwok, S Wan,
T Fujikawa, RHL Wong
Division of Cardiothoracic Surgery, Department of Surgery, Prince of Wales
Hospital, Hong Kong SAR
Background: Acute Type A Aortic dissection is a devastating clinical
emergency, urgent surgery to restore the true lumen perfusion and to
correct malperfusion is the essence for survival. International registry
data showed improving, still substantial of around 15% trend of operative mortality over years. We reviewed surgical outcomes in acute
Type A aortic dissection of our institute as a representation of local data.
Methods: Between 2/2017 to 5/2021, 136 patients in our institution
(mean age 57) have undergone open aortic surgery for acute Type A
aortic dissection, extend of surgeries involved hemi-aortic arch
replacement (87.5%), and total arch replacement (12%). Perioperative
parameters were retrospectively reviewed and analysed.
Results: All patients had emergency surgery. An 18% of patients presented with shock or malperfusion syndrome. The overall in-hospital
mortality was 5.1% (n¼7/136). Mean operative time was 396 min. All
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Efﬁcacy and Safety of Intracoronary Transplantation of
Peripheral Blood-derived Mononuclear (PBMNCs)
Autologous Stem Cells in Patients With Acute
Myocardial Infarction: A Prospective Pilot Study from
North India (ITPASC study)
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stratiﬁcation and HF development, which might allow the early risk
stratiﬁcation of STEMI by simple RT-qPCR at the emergency department.

HI Showkat, M Sohil, S Anwar
Grecian Superspeciality Hospital, Mohali, India
Background & Objectives: Myocardial necrosis starts rapidly after
coronary occlusion, usually before reperfusion can be achieved. Cardiac transfer of bone marrow and human peripheral blood mononuclear cells (PBMNCs) - derived stem cells can have a favourable
impact in patients with myocardial infarction.Our study using transplantation of non-expanded PBMNCs improved the cardiac function
in patients with myocardial infarction and is safe and feasible.
Methods: Its a prospective pilot study prospective pilot study from
region with six months of follow-up. Ten patients of ST-elevation acute
anterior wall myocardial infarction with occlusion of left anterior
descending were taken for Echocardiography (2 blind operators)
before coronary intervention. Percutanous coronary intervention of
left anterior descending (LAD) by drug eluting stent followed by
intracoronary infusion of PBMNCs was done. Ten patients of acute
anterior wall myocardial infarction were taken as control in whom only
LAD stenting was done. Echocardiography was carried out on follow
up for assesment of functions.
Results: After six months of follow up in both case and control group
there was improvement in left ventricular functions. But left ventricular functions improvement in cases where intracoronary stem cell
therapy was given in addition to LAD stenting which was statistically
signiﬁcant (P-value <0.05) in stem cell therapy group.
Conclusion: Intracoronary PBMNCs infusion is a less invasive, more
feasible, safer and a novel therapy for acute myocardial infarction
patients who have depressed cardiac function.It causes signiﬁcant
improvement in ejection fraction and wall motion score index which
are most important prognostic factor in myocardial infarction patients.
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The Evolving Characteristics and Outcomes of Acute
Myocardial Infarction in Hong Kong, 1999 - 2018
HL Li, YK Tse, Q Ren, M Wu, SY Yu, CKL Leung, SY Yu, PF Wong,
KY Li, LY Lam, HF Tse, KH Yiu
The University of Hong Kong, Hong Kong SAR
Background: The burden of myocardial infarction (MI) with its assorted
comorbid complications is increasing. Characterisation of patient characteristics complications is critical. Nonetheless, data on the evolving
proﬁles of patient features and outcomes, particularly in an Asian population, remain sparse. We aim to describe the evolving characteristics
and outcomes of MI patients in Hong Kong in the past 2 decades.
Methods: From a territory-wide database in Hong Kong, we included
patients with incident acute MI from 1999-2018. The primary outcome
was 30-day all-cause death, while secondary outcomes include haemorrhagic stroke, and pneumonia, at both 30 days and 5 years. Temporal trends in baseline characteristics were evaluated using Poisson
regression, while trends in outcomes were evaluated using multivariate Cox regression.
Results: A total of 130,218 patients (age 73.613.9 years, 40% female)
were included. Over time, mean age (annual percentage change [APC]
0.23% [0.21 to 0.24], P<0.001), mean CCI (APC 5.1%, [4.8 to 5.3],
P<0.001), and patients suffering from baseline comorbidities (range of
APC 1. 7% to 4.3%; all P<0.001) increased signiﬁcantly. The adjusted
all-cause 30-day mortality rate increased signiﬁcantly (APC 0.3% [0.1 to
0.5], P¼0.005). Strikingly, there is an alarming increase in the rate of
haemorrhagic stroke (APC 3.4% [2.3 to 4.4], P<0.001) and pneumonia
(APC 1.5% [1.3 to 1.7], P<0.001) at 30 days. Although the rate of 5-year
all-cause death declined slightly (APC -0.8% [-0.9 to -0.6], P<0.001),
there were increasing rates of haemorrhagic stroke (APC 1.0% [0.3 to
1.7], P¼0.004) and pneumonia (APC 3.8% [3.6 to 4.1], P<0.001).
Conclusions: Patients with MI have evolved to be older and more
comorbid. Alarmingly, despite reduction in long-term all-cause death
over time, the reduction was small; risk of death in short-term significantly increased and patients suffer from more complications
including haemorrhagic stroke and pneumonia. These results highlight the emergence of extra-cardiac outcomes that drive poor prognosis and accentuate the need to develop tailored strategies to tackle
these potentially lethal complications.

29

Identiﬁcation of Candidate Biomarkers for Early Risk
Stratiﬁcation of STEMI and Prediction of Post-STEMI
Heart Failure Via Gene Expression Analysis
J Xu
State Key Laboratory of Cardiovascular Disease, Fuwai Hospital & National
Center for Cardiovascular Disease, Beijing, China
Objective: Acute myocardial infarction (AMI) with the presence of STsegment elevation (STEMI) remains a common cardiac emergency
incidence worldwide. We aimed to explore the molecular mechanism
and search for the candidate biomarkers with the predictive and
prognostic potentiality that detectable in the whole blood of STEMI
patients and post-STEMI HF patients.
Materials and Methods: Microarray proﬁles of 46 STEMI patients and
84 healthy controls were collected to explore differentially expressed
genes (DEGs). Gene ontology and pathway enrichment were performed and protein interaction network was constructed. LASSO logistic regression algorithm and ROC analysis were performed to build
machine learning models for predicting STEMI. Hub genes for further
validated in post-STEMI HF patients.
Results: We identiﬁed 99 DEGs convergence in these samples
(jlog2FCj 30.8 and adjusted p-value <0.05). They were mainly enriched
in terms relating to cytokine secretion, pattern recognition receptors
signaling pathway, and immune cells activation. A cluster of 8 genes
including MCEMP1, PLAUR, GPR97, ITGAM, CLEC4D, SLC2A3,
BST1, and MMP25 was found to be signiﬁcant. A machine learning
model built by GPR97, SLC2A3, CLEC4D, PLAUR, and BST1 exerted
great value for STEMI prediction. Besides, BST1 and ITGAM might be
candidate prognostic biomarkers for post-STEMI HF.
Conclusions: We re-analyzed the integrated transcriptomic signature
of STEMI patients showing predictive potentiality and revealed new
insights and speciﬁc prospective biomarkers for STEMI risk
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Trends and Sex Differences in Characteristics and
Outcomes in Myocardial Infarction: A 20-year Analysis
HL Li, YK Tse, Q Ren, M Wu, KY Li, SY Yu, CKL Leung, SY Yu,
PF Wong, LY Lam, HF Tse, KH Yiu
The University of Hong Kong, Hong Kong SAR
Background: The recent temporal trends in sex differences in characteristics and outcomes among patients with myocardial infarction (MI),
particularly in an Asian population, remain poorly understood. We
aim to evaluate the evolving nature of sex differences over the past 2
decades in patients with MI.
Methods: From a territory-wide database in Hong Kong, we included
patients with incident acute MI from 1999-2018. Outcomes of interest
include, at 30 days, all-cause death, new-onset heart failure (HF), and
ischaemic stroke. Trends in sex differences in baseline characteristics
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AMI and anemia although liberal red blood cell transfusion tended to
reduce in-hospital mortality. The ﬁndings suggest that restrictive
transfusion strategy might be the optimal red blood cell transfusion
strategy for such patients considering the clinical beneﬁts and cost.

were evaluated using linear and Poisson regression, while differences
in outcomes were evaluated using multivariate Cox regression. FineGray model was used to evaluate account for competing risk, with allcause death deﬁned as competing event.
Results: A total of 130,218 patients (age 73.613.9 years, 40% female)
were included. Women were older (79.511.7 vs. 69.613.8 years, P<
0.001) and had a more pronounced increasing trend in age over time
(interaction P<0.001). Women were also more comorbid overall
(Charlson Comorbidity Index [CCI] 1.25 vs 0.85, age-adjusted
P<0.001). Women had more baseline hypertension, diabetes, and severe renal disease than men (age-adjusted P<0.001), while the
increasing trends in these comorbidities were all more pronounced in
men than in women (all interaction P<0.001). Women were more likely
to have ST- elevation overall (P<0.001).
Although the crude 30-day mortality rate was higher in women (32.6%
vs 23.9%), after covariate adjustment, they had a lower risk of death
(hazard ratio [HR] 0.97, 95% CI [0.96 to 0.99], P¼0.003), with no signiﬁcant interaction with time (P¼0.787). Women had a higher risk of
developing HF (HR 1.04 [1.01 to 1.08], P¼0.012) and ischemic stroke
(HR 1.36 [1.24-1.48], P<0.001) in 30 days.
Conclusions: Women MI patients were older and more comorbid
compared to men, which contributed to the higher risk of death, HF,
and ischemic stroke among women.
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High Intensity Statin Versus Low Density Lipoprotein
Cholesterol
Target
For
Patients
Undergoing
Percutaneous Coronary Intervention: Insights from a
Territory-wide Cohort Study in Hong Kong
AKY Ng 1, PY Ng 2, A Ip 2, CW Siu 2
1
Grantham Hospital
2
The University of Hong Kong, Hong Kong SAR
Background: Different guidelines recommend vastly different approaches to the lipid management strategy in patients undergoing
percutaneous coronary intervention (PCI).
Method: This was a retrospective cohort study conducting in patients
who underwent ﬁrst-ever PCI in Hong Kong between 2004 and 2017.
All participants were grouped according to attainment of low density
lipoprotein cholesterol (LDL-C) target of <55 mg/dL and with 350%
reduction from baseline without high intensity statin (group 1), or
received high intensity statin without attainment of LDL-C target
(group 2), or attainment of LDL-C target with high intensity statin
(group 3). The primary endpoint was MACE, deﬁned as a composite
outcome of all-cause mortality, myocardial infarction, stroke and any
unplanned coronary revascularization, in a time-to-ﬁrst-event analysis
up to 5 years after PCI. The secondary endpoints were individual
components of MACE and a composite endpoint of mortality,
myocardial infarction and stroke.
Results: A total of 8,650 patients were analysed with a median follow up
period of 4.2 years. After adjustment of baseline characteristics and other
medication prescriptions, the risks of MACE at 5 years were signiﬁcantly
lower with group 2 (hazard ratio [HR], 0.82; 95% conﬁdence interval [CI],
0.74 to 0.93, P¼0.003), and group 3 (HR, 0.75; 95% CI, 0.62-0.90; P¼0.002).
The primary outcome occurred at similar rates between group 2 and
group 3. Patients in both group 2 and group 3 had lower risks of composite endpoint of mortality, myocardial infarction and stroke.
Conclusions: Among patients undergoing ﬁrst-ever PCI in Hong
Kong, high intensity statin, with or without attainment of guideline
recommended LDL-C target, was associated with a lower adjusted risk
of MACE at 5 years, compared with patients who attained LDL-C
target without high intensity statin.
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Restrictive Versus Liberal Red Cell Transfusion Strategies
in Patients With Acute Myocardial Infarction: A
Systematic Review and Meta- analysis
Y Zhang, Y Liu, P He, J Chen, N Tan
Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong
Provincial Key Laboratory of Coronary Heart Disease Prevention,
Guangdong Provincial People's Hospital, Guangdong Academy of Medical
Sciences, Guangzhou, China
Background: Anemia is frequent in patients with acute myocardial
infarction(AMI), and the optimal red blood cell transfusion strategy for
patients with AMI and anemia is still controversial. We aimed to
compare the efﬁcacy of restrictive and liberal red cell transfusion
strategies in patients with AMI and anemia.
Methods: We systematically searched PubMed, EMBASE, Web of
Science, Cochrane Library, and Clinicaltrials.gov, from their inception
until March 2021. Inclusion criteria were clinical trials that compared
the efﬁcacy of restrictive and liberal transfusion strategies in patients
with AMI and anemia on all-cause mortality and major adverse cardiovascular events. The primary outcome was all-cause mortality,
including overall mortality, in-hospital, or follow-up mortality. Risk
ratios (RR) with 95% conﬁdence intervals (CI) were presented and
pooled by random-effects models.
Results: The search yielded a total of 6630 participants in six studies.
Among the included patients, the average age ranged from 69.0 to 79.5
years and 2950 (44.5%) were men. A total of 2008 patients received
restrictive red blood transfusion while 4622 patients were given liberal
red blood transfusion. No difference was found in overall mortality and
follow-up mortality between restrictive and liberal blood transfusion
groups (RR¼1.07, 95% CI¼0.82-1.40, P¼0.62; RR¼0.89, 95% CI¼0.561.42, P¼0.62). However, liberal transfusion seemed to be related to lower
in-hospital mortality (RR¼1.22, 95% CI¼1.00-1.50, P¼0.05). No secondary outcomes, including follow-up reinfarction, stroke, and acute heart
failure, differed signiﬁcantly between the two groups. In addition,
subgroup analysis showed no differences in overall mortality between
the two groups based on sample size and design.
Conclusion: Restrictive and liberal red blood transfusion have a similar
effect on overall mortality and follow-up mortality in patients with
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Impact of COVID-19 Pandemics on ST-segment Elevation
Myocardial Infarction Care in a Tertiary Center in Hong
Kong
CY Wong, MC Chan, CF Tsang, SF Chui, KC Chan, CL Fu, KT Chan,
KY Lee
Queen Elizabeth Hospital, Hong Kong SAR
Background: The ﬁrst case of COVID-19 infection in Hong Kong was
conﬁrmed on 23rd January 2020, and the Hospital Authority
announced the activation of Emergency Response Level in public
hospitals on 25th January 2020. The reduction of Emergency Room
attendance, number of ST-segment elevation myocardial infarction
(STEMI) cases with variable outcomes have been described. This study
describe the impact of COVID-19 on STEMI care in a tertiary center
providing cluster- based 24-hour primary percutaneous coronary
intervention (PPCI) service.
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identiﬁed. Patients were subsequently stratiﬁed into those with PCI
(n¼540) and without PCI (n¼184). The primary endpoint was deﬁned
as a composite of HF hospitalization and HF-related mortality.
Results: The number of obstructive lesions was 2.61.5 in patients with
PCI and 2.71.6 in those without PCI (P¼0.495) and the severity of
CAD assessed by SYNTAX score was similar between the two groups
(19.89.8 vs. 17.98.4, P¼0.071). Patients were followed up for 3 years
and a total of 46 events occurred (34 HF hospitalization and 12 HF
related mortality). The 1-year incidence rate of composite endpoint
was 1.9% in patients with PCI and 6.4% without PCI (P<0.05).
Following multivariable adjustment, the rate of primary endpoint was
signiﬁcantly lower in those with PCI compared to those without PCI
(3.9% vs. 8.2%; adjusted hazard ratio: 0.475; 95% conﬁdence interval:
0.229-0.984; P¼0.045).
Conclusions: In stable CAD patients with myocardial ischemia deﬁned
by caFFR£0.80, PCI signiﬁcantly reduces the subsequent rate of HF
hospitalization and HF-related mortality.

Method: Two periods were identiﬁed: February 2019 to January 2020
(Pre-COVID) and February 2020 to January 2021 (COVID). STEMI
cases of Kowloon Central Cluster, namely Queen Elizabeth Hospital
and transferral from Kwong Wah Hospital after ofﬁce hours were
included. Consecutive cases of STEMI from these hospitals with PPCI
performed in Queen Elizabeth Hospital were analyzed.
Results: 326 and 235 patients underwent PPCI during Pre-COVID and
COVID period respectively, with 27.9% decrease in the latter period.
Drop of cases >30% was observed in April, May, July, September 2020
and January 2021. Compared with pre-COVID period, patients in
COVID period were younger (65 vs 63 years, p¼0.029), with lower
proportion of age >¼75 years (26.1% vs 15.7%, p¼0.003). The mean
AED door to balloon (DTB) time was longer during COVID period
(89.2 mins vs 95.9 mins, p¼0.03).
There were no signiﬁcant statistical differences of proportion of
cardiogenic shock (CS) case (12.6%vs10.6%, p¼0.48), use of mechanical
circulatory support devices (MCS) (11.6%vs8.9%, p¼0.30) and crude
in-hospital mortality (12.6% vs 10.6%, p¼0.48).
Splitting the patients into CS and non-CS groups, there were also no
statistically signiﬁcant differences in in-hospital mortality (CS group:
46.3%vs56%, p¼0.45; non-CS group: 7.7%vs5.2%, p¼0.27). The rate of
mechanical complication (cardiac rupture, ventricular septal rupture
and acute severe mitral regurgitation) over the 2 periods were 1.5%
and 2.1% respectively (p¼0.39).
To reduce the infection risk, speciﬁc protocol has been derived to
handle cases of STEMI with uncertain or suspected COVID status.
Thrombolytic may be an alternative therapy in suitable patients who
have no contraindications. During COVID period, 6 patients were
given thrombolytic, with 4 due to uncertain or suspected COVID status. One patient was given thrombolytic in Pre-COVID period.
Conclusion: In our experience, there was a substantial reduction of
STEMI cases with younger patient age and longer DTB time during
COVID period. The proportion of CS cases, use of MCS, mechanical
complication and mortality rate did not show signiﬁcant differences
between 2 periods. The observations could be multi-factorial and merit
further investigations.
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Clinical Signiﬁcance of Per-vessel Treatment Adherence
in Stable Coronary Artery Disease Based on a Novel
Index: Computational Pressure-ﬂow Dynamics Derived
Fractional Flow Reserve
CKL Leung 1, LY Lam 1, KY Li 1, SY Yu 2, MZ Wu 2, QW Ren 2,
PF Wong 2, YK Tse 1, SY Yu 1, HL Li 1, Y Feng 3, Y Huo 3, H.F Tse 2,
KH Yiu 2
1
The University of Hong Kong, Hong Kong SAR
2
Queen Mary Hospital, Hong Kong SAR
3
PKU-HKUST Shenzhen-Hongkong Institution, Shenzhen, China
Background: Computational pressure-ﬂow dynamics derived fractional ﬂow reserve (caFFR) is a novel index for assessing myocardial
ischemia in patients with coronary artery disease (CAD), without the
need of invasive pressure guidewire and hyperaemic stimulus
required in conventional fractional ﬂow reserve (FFR) measurement.
Adhering to functional myocardial ischemia assessment when
deciding to perform percutaneous coronary intervention (PCI) has
been shown to improve clinical outcomes, based on per-patient level
studies. However, the clinical signiﬁcance of such treatment adherence
at per-vessel level remains undetermined.
Methods: A total of 928 stable CAD patients (mean age 66.210.5, male
72.7%) who had caFFR obtained for all three major coronary vessels
were included. The FFR threshold of 0.8 was adopted as the threshold
for caFFR to indicate functionally signiﬁcant artery stenosis which
warrants PCI, and vice versa. Based on the caFFR of each major coronary vessel and whether PCI was performed to the respective vessel,
patients were stratiﬁed into 0-1 vessel with treatment adherence group
(group 1) (n¼105), 2 vessels with treatment adherence group (group 2)
(n¼338), and 3 vessels with treatment adherence group (group 3)
(n¼485). The primary endpoint was major adverse cardiac events
(MACE), deﬁned as the composite of all-cause mortality, non-fatal
myocardial infarction and any subsequent revascularization.
Results: The severity of CAD based on SYNTAX score assessment was
18.610.2 in group 1, 14.68.9 in group 2, and 11.59.9 in group 3
(P<0.001). The MACE rates at 3 years were signiﬁcantly different
across groups 1, 2 and 3 (17.1% vs. 12.1% vs. 7.4%; P¼0.004). Compared
to group 3, the risk of MACE at 3 years was increased in group 2
(adjusted hazard ratio [HR]¼1.597; 95% conﬁdence interval [CI]¼
1.020-2.501; P¼0.041), and further increased in group 1 (adjusted
HR¼1.933; 95% CI¼1.081-3.457; P¼0.026).
Conclusions: In patients with stable CAD, the risk of MACE is incremental when fewer major coronary vessels are treated adhering to
caFFR threshold of 0.8.
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Heart Failure Hospitalization and Related Mortality
Following Percutaneous Coronary Intervention in
Ischemic Stable Coronary Artery Disease Based on a
Novel Index: Computational Pressure- ﬂow Dynamics
Derived Fractional Flow Reserve
JLY Lam 1, CKL Leung 1, KY Li 1, MZ Wu 1, 2, QW Ren 1, 2, ASY Yu 1,
PF Wong 1, HL Li 1, YK Tse 1, SY Yu 1, Y Feng 3, Y Huo 3, HF Tse 1,
KH Yiu 1, 2
1
Queen Mary Hospital, Hong Kong SAR
2
The University of Hong Kong Shenzhen Hospital, China
3
PKU-HKUST Shenzhen-Hongkong Institution, China
Background: Patients with coronary artery disease (CAD), especially
those with signiﬁcant myocardial ischemia, is at risk of heart failure
(HF). Computational pressure-ﬂow dynamics derived fractional ﬂow
reserve (caFFR) is a novel index to assess myocardial ischemia of CAD,
without the need of invasive pressure wire and hyperaemic stimulus,
as required by conventional FFR. The diagnostic performance of caFFR
has previously been validated. The clinical value of caFFR on HF
outcomes is, however, uncertain in patients with ischemic CAD. This
study evaluates the role of percutaneous coronary intervention (PCI)
on HF hospitalization and HF-related mortality in ischemic CAD patients, stratiﬁed by caFFR.
Methods: A total of 724 patients (mean age 66.210.6; male 75.0%) with
stable CAD and functional ischemia deﬁned as caFFR¼0.80 were
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aim of our study is to investigate whether the integration of global
caFFR (caFFR summation of the three coronary arteries) would enable
better risk stratiﬁcation in stable coronary artery disease (CAD) patients without ischemia-inducing stenosis.
Methods: We studied a total of 819 patients with non-ischemic lesions
on the basis of per-vessel caFFR (i.e. caFFR >0.80, or PCI-treated
ischemic lesions with post-PCI caFFR >0.90). Patients were subsequently stratiﬁed into low (n¼261), mid (n¼289) or high (n¼269) tertiles of global caFFR (<2.70, 2.70-2.76, >2.76, respectively). The primary
endpoint is major adverse cardiovascular events (MACE) at 3 years,
deﬁned as all-cause death, non-fatal myocardial infarction and any
subsequent revascularization.
Results: During a median follow-up of 32.8 months, 72 MACE
occurred, including 35 all-cause mortality, 16 myocardial infarction,
and 29 subsequent revascularization. Among patients with nonischemic per-vessel caFFR values, those in lowest tertile of global
caFFR showed the highest 3-year MACE rate compared with those in
the mid or high tertiles of global caFFR (12.3% vs 8.7% vs 5.6%,
respectively; P¼0.025). Following multivariate adjustment for demographics, baseline comorbidities and medications, the measurement of myocardial ischemia by global caFFR, as a continuous
parameter, showed a signiﬁcant inverse relationship with MACE
(adjusted Hazard Ratio [HR]¼ 0.138, 95% Conﬁdence Interval [CI]¼
0.012-0.708, P¼0.012), and recurrent episode of angina (adjusted
HR¼0.113, 95% CI¼0.539-0.840, P<0.001).
Conclusion: Even in the absence of signiﬁcant ischemia (i.e. caFFR >0.8
in any of the three coronary arteries), patients with a lower global
caFFR present a higher risk of MACE at 3-year follow-up. Our ﬁndings
suggest that the integration of global caFFR to per-vessel caFFR would
improve risk discrimination of patients with non-signiﬁcant ischemic
CAD.
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3-year Outcomes in Patients with Stable Coronary Artery
Disease Treated With Optimal Medical Therapy Alone
Based On A Novel Index: Computational Pressure-ﬂow
Dynamics Derived Fractional Flow Reserve
KY Li 1, LY Lam 1, CKL Leung 1, MZ Wu 2, QW Ren 2, PF Wong 2,
YK Tse 1, SSY Yu 1, HL Li 1, ASY Yu 2, KH Yiu 2, Y Feng 3, Y Huo 3
1
Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong
SAR
2
Department of Medicine, The University of Hong Kong, Queen Mary
Hospital, Hong Kong SAR
3
PKU-HKUST Shenzhen-Hongkong Institution, Shenzhen, China
Background: Computational pressure-ﬂow dynamics derived fractional ﬂow reserve (caFFR) is a novel index to determine the fractional
ﬂow reserve (FFR) in patients with coronary artery disease (CAD),
without the need of invasive pressure wire and hyperaemic stimulus in
conventional FFR. The aim of the study is to evaluate the clinical value
of caFFR in patients with stable CAD who were treated by optimal
medical therapy alone.
Methods: A total of 272 stable CAD patients (mean age 66.39, 65%
male) with 367 lesions were included. All of them did not undergo
percutaneous coronary intervention and were treated with optimal
medical therapy alone. Among 367 lesions, 333 of them were classiﬁed
into proximal (n¼228) or distal lesions (n¼105). The primary endpoint
was 3-year major adverse cardiovascular events (MACE), deﬁned as a
composite of death, myocardial infarction or any unplanned
revascularization.
Results: The mean caFFR was 0.880.10 in 367 lesions. During a median follow-up of 36 months, 39 composite events occurred, including
19 death, 3 myocardial infarction and 17 unplanned revascularization.
After multivariate adjustment, caFFR was an independent predictor of
MACE (adjusted hazard ratio [HR]¼0.98 per 0.01 increase in caFFR;
95% conﬁdence interval [Cl], 0.97-0.99; P¼0.01) and death (adjusted
HR¼0.97 per 0.01 increase in caFFR; 95%Cl, 0.95-0.99; P<0.01). In the
proximal lesions, there was a signiﬁcant inverse relationship between
caFFR and MACE (adjusted HR¼0.96; 95%Cl, 0.94-0.98; P<0.01). The
risk of MACE (adjusted HR¼6.89; 95%Cl, 3.38-14.04; P<0.01) and death
(adjusted HR¼7.94; 95%Cl, 3.12-20.25; P<0.01) was signiﬁcantly higher
in those with caFFR £0.8. However, such association was not observed
in distal lesions.
Conclusion: In patients with stable CAD treated with optimal medical
therapy, a lower caFFR was associated with more severe myocardial
ischemia and higher risks of adverse outcomes, especially in the proximal lesions. The ﬁnding thus supports the use of caFFR to improve riskstratiﬁcation, and predict adverse outcomes in patients with stable CAD.
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Determinants of Late Potentials in Acute Myocardial
Infarction Patients
E Ginanjar 1, L Rusdi 1, A Nachrowi 2, P Nugroho 2
1
Cardiology Division, Internal Medicine Department, Faculty of Medicine,
University of Indonesia-Cipto Mangunkusumo Hospital
2
Internal Medicine Department, Faculty of Medicine, University of
Indonesia-Cipto Mangunkusumo Hospital, Indonesia
Background: Ventricular tachyarrhythmia increases the risk of mortality after acute myocardial infarction. One of the recommended
noninvasive techniques for ventricular arrhythmia risk stratiﬁcation in
post- myocardial-infarction patients is detecting late potentials (LP) in
signal averaged-electrocardiography (SA-ECG). This study aims to
determine the prevalence of LP and to identify the determining factors
of LP in Indonesian acute myocardial infarction patients.
Subjects and methods: This cross-sectional study was conducted from
December 2019 to April 2020 at Cipto Mangunkusumo National
General Hospital, Jakarta, Indonesia. Data were collected via interviews and observation and/or obtained from the medical records
provided in our unit. SA-ECG recordings were taken in the ﬁrst 48
hours and the ﬁfth day after the onset of chest pain. Independent
variables were gathered during the patients' stay in the hospital.
Results: We observed 53 subjects, in whom the prevalence of LP was
34%. The proportion of LP was higher in subjects with prior myocardial infarction (50% vs. 30.2%; p¼0,205), left ventricle hypertrophy
(37.5% vs. 31.0%; p¼0.621), diabetes mellitus (35.3% vs. 33.3%;
p¼0.563), decrease of eGFR (40% vs. 31.6%; p¼0.560), hypertension
(83.3% vs. 19.2%; p¼0.026), hypokalemia (28.6% vs. 15.6%; p¼0.555),
hyperkalemia (100% vs. 31.4%; p¼0,111), hypomagnesemia (100% vs.
30%; p¼0.035), and hypocalcemia (41.5% vs. 15.4%; p¼0.095). In
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Integration of Global caFFR and Per-vessel caFFR for
Improved Risk Stratiﬁcation in Stable Coronary Artery
Disease Patients Without Ischemia
JLY Lam 1, CKL Leung 1, KY Li 1, MZ Wu 1, 2, QW Ren 1, 2,
ASY Yu 1, PF Wong 1, HL Li 1, YK Tse 1, SSY Yu 1, Y Feng 3, Y Huo 3,
KH Yiu 1, 2
1
Queen Mary Hospital, Hong Kong SAR
2
The University of Hong Kong Shenzhen Hospital, Shenzhen, China
3
PKU-HKUST Shenzhen- Hongkong Institution, Beijing, China
Background: Computational pressure-ﬂow ﬂuid dynamics derived
fractional ﬂow reserve (caFFR) is a novel angiographic-derived index
that correlates closely with conventional fractional ﬂow reserve (FFR)
without the need of wire introduction and hyperemia induction. The
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many research for decades. Colchicine inhibits tubulin polymerization and has been used in cardiovascular practice mainly for the
treatment of pericarditis. However, recent studies have shown its
beneﬁt when used for acute coronary events. The objective of this
meta-analysis is to reexamine the role of colchicine in reducing
cardiovascular events in acute coronary syndromes in the light of
more recent trials.
Methods: A systematic search for randomized controlled trials which
involves use of colchicine and acute coronary syndrome was done
using PubMed, Google Scholar, MEDLINE and Clinicaltrials.gov.
Studies done in the last decade and those that involved human subjects were included in the study.
Results: Seven RCT's (n¼11,282 participants) were included in this
meta- analysis comparing colchicine vs. placebo for patients being
treated for acute coronary syndrome. Dose ranged from 0.5 mg/day to
1 mg/day. Among patients being treated for acute coronary syndrome,
colchicine was associated with a signiﬁcant reduction in composite
cardiovascular outcomes (RR 0.69, 95% CI 0.60-0.79, P<0.00001, I2
31%), unstable angina (RR 0.67, 95% CI 0.55-0.82, P<0.0001, I2 53%) and
myocardial infarction (RR 0.75, 95% CI 0.62-0.92, P<0.005, I2 41%).
Serious gastrointestinal events were evident in the colchicine group
with no statistical difference between the two treatment arms (RR 1.28,
95% CI 0.98-1.67, P 0.07, I2 12%).
Conclusion: Use of colchicine reduces the risk if composite cardiovascular outcomes, recurrence of unstable angina and myocardial
infarction among patient who had acute coronary syndrome. There
was no statistically signiﬁcant difference between colchicine and placebo in terms of serious gastrointestinal events. It may be possible that
colchicine may be part of the standard treatment in patients with acute
coronary syndrome.

bivariate analysis, hypertension and hypomagnesemia were associated with LP. In multivariate analysis, hypertension was associated
with increased risk of LP (p¼0.031; OR¼3.900; IK95%¼1.136-13.387).
Conclusion: LP is associated with hypertension.
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How to Bridge Residual Distance to Reach Low-densitylipoprotein Cholesterol Targets in Acute Coronary
Syndrome Patients After Initial Statin Therapy
B Yan, A Lai
The Chinese University of Hong Kong, Hong Kong SAR
Background: Current guidelines recommend intensive low-densitylipoprotein cholesterol (LDL-C) lowering by 350% to target LDL-C <1.4
mmol/L after acute coronary syndrome (ACS). Residual distance to LDLC target can help select treatment strategy after initial statin therapy.
Purpose: We evaluated residual distance to guideline recommended
target LDL-C and the proportion of ACS patients who are projected to
reach target LDL-C by different statin and non-statin lipid-lowering
strategies.
Methods: We retrospectively analyzed 46,114 patients admitted with
ACS who survived 1 year from 18 acute hospitals in Hong Kong between Jan 2014 and Dec 2018. Patients were divided into (i) high potency
(HP-S; rosuvastatin 320 mg, atorvastatin 340 mg or simvastatin 380 mg);
(ii) non-high potency (NHP-S; other statin doses) statin users and
(iii) no statin therapy. We calculated the mean distance and percentage
LDL-C reduction required to reach dual LDL-C targets (>50%
reduction from baseline and <1.4 mmol/L). We assumed up-titration
from NHP-S to HP-S would further reduce LDL-C by approximately 510%; addition of ezetimibe 15-20% and PCSK-9 inhibitor 50-60%.
Results: Of 46,114 patients (60.7% males, mean age 76.213.3 years),
80.4% (n¼10945/13614) had LDL-C 31.4 mmol/L at 12-month after
index ACS with 60.2% (n¼18319/30450), 31.9% (n¼9726/30450) and
8.0% (2405/30450) of patients on no statin, NHP-S and HP-S, respectively. 86% of HP-S and 93% of NHP-S users did not reach dual LDL-C
targets at 12-month. Among patients on NHP-S and HP-S, the mean
LDL-C at 12-month was 2.00.7 and 2.10.9 mmol/L; and mean percentage LDL-C reduction required to reach dual LDL-C targets was
22.433% and 18.836%, respectively. Projected proportion of NHP-S
users to reach LDL-C targets is 11% (n¼430/3966) by up-titrating to
HP-S, 21% (n¼828/3966) by up-titration to HP-S plus ezetimibe and
100% (n¼3966/3966) with PCSK-9 inhibitor plus HP-S and ezetimibe.
Projected proportion of HP-S users to reach LDL-C targets is 13%
(n¼143/ 1099) by ezetimibe and 100% (n¼1099/1099) with addition of
PCSK-9 inhibitor.
Conclusions: The use of high-potency statin was low and almost all
statin users did not reach dual LDL-C targets at 12-month after index
ACS. High potency statin plus ezetimibe is projected to bridge about a
ﬁfth of these patients to target LDL-C. PCSK-9 inhibitor is likely
needed in the majority of patients who have not achieved target LDL-C
at 12-month after ACS to reach guideline recommendations.
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An Android App
Apolipoprotein B☆

"Apo

B

Calculator"

Calculates

P Dorairaj, M S, S Raju, A Chandrasekhar
Ashwin Clinic, Chennai, India
Background: Apolipoprotein B an important risk predictor for ASCVD
is not freely available.
Objectives: To derive the Apo B from a lipid proﬁle, using a regression
equation and a neural network and compare the results. LDL-C by
both Friedewald equation and direct LDL C were compared with
special reference to low LDL. An android app "Apolipoprotein B
Calculator" was developed to calculate and show the predictive accuracy of these results
Methods: 885 persons were split into a training and validation set of
442 and 443 persons.
Results: The regression equation Apo B ¼ 25.199+0.266 (LDL)+0.062
(TGL)+0.248 (Non-HDL-C) was the best predictor of Apo B when
directly measured LDL-C was used and Apo B ¼ 25.077+0.528
(F.LDL)+0.138 (TGL) when Friedewald equation was used. The predictive accuracy of Apo B from direct, and Friedewald LDL was 87.4%
and 86.4% with regression equation and 75% and 85% with neural
network. When LDL-C was <70 mg%, the accuracy of the Friedewald
equation was a better predictor of Apo B (70% vs 59.8%).
Conclusion: The regression equation derived from directly measured
LDL-C and Friedewald equation derived LDL-C, and the neural
network using the Friedewald equation showed near similar efﬁcacy in
predicting the Apo B value (87.4%, 86.4% and 85%). A regression
equation using a Friedewald formula is a better predictor of Apo B at
LDL-C levels <70 mg%. The app "Apo B Calculator" can predict the
Apo B from both directly measured and Friedewald equation derived
LDL-C and give the predictive accuracy for the method.
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Colchicine in Patients With Acute Myocardial Infarction:
An Updated Meta-analysis of Randomized Controlled
Trials
RJ Mendoza, R Jimenez, RH Tiongco II, JA Bautista
St. Luke's Medical Center Global City, Taguig, Philippines
Background: Improvement in cardiovascular outcomes and treatment with anti-inﬂammatory agents have been the subject of

27

J HK COLL CARDIOL 2022;28(3):i 1–42

sub-distribution hazard ratio [SHR]¼0.42; 95% Conﬁdence Interval
[CI], 0.38 to 0.46) after accounting for death as a competing risk.
Moreover, the male gender was associated with a 51% lower risk of
dementia incidence (multivariable-adjusted SHR¼0.59; 95%CI (0.540.65) compared with females.
Conclusions: Our study suggests that there is substantial sex difference
in the incidence of dementia among HF patients. Moreover, statin use
is associated with a signiﬁcantly lower risk of incident dementia in HF.

ABSTRACTS: HEART FAILURE
11

Stress (Tako-tsubo) Cardiomyopathy in Critically-ill
Patients in ICU Setting at a Teriary Care Center in
North India: A 2 Year Study
HI Showkat, S Anwar
Grecian Superspeciality Hospital, India
Background: Tako-tsubo Cardiomyopathy also called as Stress Cardiomyopathy (SC) is a transient ventricular dysfunction associated
with regional wall abnormalities but normal coronaries, has been reported in the critically ill patients in ICU setting.
Method: This is a prospective observational study of critically-ill patients who got admitted to the ICU at tertiary cardiac center over a
period of two years (2016-2017) & detected to have Taka-tsubo
cardiomyopathy.
Results: Out of 1636 critical patients admitted in the ICU, 16 patients
(0.9%) were diagnosed to have SC with male/female ratio of 1:4.2. 50%
patients presented with dyspnea while 75% presented with chest pain
& 62.5% patients were having features of heart failure. All patients had
ECG, cardiac enzymes & Echocardiography were done while Coronary
angiography (CAG) was done only in 13 (81.25%) cases. ECG suggestive of Acute Myocardial Infarction was seen in 12 (75%) patients.
Typical Tako-tsubo cardiomyopathy changes were seen on echocardiography in 14 (87.5%) and atypical in 2 (12.5%) of cases. CAG done in
13 patients showed no signiﬁcant epicardial coronary artery disease.
Out of 16 patients, one patient died in the hospital. All patients showed
complete reversal of Left Ventricular dysfunction & Regional Wall
Motion abnormalties (RWMA) in 3 to 6 months.
Conclusions: Tako-tsubo cardiomyopathy is reversible cardiac disorder which may rarely be detected in the critically-ill patients who are
admitted in ICU. It can precipitate arrhythmias and/or heart failure
which may lead to increased mortality. High index of suspicions is
required for the early detection.
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Heart Failure Outcomes After Percutaneous Coronary
Intervention in Non-ischemic Stable Coronary Artery
Disease
Patients
Based
on
a
Novel
Index:
Computational
Pressure-ﬂow
Dynamics
Derived
Fractional Flow Reserve
CKL Leung 1, LY Lam 1, KY Li 1, SY Yu 2, MZ Wu 2, QW Ren 2,
PF Wong 2, YK Tse 1, SY Yu 1, HL Li 1, Y Feng 3, Y Huo 3, HF Tse 2,
KH Yiu 2
1
The University of Hong Kong, Hong Kong SAR
2
Queen Mary Hospital, Hong Kong SAR
3
PKU-HKUST Shenzhen-Hongkong Institution, Shenzhen, China
Background: Computational pressure-ﬂow dynamics derived fractional ﬂow reserve (caFFR) is a novel index to evaluate the extent of
functional myocardial ischemia in coronary artery disease (CAD) patients, eliminating the need of an invasive pressure wire and hyperaemic stimulus needed in conventional fractional ﬂow reserve
measurement. The diagnostic performance of caFFR has been validated previously and is potentially useful in guiding percutaneous
coronary intervention (PCI) treatment in CAD patients. However, the
clinical value of caFFR on heart failure (HF) outcomes is uncertain in
CAD patients who do not have signiﬁcant functional myocardial
ischemia. This study aims at evaluating the impact of PCI on HF
hospitalization and HF associated mortality in non-ischemic stable
CAD patients as stratiﬁed by caFFR.
Methods: A total of 420 patients (mean age 66.911.0; male 69.0%) with
stable CAD without signiﬁcant functional myocardial ischemia as
deﬁned by caFFR>0.80 were included. Patients were subsequently
stratiﬁed into those with PCI (n¼307) and without PCI (n¼113). The
primary endpoint was deﬁned as a composite of HF hospitalization
and HF associated mortality.
Results: The number of obstructive lesions was 1.81.1 in patients with
PCI and 1.40.8 in those without PCI (P¼0.001). The severity of CAD
assessed by SYNTAX score was higher in patients with PCI compared to
those without PCI (10.15.8 vs. 6.23.9, P<0.001). A total of 37 events
occurred at 3 years (28 HF hospitalization and 9 HF associated mortality).
The 1-year incidence rate of primary endpoint was 3.3% in patients with
PCI and 3.5% in those without PCI (P¼1.000). With multivariable
adjustment, the primary endpoint rate at 3 years was similar between
patients with PCI and those without PCI (8.1% vs. 6.2%; adjusted hazard
ratio¼1.039; 95% conﬁdence interval¼0.438-2.468;P¼0.931).
Conclusion: In stable CAD patients without signiﬁcant functional
myocardial ischemia, deﬁned by caFFR>0.80, PCI does not prevent HF
hospitalization and HF associated mortality.
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Statin Use is Associated With Lower Risk of New Onset
Dementia in Patients With Heart Failure: A Populationbased Study
QW Ren 1, YK Tse 1, HL Li 1, SY Yu 1, PF Wong 1, MZ Wu 1, HF Tse 2,
KH Yiu 2
1
The University of Hong Kong
2
Queen Mary Hospital, Hong Kong SAR
Background: Increasing number of heart failure (HF) patients diagnosed with dementia due to improved treatment and aging population. Data relating to the association of statin use on the risk of
dementia incidence among patients with HF are sparse.
Methods: Using a previously validated territory-wide clinical information registry, statin use was ascertained among all eligible patients
with HF (N¼241,995) from 1996 to 2019. Propensity score matching was
used to balance baseline covariates between statin nonusers (167,738
patients) with statin users (74,257 patients). Competing risk regression
with Cox proportional-hazard models was performed to estimate the
risk of incident dementia associated with statin use.
Results: Of all eligible subjects, the mean age was 76.513.0 years,
115,371 (47.7%) was male. Over a median follow-up of 2.7 years
(interquartile range [IQR]: 0.6 to 6.7), 13,482 (5.6%) patients were
diagnosed with dementia including Alzheimer's disease (N¼5,253),
senile dementia uncomplicated (N¼4,273), arteriosclerotic dementia
(N¼3,262), and others (N¼694). Statin use (vs. none) was associated
with a 58% lower risk of dementia incidence (multivariable-adjusted
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The Inﬂuence of Dapagliﬂozin on Functional Heart
Parameters in Patients With Type 2 Diabetes Mellitus
and Prior Myocardial Infarction
L Zhuravlyova, M Filonenko, M Kulikova, N Sokolnikova
Kharkiv National Medical University, Kharkiv, Ukraine
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Background: Sodium-glucose cotransporter-2 inhibitors are the new
promising oral hypoglycemic drugs, which potentially may reduce the
risk for for cardiovascular mortality or heart failure hospitalization.
Purpose: To determine the effect of dapagliﬂozin on left ventricular
systolic function in patients with type 2 diabetes mellitus (T2DM) and
prior myocardial infarction (MI).
Methods: A total of 35 patients with T2DM and prior MI were examined (mean age 598, body mass index 32.64.7, HbAlc 9.22.1).
Cardiac ultrasonography was performed twice with 6-month interval
within the ﬁrst year post-MI. All patients had reduced ejection faction
(EF<45%). All patients received metformin initially, dapagliﬂozin was
added to improve glycemic control. Metabolic parameters measured
included fasting plasma glucose, immune-reactive insulin, glycosylated hemoglobin and HOMA-IR index.
Results: During the studied period, examined patients demonstrated
a signiﬁcant decrease in left ventricular end diastolic volume (-15.3%;
53.23.7 mm; p¼0.02) and left ventricular end systolic volume (-18.5%;
38.33.3 mm; p¼0.03), while EF increased +5.4% (45.82.4%;
p¼0.006). An increase in EF was noted in total of 82.3% of patients by
the time of the second visit. Also, a signiﬁcant improve of glycemic
control was found in examined patients - HbAlc decreased by 1.03
(8.22.2%).
Conclusion: The obtained data suggest that the use of dapagliﬂozin
in combination with metformin not only improves glycemic
control in patients with T2DM and prior MI, but also promotes the
recovery of left ventricular systolic function and myocardial
contractility, thus slowing down the development of heart failure in
such patients.

ABSTRACTS: HYPERTENSION AND HYPERLIPIDAEMIA
5

Aggressive Lipid Lowering After CABG: What is the Ideal
Target?
K Lim, CHM Wong, T Fujikawa, SCY Chow, YK Ho, RHL Wong
Prince of Wales Hospital, Hong Kong SAR
Background: Secondary prevention is critical to long-term event-free
survival after CABG. Although the use of high-intensity statins are
highly recommended by most American and European guidelines,
data regarding the ideal low density lipoprotein (LDL) and non-highdensity lipoprotein (non-HDL) cholesterol target is scare.
Methods: We performed a retrospective analysis of 335 consecutive
patients who underwent isolated CABG from 1st January 2007 to 31st
December 2008 at the Prince of Wales Hospital. Available lipid measurements in the years following CABG were obtained, and annualized lipid exposure was calculated for LDL and non-HDL. Database
lock date was 15th August 2020.
The primary endpoint was cardiac death. The secondary endpoint was
non-fatal cardiac events, which is a composite of (1) fatal and non-fatal
myocardial infarction, (2) target lesion revascularization (TLR) and (3)
hospitalization for unstable angina.
Survival estimates were generated with the Kaplan–Meier method.
Event- free survival models were developed based on time to the
earliest event. Cox proportional hazards regression was used to
calculate hazards ratio.
Results: There were 3 inpatient deaths (0.90%). Follow-up was complete in 97.6%. 22.4% had a cardiac event and 9.6% requiring TLR.
The regression model included the seven clinical factors of the SYNTAX II score as well as the presence of diabetes. Non-HDL and LDL
were incorporated separately to avoid collinearity. Left ventricular
ejection fraction, the presence of diabetes, LDL and non-HDL were
independent predictors of cardiac death. However, neither LDL nor
non-HDL predicts cardiac events.
Area under the receiving operating characteristics curve (AUC)
analysis was performed to determine an ideal LDL and non-HDL
target associated with reduced cardiac death. The AUC was
0.694 [95% CI 0.575-0.813] (p¼0.002) for non-HDL and 0.660 [95%
CI 0.533-0.787] for LDL (p¼0.009) respectively. The Youden Index was
0.076 at a cut- off of 1.963 mmol/L for non-HDL and 1.475 mmol/L
for LDL.
Conclusion: Exposure to elevated LDL and non-HDL cholesterol
independently predicts cardiovascular mortality after CABG.
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The Study of the Relationship Between Left Atrial
Volume and Left Ventricular Diastolic Dysfunction and
Left Ventricular Hypertrophy: Correlation of Left Atrial
Volume With Cardiovascular Risk Factors
SG Pawar 1, A Mulay 2
1
Bharati Vidyapeeth Medical College Hospital and Research Center
2
N M WADIA Institute of Cardiology, Pune, India
Introduction: In approximately 30-50% of the individuals who develop
congestive cardiac failure the systolic function as assessed by left
ventricular (LV) ejection fraction is either normal or relatively normal.
Aim: To study the relationship between left atrial (LA) volume and LV
diastolic dysfunction and LV hypertrophy and correlate LA volume
with cardiovascular risk factors.
Methodology: A total of 400 patients were included in the study. These
patients underwent a screening echocardiography to diagnose left
ventricular hypertrophy and diastolic dysfunction.
Result: There is a signiﬁcant correlation between left ventricular hypertrophy and diastolic dysfunction. 86% patients with evidence of
diastolic dysfunction by tissue Doppler had a higher left atrial volume.
Conclusion: Increased left ventricular mass is associated with
increasing severity of diastolic dysfunction. Increased left ventricular
mass is also associated with increased left atrial volume indexed to
body surface area. Left atrial volume correlates with the duration of
type 2 diabetes. Increasing severity of left ventricular diastolic
dysfunction correlates signiﬁcantly with left atrial
volume indexed to body surface area. At milder degrees of diastolic
dysfunction, left atrial enlargement may not be the best predictor of
severity. But with increasing severity of diastolic dysfunction in left
ventricular hypertrophy, left atrial volume indexed to body surface
area may be a sensitive and easy marker for assessment of severity and
thus the long-term prognosis in terms of atrial ﬁbrillation, stroke and
mortality.
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Proportion of Patients Taking Indapamide Developing
Severe Hypokalaemia
Z Lin, V Tang, MF Tsoi, BMY Cheung
Department of Medicine, The University of Hong Kong, Hong Kong SAR
Background: Indapamide was by far the most commonly used diuretic
for hypertension in Hong Kong. Yet, hypokalaemia is a well-recognized adverse effect. To evaluate the proportion of patients taking
indapamide who developed severe hypokalaemia, deﬁned as
requiring hospitalization, we searched the Hong Kong Hospital Authority Clinical Data Analysis and Reporting System, a territory-wide
database of computerised medical records.
Methods: All hypertensive patients prescribed indapamide monotherapy in 2007-2016 and all admissions due to hypokalaemia in 20072018 were traced. Factors associated with hospitalisation were studied
using multivariable logistic regression.
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Background: Even a slight increase in blood pressure (BP) contributes
to the progression of cardiovascular pathology in patients with diabetes mellitus (DM). Currently, a plenty of data are available on the
inﬂuence of various factors, such as oxidative stress, arterial hypertension (AH), obesity, etc., on the development of non-coronary
myocardial diseases in diabetic patients. However, the existence of
relationships between adipokines (in particular, resistin) and hypertension in patients with type 2 diabetes remains understudied.
The aim of our study was to identify the relationship of resistin with the
level of blood pressure in patients with type 2 diabetes with and
without hypertension.
Methods: The ﬁrst group consisted of 65 patients with type 2 diabetes
with concomitant hypertension, the second group included 37 patients
with type 2 diabetes without hypertension. Groups were comparable
in age and gender. Systolic blood pressure (SBP), diastolic blood
pressure (DBP) were measured; the average hemodynamic blood
pressure (AHBP) was determined in all patients. The resistin level was
determined by the sandwich immunoassay method.
Results: In the 1st group of patients, the level of SBP (mm Hg) was
147.842.21, DBP (mm Hg) - 93.521.83, AHBP (mm Hg) - 11.732.98.
In the 2nd group of patients, the SBP level was 124.222.08, DBP 83.411.47, AHBP - 97.101.66. The level of resistin (ng/ml) in the 1st
group of patients was 13.960.73, and in the 2nd group - 11.240.46. A
signiﬁcant relationship was found between AHBP and resistin level
(p<0.05) in the 1st group of patients (R¼0.34), while in the 2nd group
such relationship was also present, but insigniﬁcant (R¼0.22, p>0.05).
Conclusions: Patients with type 2 diabetes and arterial hypertension
have higher level of resistin than patients with type 2 diabetes without
hypertension and also a signiﬁcant relationship was found between
the level of average hemodynamic blood pressure and resistin in the
main group. We believe that resistin, along with other factors, is
involved in the development of cardiovascular pathology in patients
with diabetic cardiomyopathy, and this contribution is more signiﬁcant
in patients with hypertension.

Results: During the study period, 62,881 patients were started on
indapamide and 509 (0.81%) were hospitalised for hypokalaemia. 59%
of these hospitalisations occurred within 16 weeks. Female sex
(OR¼1.73; 95%CI, 1.43-2.09) and immediate-release formulation
(OR¼1.44; 95%CI, 1.16-1.78) were associated with hospitalisation. In
the multivariable model, advanced age was not a signiﬁcant predictor.
There were no deaths during hospitalisation and the median length of
hospital stay was one day.
Conclusion: In this large population-based study with 147614 personyears of follow-up, severe hypokalaemia requiring hospitalisation was
uncommon among hypertensive patients on indapamide. Half of these
occurred during the ﬁrst 16 weeks. Female sex and the immediate
release formulation increased the risk. We conclude that using indapamide to treat hypertension is safe, even in the elderly, especially if
the sustained release formulation is used and electrolytes are monitored periodically.
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Prevalence of Metabolic Syndrome in the United States
National Health and Nutrition Examination Survey
(NHANES) 2011-2018
X Liang, B Or, M.F Tsoi, BMY Cheung
Division of Clinical Pharmacology and Therapeutics, Department of
Medicine, The University of Hong Kong, Hong Kong SAR
Background: Metabolic syndrome (MetS) is a cluster of risk factors
presaging the development of cardiovascular disease and diabetes. It is
a risk factor for severe coronavirus disease 2019 (COVID-19). To estimate the prevalence of MetS in the US National Health and Nutrition
Examination Survey (NHANES) 2011-2018.
Methods: This cohort study included 22370 eligible participants
aged 320 years from the NHANES 2011-2018. MetS was deﬁned
as the presence of at least three of these components: central
obesity, reduced high-density lipoprotein, elevated triglycerides,
elevated blood pressure and elevated fasting blood glucose. The
prevalence of MetS was estimated taking into account the complex
sampling. The time trend was evaluated using logistic regression.
Annual percentage changes (APC) were measured trend in MetS
prevalence.
Results: The prevalence of MetS was 36.2% (95% CI, 32.3-40.3), 34.8%
(95% CI, 32.3-37.4), 39.9% (95% CI, 36.6-43.2) and 38.3% (95% CI,
35.3-41.3) in 2011-2, 2013-4, 2015-6, 2017-8, respectively (P for
trend ¼.08). Among the MetS components, the prevalence of
elevated glucose increased from 48.7% (95% CI, 45.9-51.5) in 2011-2 to
64.3%
(95% CI, 61.0-67.4) in 2017-8 [P for trend <0.001; APC¼11.7, (95% CI,
3.5-21.0)]. The prevalence of MetS in non-Hispanic Asian increased
from 21.8% (95% CI, 16.7-28.0) in 2011-2 to 31.2% (95% CI, 27.4-35.3) in
2017-8 [P for
trend <.001; APC¼14.6, (95% CI, 2.5-34.8)].
Conclusion: The prevalence of MetS remained stable during 2011 to
2018. Lifestyle modiﬁcation is needed, especially among non-Hispanic
Asians to prevent the metabolic syndrome and the associated risks of
diabetes and cardiovascular disease.
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Hypertension as an Intensiﬁcation Factor of Metabolic
and Inﬂammatory Deviations in Patients With Nonalcoholic Fatty Liver Disease
A Rozhdestvenska, N Zhelezniakova
Kharkiv National Medical University, Kharkiv, Ukraine
Background: Arterial hypertension (HT) is of the main cardiometabolic
pathologies, affecting about 30% of the population, and about 50% of
patients with HT have non-alcoholic fatty liver disease (NAFLD).
Convincing evidence suggests a bidirectional effects of pathologies.
Objective: to study the effect of HT on the course of NAFLD in patients
with comorbidity of pathologies.
Methods: We examined 63 patients with HT I-II grade in combination
with NAFLD in non-alcoholic steatohepatitis (NASH) stage and 52
patients with isolated NASH. The control group consisted of 20 relatively healthy volunteers. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were determined by spectrophotometric
method. The C-reactive protein (CRP) levels were evaluated using a
highly sensitive method (hs-CRP ELISA) (Biomerica, USA). HOMA-IR
was calculated according to the generally accepted formula. Statistical
analysis was performed according to standart methods.
Results: There were signiﬁcantly more cases of moderate (41.27%) and
severe (7.94%) steatohepatitis in HT and NAFLD group, while in the
group with isolated NASH moderate NASH was only in 7.69% of patients (df¼1, c2 ¼16.657, p<0.001), and no cases of severe pathology were
determined (df¼1, c2 ¼4.315, p¼0.038). CRP level averaged 7.90 mg/l (SD
1.57) in patients with HT and NAFLD versus 6.55 (SD 1.61) in patients
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A Connection of Resistin With Arterial Hypertension in
Patients With Siabetes Mellitus
L Zhuravlyova, N Sokolnikova, M Filonenko, T Rogachova
Kharkiv National Medical University, Kharkiv, Ukraine
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with isolated NAFLD and 2.07 mg/l (SD 0.33) in control values (p<0.001).
Liver enzymes were also signiﬁcantly increased in patients with HT
and NAFLD. ALT in comorbid patients averaged 79.00 IU/l (SD 13.86),
that was higher, than in NAFLD group (69.00 IU/l (SD 9.88), p<0.001)
and in control group (20.00 IU/l (SD 5.50), p<0.001) in 1,14 and 3,95
times, respectively. AST level was 75.05 IU/l (SD 14.60) in patients with
HT and NAFLD versus 54.00 IU/l (SD 6.88) in isolated NAFLD patients
and 16.50 IU/l (SD 5.00) in control results (p<0.001).
The HOMA-IR in HT and NAFLD patients was 4.67 mmol/LmOD/ml
(SD 0.66) versus 3.40 (SD 0.47) in group with isolated NAFLD and 2.28
(SD 0.26) in control group (p<0.001).
Conclusion: NAFLD is much more severe in patients with HT, and its
course is associated with a more pronounced inﬂammatory response
and more striking liver enzymes changes, that may be a consequence
of increased insulin resistance. These data allow us to draw conclusions about the serious negative impact of HT on course of NAFLD in
patients with this comorbidity.

steatohepatitis in patients with NAFLD: OR¼1.075 [95,0%CI 1.0071.147], p¼0.030.
Conclusions: Hypertension in NAFLD-patients is associated with
progression of liver damage, which manifests by increase in liver
enzymatic activity. The use of APRI can be an informative non-invasive
indicator of the liver damage degree in patients with NAFLD and
hypertension, and more clearly reﬂect the condition of liver parenchyma than levels of liver enzymes.
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Background: Recognizing traditional risk factors is important to secondary prevention for cardiovascular diseases (CVD) event recurrence. The aim of this study was to investigate the effect of traditional
risk factors with CVD event recurrence by using the data from the
Bethesda Stroke Registry in Indonesia.
Methods: This cross-sectional study was based on a stroke registry,
data were collected using electronic medical records in the Bethesda
Hospital Yogyakarta Indonesia. All patients 318 years of age, who
developed ischemic stroke between January 1, 2011, and December 31,
2018, were included in this study. Traditional risk factors included
genre, age, hypertension, type 2 diabetes-mellitus(T2DM), atrial
ﬁbrillation (AF), and hyperlipidemia. The statistical measures calculated were chi-square- test and logistic regression.
Results: Among the 8248 patients involved in this study, there were
4937 (59.9%) men patients and 3311(40.1%) women patients. Of these
patients, aged 350 years old of stroke was 6979( 84.6%). Multivariate
analysis showed men (p:0.001, RR:1.186, 95%CI:1.068-1.317), older age
(p<0.001, RR:1.363, 95% CI:1.205-1.542), T2DM (p<0.001, RR:1.363, 95
%CI:1.205-1.542) and hypertension (p 0.002, RR:1.174, 95 %CI:1.0601.300) was signiﬁcantly associated with recurrence CVD event.
Conclusions: Older age, men, hypertension, and T2DM were independent predictors of recurrent CVD events. Recurrent CVD event
patients were more likely to had older age, men, hypertension, and
T2DM.
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The Determinant of Traditional Risk Factors for
Cardiovascular Disease Event Recurrence in the
Atherosclerotic Disease: A Multivariate Analysis Study
NH Karunawan 1, R.T Pinzon 2
Tugurejo General Hospital, Semarang
2
Duta Wacana Christian University, Yogyakarta, Indonesia
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Clinical Signiﬁcance of the AST to Platelet Ratio Index in
Patients With Non-alchoholic Fatty Liver Disease and
Hypertension
I Tverezovska, N Zhelezniakova
Kharkiv National Medical University, Kharkiv, Ukraine
Background: Hypertension is considered as one of the etiological
factors of metabolic disorders in liver. NAFLD is the most common
cause of chronic liver disease with a prevalence of 20.0-50.0%. Liver
tests might not always reliably reﬂect the degree of liver damage in
NAFLD with pre-existing hypertension, while APRI is an indicator of
long-term fatty degeneration of liver tissue and more accurately reﬂects the actual degree of damage to the liver parenchyma.
Aim: To determine the role of hypertension in the progression of liver
damage in patients with NAFLD.
Methods: Main group: 26 patients with hypertension (grade 1-2 and
stage 1-2) in combination with NAFLD; comparison group - 23 patients
with an isolated NAFLD. Control group - 22 relatively healthy individuals. Patients underwent an examination according to Healthcare
Protocols, including liver tests and assessment of hepatic steatosis. The
APRI index was calculated as the ratio of ACT to its upper limit value
and to platelet level. Logistic regression was used to assess the association between parameters.
Results: Among patients with comorbid NAFLD and hypertension,
40.9% of steatosis and 59.1% of steatohepatitis were detected. In
comparison group corresponding indicators were 73.7% and 26.3%
(p¼0,035). In main group SBP and DBP were 149.97.4 mmHg and
87.47.6 mmHg and signiﬁcantly (p<0.001) exceeded values in comparison group (123.59. 7 mmHg and 76.910.7 mmHg).
Mean ALT and AST in controls were 25.19.4 U/l and 22.38.9 U/l. In
patients with isolated NAFLD -35.710.3 U/l and 33.318.7U/l; and in
main group -47.98.4 U/l and 41.66.7U/l. Parameters were signiﬁcantly higher in patients of main than of comparison group (p<0.001
and p¼0.004). Despite signiﬁcant difference, no signiﬁcant association
was found between hypertension, ALT, and AST levels.
APRI in controls was 0.30.1; in main group -0.70.2, which signiﬁcantly (p¼0.001) exceeded the value in comparison group (0.4 0.1).
Signiﬁcant association between APRI and concomitant hypertension in
patients with NAFLD was found: OR¼0.001 [95.0%CI 0.000-0.079],
p¼0.003.
Steatohepatitis was signiﬁcantly associated with concomitant hypertension (OR¼0.247 [95.0%CI 0.065-0.934], p¼0.039). Analysis showed
association of steatohepatitis with 2nd stage hypertension (OR¼7,000
[95.0%CI 1,014-48,312], p¼0.048). SBP was associated with
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Strategies to Bridge Therapeutic Gap in Low-densitylipoprotein Cholesterol Lowering Among 90,818 Chinese
With Atherosclerotic Cardiovascular Diseases
B Yan, H Sun, A Lai
The Chinese University of Hong Kong, Hong Kong SAR
Background: Current guideline recommends addition of proprotein
convertase subtilisin kexin type 9 inhibitors (PCSK9i) to achieve lowdensity-lipoprotein cholesterol (LDL-C) lowering by 350% to target
LDL-C <1.4 mmol/L for patients with atherosclerotic cardiovascular
disease (ASCVD) already on maximum tolerated dose of statin. We
aimed to evaluate the residual distance to target LDL-C in ASCVD
patients on statin monotherapy and the projected improvement by uptitration to high potency statin, addition of ezetimibe and PCSK9i.
Methods: We retrospectively analyzed 90,818 patients with ASCVD on
stable statin monotherapy prior to lipid proﬁle assessment from 43
public hospitals in Hong Kong between Aug 2016 and Jul 2020. Patients
were divided into (i) high potency statin (HP-S; rosuvastatin 320 mg,
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atorvastatin 340 mg or simvastatin 380 mg) and (ii) non-high potency
statin (NHP-S; other statin doses) statin users. We calculated the mean
percentage LDL-C reduction required to reach the target of LDL-C
lowered by 350% and <1.4 mmol/L. We assumed up-titration from
NHP-S to HP-S would further reduce LDL-C by approximately 10%;
addition of ezetimibe 20% and PCSK9i 60%.
Results: Of 90,818 patients (63.2% male, mean age 66.911.3), 80.3%
had coronary artery, 1.7% had peripheral artery and 21.1% had cerebrovascular disease; 18.7% were on HP-S and 81.3% on NHP-S. LDL-C
target was not achieved in 96.9% (n¼71,545/73,865) patients on NHP-S
and 93.9% (n¼15,911/16,953) patients on HP-S. In these patients, mean
LDL-C was 1.80.6 and 1.90.6 mmol/L and mean percentage LDL-C
reduction required to reach LDL-C target was 40.615.3% and
36.526.2%, respectively. The proportion of patients who required 510%, 10-30%, 30-50% and 350% further reduction to reach target LDL-C
were 1.3%, 22.6%, 44.1%, 31.2% on NHP-S, and 7.6%, 23%, 28.9%,
32.8% on HP-S, respectively. Proportion of NHP- S patients projected
to reach LDL-C goal by up-titrating to HP-S is 2.2% (n¼1,561/71,545).
Addition of ezetimibe is projected to achieve LDL- C target in 21.9%
(n¼18,787/85,895) patients on HP-S who are not at goal. Overall, 76.7%
(n ¼67,108/87,456) of patients on HP-S and ezetimibe were expected to
need PCSK9i and is projected to achieve LDL-C target in 96.4% of cases
(n¼64,671/67,108).
Conclusions: Our 'real-world' study showed the use of HP-S in ASCVD
patients was low and >90% did not reach LDL-C target. High potency
statin plus ezetimibe was projected to bridge more than one ﬁfth of
these patients to target LDL-C. PCSK9i is likely required in signiﬁcant
number of patients despite HP-S plus ezetimibe.
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Proton Pump Inhibitor and Infection in Patients With STElevation Myocardial Infarction
YH Liu 1, PC He 1, YN Dai 1, CY Duan 2, N Tan 1, JY Chen 1
1
Guangdong Provincial People's Hospital
2
Southern Medical University, China
Background: Infectious complications are prevalent in patients with
acute myocardial infarction (AMI), which worsens their outcomes.
Proton pump inhibitor (PPI) usage potentially increases infection in
several cohorts. However, whether PPI therapy affecting the development of infection in AMI patient is poorly understood.
Methods: In this prospective study, we consecutively enrolled STelevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI) from January 2010 to June 2018.
The patients were then divided into a PPI group and a non-PPI group,
according to whether a PPI was given after admission. The primary
endpoint was infection during hospitalization.
Results: A total of 3027 patients were enrolled, and 310 (10.2%) patients
developed infection during hospitalization. Higher incidence of
infection was observed in the PPI users when compared to non-PPI
users (11.5% versus 7.0%, P<0.001). Multivariate logistic regression
analysis showed that PPI use was positively associated with infection
(OR¼1.78, 95% CI¼1.22-2.59, P¼0.003), in-hospital all-cause mortality
(OR¼2.13, 95% CI¼1.14-3.99, P¼0.018), and major adverse clinical
events (MACE) (OR¼2.42, 95% CI¼1.44-4.09, P¼0.001). The propensity
score analyses further veriﬁed these ﬁndings.
Conclusions: PPI usage was associated with higher incidence of
infection during hospitalization, in-hospital all-cause mortality, and
MACE in STEMI patients.

ABSTRACTS: PERCUTANEOUS CORONARY INTERVENTION
1

The Optimal Percutaneous Coronary Intervention
Strategy For Patients With ST-segment Elevation
Myocardial Infarction and Multivessel Coronary Artery
Disease: A Pairwise and Network Meta- analysis

45

Retrospective Study on Primary Percutaneous Coronary
Intervention Versus Thrombolytic Therapy Outside
Ofﬁce Hours Under the New Cluster-based 24-hour
Primary PCI Program

MJ Hu
State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National
Center for Cardiovascular Diseases, Beijing, China

PH Lee
Queen Elizabeth Hospital, Hong Kong SAR

Background: The option of percutaneous coronary intervention (PCI)
strategy is still at dilemma in patients with ST-segment elevation
myocardial infarction (STEMI) and multivessel coronary artery disease.
Methods: Trials that randomized patients with STEMI and multivessel
coronary artery disease to immediate multivessel PCI, staged multivessel PCI, or culprit-only PCI and prospective observational studies
that investigated all-cause death were included. Random effect risk
ratio (RR) and 95% conﬁdence interval (CI) were conducted.
Results: A total of 13 randomized trials with 7,627 patients and 21
prospective observational studies with 60,311 patients were included.
In the pairwise and network meta-analysis based on randomized trials,
multivessel PCI (immediate or staged) was associated with a lower risk
of long-term major adverse cardiac events (MACE; RR: 0.58; 95% CI:
0.45 to 0.74) compared with culprit-only PCI, which was mainly due to
lower risks of myocardial infarction (RR: 0.67; 95% CI: 0.51 to 0.88) and
revascularization (RR: 0.38; 95% CI: 0.28 to 0.51), without any signiﬁcant difference in all-cause death. However, results from real-world
prospective observational studies suggested that staged multivessel
PCI reduced all-cause death, whereas immediate MV-PCI increased
short-term all-cause death relative to culprit-only PCI.
Conclusions: For low-risk patients, MV-PCI at an immediate or staged
procedure was preferred due to improvements in long-term outcomes,
whereas in high-risk patients, staged MV-PCI was preferred yet immediate MV-PCI may increase short-term all-cause death, which
should be evaluated in future randomized trials.

Introduction: Acute STEMI represents a unique patient population
carrying high morbidity and mortality. Timely effective coronary
reperfusion is the major determinant of patient outcome. In Hong Kong,
thrombolytic therapy remains the mainstay of reperfusion strategy in
STEMI patients presenting outside ofﬁce hours. A 24-hour PCI program
was launched in October 2018 based on Kowloon Central Cluster.
Objective: To compare 30-day mortality and major bleeding event in
patients receiving historical thrombolytic therapy and primary PCI as
the reperfusion strategy for patients with acute STEMI presenting
outside ofﬁce hours.
Method: A single center retrospective study was conducted in Queen
Elizabeth Hospital on consecutive STEMI patients presented outside
ofﬁce hours, who received urgent thrombolytic therapy between
January 2016 and September 2018 and primary PCI between October
2018 and December 2019. The primary endpoints measured were 30day mortality and major bleeding event, deﬁned as BARC type 3 or
type 5. The secondary endpoints measured were thrombolytic failure
rate, unplanned revascularization and hospital length of stay.
Results: 188 patients in thrombolytic group and 143 patients in primary
PCI group were analyzed. 30-day mortality occurred in 11.7% and 4.2%
of patients in thrombolytic therapy group and primary PCI group
respectively (P¼0.02). Major bleeding events occurred in 8% and 2.1% in
thrombolytic and primary PCI group respectively (P¼0.02). Among the
subset of patients who presented early (£3 hours from symptoms onset),
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that PCI should be advocated to intermediate lesions even without
myocardial ischemia.

there was a trend towards lower mortality rate (4.9% vs 6.8%, P¼0.58)
and fewer major bleeding events (3.7% vs 6%, P¼0.47) in primary PCI
group. Among the subset of elderly population (age 375), primary PCI
group has a signiﬁcantly lower composite outcome (17.6% vs 41.9%,
P¼0.03) and fewer major bleeding events (8.8% vs 29%, P¼0.04).
Regarding 30-day mortality in this subset, primary PCI group also had
lower 30-day mortality rate (17.6% vs 38.7%, P¼0.06), though this did not
reach statistical signiﬁcance. Thrombolytic failure occurred in 31.4% of
patients and unplanned revascularization in 25.5% of patients receiving
thrombolytic therapy. The median length of stay was not different between the two groups (5 [IQR 4-7] days vs 4 [IQR 3-7] days, P¼0.29).
Conclusion: Compared with thrombolytic therapy, primary PCI in
patients with acute STEMI presenting outside ofﬁce hours is associated
with lower risks of 30-day mortality and major bleeding event. The
superiority of mechanical reperfusion strategy was consistent across
the different age categories.
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LGE-cMRI
Assessment
of
Volume
Controlled
Reperfusion Method in Primary Percutaneous Coronary
Intervention in Patients With ST Elevated Myocardial
Infarction
JF He, LF Wang
Heart Center, Beijing Chao-yang Hospital, Capital Medical University,
Beijing, China
Objectives: We create a procedure based on postconditioning and
gradual reperfusion, "Volume Controlled Reperfusion Revascularization" method (VCR) in primary percutaneous coronary intervention.
The aim of this experimental study is to assess feasibility and effect of
VCR and if this method will attenuate reperfusion injury in microvascular obstruction.
Methods: VCR method, Basically, contemporaneous forward blood
ﬂow balloon inﬂation blocking at the occlusion site and prolonged
distal reperfusion via aspiration catheter. Active NC balloon inﬂation
at occlusion site, while keeping NC balloon inﬂation, aspiration catheter was positioned 10-15 mm advanced of NC balloon, intra- aspiration catheter infusion of mixture solution (artery blood 10 ml+ heparin
NS 10 ml), 20 ml/min for 10 mins, adjust volume and speed according
to blood pressure and heart rate variation. Stent or DCB as usual. After
several successful operation on RCA, 10 patients with acute STsegment elevation myocardial infarction (STEMI) with angiography
conﬁrmed proximal complete occlusion on dominant blood vessel
were non-randomly enrolled (symptom to angiography <12h). 5 cases
in VCR group with volume- controlled reperfusion revascularization
method, 5 cases in control group with conventional PCI method.
Microvascular obstruction (MVO) has been calculated by late gadolinium-enhanced cardiovascular magnetic resonance (LGE-cMRI).
Base line information, angiographic features before and after procedure, in-hospital status and MVO were compared.
Results: Successful PCI procedure, safe in-hospital treatment and LGEcMRI assessment for MVO. Group difference were found in age group
and PCI to MRI interval ( 53.87.6 vs 70.24.44, P¼0.0031; 7.42.3 vs
10.41.67, P¼0.046) between VCR and control group, respectively.
There was no statistic difference in other base line information, peak
myocardial enzyme, and BNP. MVO and MVO mass ratio was significantly lower in VCR group (0.780.96 vs 2.801.37, P¼0.0317;
0.005850.00080 vs 0.024930.01501, P¼0.0372). TIMI III blood ﬂow
found in VCR group. Re-myocardial infraction nor target vessel
revascularization was documented in-hospital or 30-days follow up.
Conclusion: Among the selected small sample cases, volumecontrolled reperfusion method procedure was clinical safe and feasible
without additional side effect. TIMI III blood ﬂow and less MVO were
documented.
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Long-term Prognostic Implications of Percutaneous
Coronary Intervention in Acute Coronary Syndrome
Patients With Intermediate Lesions That are Nonischemic on the Basis of Computational Pressure-ﬂow
Dynamics Derived Fractional Flow Reserve
JLY Lam 1, CKL Leung 1, KY Li 1, HL Li 1, MZ Wu 1, 2, QW Ren 1, 2,
YK Tse 1, SY Yu 1, ASY Yu 1, PF Wong 1, Y Feng 3, Y Huo 3, HF Tse 1,
KH Yiu 1, 2
1
Queen Mary Hospital, Hong Kong SAR
2
The University of Hong Kong Shenzhen Hospital, Shenzhen, China
3
PKU-HKUST Shenzhen- Hongkong Institution, Shenzhen, China
Background: A substantial proportion of patients with acute coronary
syndrome (ACS) may have intermediate lesion(s) that are nonischemic during emergency coronary angiography. The long-term
prognosis of such patients, compared to stable ischemic heart disease
(SIHD), is uncertain. The role of PCI in such ACS patients remains
underexplored. Computational pressure-ﬂow dynamics derived fractional ﬂow reserve (caFFR) has been developed to assess myocardial
ischemia without invasive pressure wire and hyperemic stimulus. Our
aim is ﬁrst to assess the prognostic differences between ACS and SIHD
with non-ischemia intermediate lesions. Second, we ascertain whether
PCI in these ACS patients provides survival beneﬁt.
Methods: We studied 551 patients (mean age 64.4 years; male 59.9%)
with absence of myocardial ischemia, deﬁned as caFFR¼0.80 in all
vessels. Patients were stratiﬁed into those with ACS (n¼132) and those
with SIHD (n¼491). Among the ACS cohort, patients were divided into
those with PCI (n¼83) and with medical therapy (MT) (n¼49). The
SIHD cohort, all treated with MT, was considered as the referent
group. The primary endpoint was major adverse cardiovascular events
(MACE) at 3 years, deﬁned as a composite of all-cause mortality,
myocardial infarction (MI), and any revascularization.
Results: During a follow-up of 36 months, 54 MACE occurred,
including 38 all-cause mortality, 5 MI, and 14 revascularization.
Compared to SIHD, ACS was independently associated with MACE
even in the absence of myocardial ischemia (adjusted HR¼2.531; 95%
CI¼1.397-4.586; P¼0.002). The 3-year incidence rate of MACE was the
highest in ACS patients with MT, followed by ACS patients with PCI;
SIHD patients had the lowest incidence rates (30.6% vs 12.0% vs 5.9%,
P<0.001). Similar ﬁndings were observed for hospitalization for heart
failure (14.3% vs 6.0% vs 3.1%, P¼0.031) and cardiovascular death
(8.2% vs 4.8% vs 0.4%, P<0.001) at 3 years.
Conclusion: In patients with intermediate lesion(s) without myocardial
ischemia, those presented with ACS had a higher risk of MACE at 3
years compared to SIHD. In patients with ACS, our ﬁnding suggests
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Comparison of Acute Angiographic Result And 1-year
Clinical Outcome of Intravascular Ultrasound Versus
Angiography Guided Percutaneous Cardiac Intervention
For Patients With Chronic Total Occlusion
JC Bi, WK Hau, BP Yan
Department of Medicine & Therapeutics, Faculty of Medicine, The Chinese
University of Hong Kong, Hong Kong SAR
Background: The impact of intravascular ultrasound (IVUS) on longterm clinical outcome in patients undergoing percutaneous coronary
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Results: The mean post-PCI caFFR was 0.910.04 and the interquartile
range was 0.89-0.94. The post-PCI caFFR was obtained in left anterior
descending artery in 138 (60%) patients, left circumﬂex artery in 20
(8.7%) patients, and right coronary artery in 72 (31.3%) patients. The
primary endpoint events occurred in 21 (9.3%) patients at 3 years. With
multivariable adjustment, per 0.01 increase in post-PCI caFFR was
associated with a signiﬁcantly lowered risk of primary endpoint events
at 3 years (adjusted hazard ratio [HR]¼0.905; 95% conﬁdence interval
[CI]¼0.840-0.973; P¼0.007). When the components of primary
endpoint were analyzed individually, per 0.01 increase in post-PCI
caFFR was associated with signiﬁcantly lowered risk of HF related
mortality (adjusted HR¼0.778; 95% CI¼0.622-0.973; P¼0.028) but not
HF related hospitalization at 3 years (adjusted HR¼0.981; 95%
CI¼0.865-1.111; P¼0.758).
Conclusion: In patients who presented with STEMI, higher post-PCI
caFFR is associated with signiﬁcantly lowered risk of HF related outcomes at 3 years, mainly driven by the lowered risk of HF related
mortality.

intervention (PCI) for chronic total occlusion (CTO) is not well established. This study aimed to evaluate IVUS guided compared to angiography-only guided CTO-PCI on acute angiographic result and 1year clinical outcome.
Methods: We analysed 528 consecutive patients undergoing CTO-PCI
at a University afﬁliated hospital in Hong Kong from February 2009 to
December 2016. Baseline patient characteristics, procedural characteristics, and 1-year clinical outcomes including cardiac death, nonfatal myocardial infarction (MI), target lesion revascularization (TLR),
and composite target lesion failure (TLF) were evaluated. The use of
IVUS, and the choice of PCI devices including plain old balloon angioplasty (POBA), bare metal stent (BMS), and drug eluting stent
(DES), were at the discretion of the operator. Propensity score
matching (PSM) was performed to reduce treatment selection bias and
potential confounding factors.
Results: 275 patients underwent 288 angiography-only guided and 253
patients underwent 268 IVUS-guided CTO-PCI. IVUS-guided CTOPCI was associated with higher procedural success compared to angiography-only guided CTO-PCI (77.5% vs. 55.3%, p<0.001). The types of
PCI devices used showed signiﬁcant group differences (p<0.001) where
DES were used more often in the IVUS-guided CTO- PCI group
compared with angiography-only guided group (85.3% vs. 65.6%),
while BMS were used less in IVUS-guided CTO-PCI group (9.3% vs.
26.1%). After PSM for successful CTO stented patients, angiographyIVUS guidance was associated with more post stent balloon dilatation
(84.7% vs. 56.3%, p<0.001), less residual stenosis (2.2% vs. 10.8%,
p<0.001), longer total stent length (44.1623.88 mm vs. 33.5218.90
mm, p<0.001), larger ﬁnal angiographic stented diameter (3.120.63
mm vs. 2.940.48 mm, p<0.001), and larger ratio of ﬁnal angiographic
stented diameter to stent diameter (1.100.14 vs. 1.050.09 p<0.001).
IVUS guided CTO-PCI was associated with lower 1-year TLF rates
compared to angiography-only guidance (3.0% vs. 10.0%, p¼0.012).
Conclusion: The use of IVUS was associated with higher success rates,
more aggressive post-dilatation and better 1-year clinical outcomes
compared to angiography-only guided strategy in CTO-PCI.
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Revascularization Vs Optimal Medical Therapy for
Coronary Stenosis With Grey-zone caFFR
JLY Lam 1, CKL Leung 1, KY Li 1, MZ Wu 1, 2, QW Ren 1, 2, ASY Yu 1,
PF Wong 1, HL Li 1, YK Tse 1, SSY Yu 1, Y Feng 3, Y Huo 3,
KH Yiu 1, 2
1
Queen Mary Hospital, Hong Kong SAR
2
The University of Hong Kong Shenzhen Hospital, Shenzhen, China
3
PKU-HKUST Shenzhen- Hongkong Institution, Shenzhen, China
Background: The optimal cut-off value of fractional ﬂow reserve
(FFR) for revascularization is debated. Existing studies on clinical
decision- making in coronary stenosis with grey-zone FFR (0.75-0.80)
yielded inconsistent results. Computational pressure-ﬂow ﬂuid
dynamics derived fractional ﬂow reserve (caFFR) is a novel angiography-derived index that correlates closely with conventional
FFR. We evaluated the prognosis for revascularization vs optimal
medical therapy in coronary stenosis with caFFR values in the grey
zone.
Methods: This study retrospectively included 329 coronary stenosis
with grey-zone caFFR, deﬁned as 0.75-0.80, in 329 patients. The patients were stratiﬁed into those treated with revascularization (n¼197)
or optimal medical therapy alone (n¼132). The primary outcome was
major adverse cardiovascular events (MACE, deﬁned as a composite of
all-cause mortality, non-fatal myocardial infarction, and unplanned
revascularization) at 3 years, and secondary outcomes included cardiovascular death (CV), recurrent episode of angina, and hospitalization for heart failure (HHF) at 3 years.
Results: The 3-year incidence rate of MACE was signiﬁcantly higher in
patients treated with optimal medical therapy compared to those
treated with revascularization (18.2% vs. 9.6%, P¼0.024), which was
mainly driven by the rate of all-cause death (10.6% vs. 4.1%, P¼0.020).
The incidences of CV death and HHF were also signiﬁcantly higher in
patients treated with optimal medical therapy (6.1% vs. 1.5%, P¼0.031;
8.3% vs. 3.0%, P¼0.034, respectively). Multivariate Cox regression
analysis demonstrated that revascularization was associated with a
lower 3-year risk of MACE (adjusted Hazard Ratio [HR]¼0.498; 95%
Conﬁdence Interval [CI]¼0.272-0.910; P¼0.023), CV death (adjusted
HR¼0.247; 95% CI¼0.065-0.936; P¼0.040), and HHF (adjusted
HR¼0.327, 95% CI¼0.120-0.894; P¼0.029). The risk of recurrent angina
was nonetheless similar between the two groups (adjusted HR¼0.623,
95% CI¼0.368-1.056; P¼0.079).
Conclusion: For coronary stenosis with grey-zone caFFR, revascularization was associated with improved 3-year MACE outcome compared
to optimal medical therapy alone.
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Heart Failure Outcomes Following Percutaneous
Coronary Intervention in ST-elevation Myocardial
Infarction Patients Based on a Novel Index:
Computational
Pressure-ﬂow
Dynamics
Derived
Fractional Flow Reserve
CKL Leung 1, LY Lam 1, KY Li 1, SY Yu 2, MZ Wu 2, QW Ren 2,
PF Wong 2, YK Tse 1, SY Yu 1, HL Li 1, Y Feng 3, Y Huo 3, HF Tse 2,
KH Yiu 2
1
The University of Hong Kong, Hong Kong SAR
2
Queen Mary Hospital, Hong Kong SAR
3
PKU-HKUST Shenzhen-Hongkong Institution, Shenzhen, China
Background: Computational ﬂuid dynamics derived fractional ﬂow
reserve (caFFR) is a novel index for evaluating the severity of
myocardial ischemia in patients with coronary artery disease, eliminating the need of pressure wire and hyperaemic stimulus required in
traditional fractional ﬂow reserve (FFR) measurement. After percutaneous coronary intervention (PCI) in ST-elevation myocardial infarction (STEMI) patients, there may be varying degree of residual
ischemia in the involved artery, affecting clinical outcomes. We aimed
at evaluating the clinical signiﬁcance of post-PCI caFFR on heart failure
(HF) outcomes in patients who presented with STEMI.
Method: A total of 230 patients (mean age 63.113.5, male 80%) who
presented with STEMI and subsequently received PCI were included
in this study. The caFFR values of these patients were computed based
post-PCI angiograms. The primary endpoint was deﬁned as a composite of HF related mortality and HF related hospitalization.
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higher PCWP was associated with the primary endpoint with 1.18 of
adjusted hazard ratio (95% conﬁdence interval 0.99-1.41). A cutoff of
PCWP >11 mmHg stratiﬁed the cumulative incidence of the primary
endpoint (2-year incidence of 31% versus 8%). The up-titration of diuretics dose was associated with the event freedom among those with
PCWP >11 mmHg.
Conclusions: Insufﬁcient cardiac unloading following TAVR was
associated with clinical outcomes. The implication of aggressive
intervention to improve mild pulmonary congestion is the next
concern.

ABSTRACTS: STRUCTURAL HEART INTERVENTION
12

A Retrospective Case Control Study on Efﬁcacy of Stroke
Prevention and Bleeding Risk Between Atrial Fibrillation
Patients Who Had Left Atrial Appendage Occlusion
(LAAO) Performed Against Patients Put on Non-vitamin
K Antagonist Oral Anticoagulants (NOAC)
M Chiang, SF Chui, A Chan, V Luk, LK Chan, CY Wong, M Lee,
KT Chan
Queen Elizabeth Hospital, Hong Kong SAR
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Background: Stroke is one of the most devastating complication of
Atrial Fibrillation. Both LAAO and NOAC are effective means for
stroke prevention but head-to-head trial result is not available.
Objective: Our study is to determine the efﬁcacy of LAAO versus
NOAC on stroke (overall, ischaemic, haemorrhagic) prevention and
bleeding risk(overall, gastrointestinal and intracranial haemorrhage).
Method: A single centre retrospective case-control study, targeting
patients suffering from AF indicated for anticoagulation. Consecutive
patients with LAAO performed or NOAC newly started between 1st
February 2013 till 1st November 2017 were recruited, with outcome
analysed until 31 August 2018. LAAO (Index) and NOAC (Control) cases
were matched in 1:3 ratio with 3 criterias: 1) best matched CHA2DS2Vasc score 2) best matched HAS-BLED 3) best matched intervention-toanalysis period and duration; for most valid comparison. Risk-free
survival analysis was performed with Kaplan-Meier method, with differences compared by log-rank test. Multivariate analysis was performed on bleeding risk to isolate independent variables.
Results: 400 cases were included (100 LAAO, 300 NOAC).
There was no signiﬁcant difference in stroke (p¼0.98), ischaemic stroke
(p¼0.78) and haemorrhagic stroke (p¼0.84) risk between the LAAO/
NOAC groups. There was signiﬁcantly less gastrointestinal bleeding
(p<0.005) and overall bleeding (p¼0.02) in the LAAO group, with
relative risk reduction of 81% in overall bleeding. The overall bleeding
was clinically signiﬁcant as the majority of which was classiﬁed as
"requiring medical attention" based on the TIMI bleeding grade.
However, there was no signiﬁcant difference in risk of intracranial
hemorrhage (p¼0.98).
Conclusion: LAAO was as effective as NOAC in stroke prevention,
with decreased risk of gastrointestinal and overall bleeding.

Epidemiology of Infective Endocarditis in Hong Kong,
2000-2019
HL Li, SY Yu, YK Tse, M Wu, Q Ren, SY Yu, PF Wong, HF Tse,
KH Yiu
The University of Hong Kong, Hong Kong SAR
Background: Despite improvements in therapeutic strategies, the
mortality and morbidity of infective endocarditis (IE) remain high. The
incidence and outcomes of IE, particularly in an Asian population, are
poorly understood and characterised, and the effect of antibiotic prophylaxis guidelines revision on the incidence of IE remains unexplored. We aim to describe temporal changes in the epidemiology and
surgery for IE in Hong Kong in the past 2 decades.
Methods: From a territory-wide database in Hong Kong, all patients
aged 20 or above diagnosed with incident IE from 2000-2019 were
included. Temporal trends in the incidence of IE, surgical intervention,
and Charlson Comorbidity Index (CCI) were characterised using
Poisson regression, expressed in annual percentage change (APC [95%
CI]). Interrupted time series was used to evaluate the change in incidence after antibiotic prophylaxis guidelines revision. Temporal
trends in 1-year all-cause mortality were evaluated using multivariable
Cox regression.
Results: A total of 5,657 patients (59.918.3 years, 37.2% females) were
included. The crude incidence remained was stable from 2000- 2019,
and remained unchanged following the revision of antibiotic prophylaxis guidelines in 2009 (relative risk of change¼0.90 [0.64 to 1.00],
P¼0.065). Concordant with an increase in the mean age of IE patients
(APC 0.9% [0.8 to 1.1], P<0.001), the comorbidity burden grew substantially from 2000 (CCI 0.551.2) to 2019 (CCI 1.091.66). The rate of
surgery signiﬁcantly increased from 5.3% in 2000 to 17.8% in 2019 (APC
2.7% [1.1 to 4.3], P¼0.004), and surgery at 1 year was associated with a
45% risk reduction in 1-year all-cause mortality (Hazard Ratio 0.55
[0.46 to 0.65], P<0.001). Nevertheless, the crude all-cause mortality rate
at 1 year increased from 27.4% in 2000 to 31.5% in 2019 (adjusted APC
-0.7% [-1.6 to 0.1], P¼0.087).
Conclusions: The incidence of IE did not change following the antibiotic prophylaxis guidelines revision. Patients with IE have evolved to
be older and more comorbid. Despite an increasing rate of surgery, the
mortality of IE remained irresistibly high.

ABSTRACTS: VALVULAR HEART DISEASE
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Prognostic Implication of Insufﬁcient Cardiac Unloading
Following TAVR
T Imamura, M Sobajima, S Tanaka, R Ushijima, N Fukuda, H Ueno,
K Kinugawa
University of Toyama, Toyama, Japan
Background: Several risk factors associating with clinical outcomes
following transcatheter aortic valve replacement (TAVR) are known,
whereas the implication of insufﬁcient cardiac unloading following
TAVR remains unknown.
Objectives: We investigated the prognostic impact of insufﬁcient cardiac unloading following TAVR.
Methods: We retrospectively included the patients with severe aortic
stenosis who underwent hemodynamic assessments using right heart
catheterization following TAVR. The impact of elevated pulmonary
capillary wedge pressure (PCWP) on cardiovascular mortality or heart
failure readmission was investigated.
Result: Eighty-two patients (median 86 years old, 57 women) were
included. Median PCWP following TAVR was 9 (7, 13) mmHg. A
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Microbiology of Infective Endocarditis in Hong Kong
from 2000 - 2019: a 20-year Analysis
HL Li, YK Tse, SY Yu, M Wu, Q Ren, CKL Leung, LK Yu, SY Yu,
PF Wong, LY Lam, HF Tse, KH Yiu
The University of Hong Kong, Hong Kong SAR
Background: Infective endocarditis (IE) is associated with high mortality and complex microbiological proﬁle. The antibiotic prophylaxis
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The surgical cohort also had a lower risk of complications, including
acute kidney injury (HR 0.61, [0.43-0.87], P¼0.006), systemic embolism
(HR 0.35 [0.23-0.55], P<0.001), ischaemic stroke (HR 0.37 [0.24-0.55],
P<0.001), cardiac dysrhythmia (HR 0.79 [0.66-0.95], P¼0.011), and
pneumonia (HR 0.36 [0.26-0.49], P<0.001).
In the surgical cohort, compared to those who had early surgery
(N¼181), those with delayed surgery had a lower risk of all-cause death
(HR 0.58 [0.34- 0.99], P¼0.045) and complications at 1 year.
Conclusions: Surgical intervention signiﬁcantly reduced the risk of
death and complications in patients with infective endocarditis.
Delayed surgical intervention appeared to be more protective.

guidelines underwent a major revision in 2009 to reduce unnecessary
antibiotic exposure. The understanding on the microbiology in an
Asian population is lacking. We aim to describe the trends in the
microbiology of IE in Hong Kong in the past 2 decades.
Methods: All patients aged 20 or above diagnosed with incident IE with
blood culture results from 2000-2019 were included from a territorywide database in Hong Kong. Association between microbiology and
1- year all-cause death was evaluated using a multivariable Cox proportional-hazards model was used, adjusted with demographics and
comorbidities. Temporal trends in the proportion of each organism
were characterised using Poisson regression. Interrupted time series
was used to evaluate the change in the organism-speciﬁc incidence
after the revision of guidelines.
Results: In a total of 5,657 patients (age 59.918.3 years, 37.2% females),
there were 2,185 (38.6%) patients with culture-negative endocarditis.
Staphylococcus aureus (22.4%) was the most common organism identiﬁed. There was a signiﬁcant reduction in the proportion of culturenegative endocarditis, and a signiﬁcant increase in the proportion of
endocarditis due to Staphylococcus aureus and Streptococci. After
guidelines revision in 2009, there was no signiﬁcant change in organism- speciﬁc incidence. Compared to patients with culture-negative
endocarditis, those infected with Staphylococcus aureus, other Staphylococci, and Enterococci had a higher risk of 1-year all-cause death.
There was a signiﬁcant increase in the proportion of methicillinresistant Staphylococcus aureus (MRSA) endocarditis (annual percentage change 4.1%[1.9 to 6.3], P<0.001), with no signiﬁcant interval
change after 2009. Patients infected with MRSA had a higher all-cause
death (Hazard Ratio 2.00[1.70-2.36], P<0.001).
Conclusions: Over time, there were fewer cases of culture-negative
endocarditis, and the revision of antibiotic prophylaxis guidelines did
not result in a signiﬁcant change in the microbiological proﬁle. There
was an increasing trend for MRSA endocarditis, which was associated
with a higher risk of death.
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Prognostic Value of Combined Hepatorenal Dysfunction
and Malnutrition in Patients Undergoing Valvular Heart
Surgery
SYK Tse, HL Li, SY Yu, MZ Wu, QW Ren, Y Chen, SY Yu, PF Wong,
LY Lam, KY Li, KL Leung, HF Tse, KH Yiu
The University of Hong Kong, Queen Mary Hospital, Hong Kong SAR
Background: The discriminatory accuracy of valvular surgery riskscoring systems is modest despite an increasing volume and
complexity of valvular heart disease (VHD) patients. Hepatorenal
dysfunction and malnutrition, as frequent extra-cardiac manifestations
of VHD, may provide combined value for risk-stratiﬁcation in valvular
surgery. As such, we sought to evaluate the prevalence, temporal
changes, and prognostic implications of concomitant hepatorenal
dysfunction and malnutrition before and after valvular surgery.
Methods: Baseline and temporal changes in hepatorenal function
(assessed by the modiﬁed model for end-stage liver disease [MELDXI] score) and nutritional status (assessed by Controlling Nutritional
Status [CONUT] score) were correlated with adverse events (composite of all- cause mortality and hospitalization for heart failure) using
Cox proportional hazards analyses, adjusted with clinical and echocardiographic characteristics, medications, type of valvular intervention, and cardiac surgery risk-stratiﬁcation models (EuroSCORE II and
STS score).
Results: Overall, 909 patients undergoing valvular surgery were
included in our study, of which 216 (24%) and 554 (61%) had hepatorenal dysfunction (MELD-XI >12.43) and malnutrition (CONUT32),
respectively. MELD-XI scores were modestly correlated with CONUT
scores (R¼0.36, p<0.001), with concomitant hepatorenal dysfunction
and malnutrition present in 177 (19%) patients.
Over a median follow-up of 4.1 years, 101 (11%) patients died and 119
(13%) were hospitalized for heart failure. There was a stepwise increase in mortality (c2 89.1, p<0.001) and adverse events (c2 92.9,
p<0.001) from patients with normal hepatorenal function and nutrition
to concomitant hepatorenal dysfunction and malnutrition. This association remained consistent in fully adjusted models. MELD-XI and
CONUT scores signiﬁcantly improved the discriminatory accuracy of
EuroSCORE II (area under the curve [AUC]: 0.80 vs 0.73, p<0.001) and
STS score (AUC: 0.79 vs 0.72, p¼0.004) for all-cause mortality.
In patients with MELD-XI and CONUT scores 1 year after surgery
(n¼707), DMELD-XI (follow-up MELD-XI minus baseline MELD-XI
score) and DCONUT scores were signiﬁcantly associated with adverse
events (Hazard Ratio [HR] 1.08, 95% Conﬁdence Interval [CI] 1.03- 1.14,
p¼0.001 for DMELD-XI; HR 1.18, 95% CI 1.02-1.35, p¼0.02 for DCONUT). Patients with persistent hepatorenal dysfunction and malnutrition experienced worse survival (log-rank c2 65.2, p<0.001) and
adverse events (log-rank c2 90.4, p<0.001).
Conclusions: Concomitant hepatorenal dysfunction and malnutrition
is prevalent in patients undergoing valvular surgery. Their status at
baseline and temporal changes after surgery are strongly associated
with increased mortality and adverse events. These ﬁndings highlight
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Survival Beneﬁts and Optimal Timing for Surgical
Intervention for Infective Endocarditis
HL Li, YK Tse, SY Yu, Q Ren, M Wu, CKL Leung, KY Li, SY Yu,
PF Wong, LY Lam, HF Tse, KH Yiu
The University of Hong Kong, Hong Kong SAR
Background: Albeit often indicated in infective endocarditis (IE), the
beneﬁts and optimal timing of surgery have not been validated in
large- scale studies. We aim to address these knowledge gaps for patients with IE in Hong Kong.
Methods: From a territory-wide database in Hong Kong, patients aged
20 or above diagnosed with incident IE from 2000-2019 were included.
Patients were divided into those who received surgical intervention
within 1 year of IE (surgical cohort) and those who did not (control
cohort). The two cohorts were then compared using inverse probability
weighting of the covariate balancing propensity score. Multivariate
Cox regression was used to evaluate the association between surgical
intervention and death, with "doubly-robust estimation" used to
minimise confounding. For complications, a Fine-Gray model was
used to account for competing risk.
The surgical cohort was subdivided into early (£7 days of hospitalisation) or late surgical intervention; a similar propensity score analytic
approach was used to evaluate the effects of early vs. late intervention.
Results: A total of 5,657 patients (age 59.918.3 years, 37.2% females)
were included, of which 930 (16.4%) received surgical intervention in 1
year. The surgical cohort had a 45% risk reduction in all-cause death
(hazard ratio [HR] 0.55, 95% CI [0.46-0.65], P<0.001), and the association remained consistent in subgroup analysis stratiﬁed by age, sex,
and microorganisms.
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decade has been performed with a Langston® Dual Lumen Catheter
(Teleﬂex – Morrisville, NC), which has a 6Fr outer catheter and a 4Fr
inner lumen enabling simultaneous measurement of left ventricular
(LV) and aortic (AO) pressures. The catheter was recalled in March
2020 due to several instances of separation of the inner catheter during
power injection. This leaves cardiologists without a straightforward
technique for simultaneously measuring LV and AO pressures in the
cath lab. A commercially available Swan-Ganz thermodilution pulmonary artery catheter can be used to obtain this gradient via a single
arterial puncture. The catheter has similar advantages like Langston®
Dual Lumen Catheter over other methods used to measure the
gradient in aortic stenosis, but without safety concerns. However, it has
not been critically evaluated.
Method: In order to assess the performance and accuracy of this
catheter compared to the standard echocardiography pressure
gradient, we studied 20 patients with aortic stenosis using Swan-Ganz
thermodilution pulmonary artery catheter systems and standard
transthoracic echocardiography.
Result: Calculated aortic valve areas in these groups of patients ranged
from 0.23 cm2 to approximately 1.65 cm2. Correlation between gradients obtained by the two methods was strong as evaluated by
regression analysis with an r value of 0.79 (r2¼0.637). No complications
were encountered while using the Swan-Ganz catheter system.
Conclusion: We conclude that the Swan-Ganz thermodilution pulmonary artery catheter provides accurate data in the hemodynamic
evaluation of aortic stenosis.

the prognostic importance of pre- and post-operative hepatorenal and
nutritional assessment in valvular surgery.
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Contemporary Trends and Outcomes
Interventions in Hong Kong, 2001-2019

of

Valvular

SYK Tse, HL Li, SY Yu, MZ Wu, QW Ren, Y Chen, SY Yu, PF Wong,
LY Lam, KY Li, KL Leung, HF Tse, KH Yiu
The University of Hong Kong, Queen Mary Hospital, Hong Kong SAR
Introduction: Valvular heart disease is a major health burden that
carries a survival penalty only attenuated by surgical correction. Aging
populations and transcatheter therapies have inﬂuenced the volume
and risk proﬁles of patients undergoing valvular interventions, yet this
paradigm shift has not been explored in an Asian population. Our
study aims to describe the temporal trends in the incidence, patient
proﬁles, and outcomes of valvular interventions in Hong Kong.
Methods: Using a well-validated territory-wide database, we identiﬁed
patients aged 320 years who underwent valvular interventions between
2001 and 2019 in Hong Kong. Temporal trends in incidence and patient
characteristics (age and mean Charlson Comorbidity Index [CCI])
were evaluated using Poisson regression analysis and expressed as
annual percentage change (APC [95% CI]). Outcomes of interest
include all- cause mortality and complications (infective endocarditis
and new-onset atrial ﬁbrillation), adjusted for baseline demographics
and comorbidities.
Results: Overall, 11277 patients (age 58.813.5 years, 51.9% male) were
included in the study. The annual number of valvular interventions
increased from 297 in 2001 to 860 in 2019 (APC 1.1% [0.8% to 1.5%],
P<0.001), which was the most prominent among patients 360 years of
age. Concordant with an increase in mean age (APC 0.9% [0.9% to
1.0%], P<0.001), patients' comorbidity burden grew substantially over
time (AP\C 2.7% [2.3% to 3.1%], P<0.001).
The total volume and proportion of aortic valve procedures grew
signiﬁcantly from 108 in 2001 to 462 in 2019 (APC 1.0% [0.4% to 1.5%],
P<0.001), which was contributed in part by an increase in transcatheter
aortic volume implantation from 2011 to 2019 (APC 9.6% [5.2% to
14.4%], P<0.001). Despite an increase in the volume of mitral valve
procedures, their proportion has declined substantially (APC-2.0%
[-2.5% to -1.6%], P<0.001), whereby mitral valve repair (APC 3.4%
[2.6% to 4.3%], P<0.001) is increasingly performed compared to mitral
valve replacement (APC -4.5% [-5% to -3.9%], P<0.001).
The adjusted rates of 1-year mortality decreased from 12% in 2001 to
9% in 2019 (APC -2.1% [-3.2% to -0.9%], P<0.001). Alarmingly, the rates
of infective endocarditis (APC 2.3% [1.0% to 3.5%], P<0.001) and newonset atrial ﬁbrillation (APC 2.5% [1.3% to 3.6%], P<0.001) at 1-year
after intervention increased signiﬁcantly.
Conclusions: The burden of valvular interventions has grown substantially, with patients becoming older and more comorbid. Despite
continuous improvements in short-term mortality, complications such
as infective endocarditis and new-onset atrial ﬁbrillation continue to
climb, which calls for potential strategies for their reduction.
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Predictors and Prognostic Implications of Residual
Tricuspid Regurgitation After Tricuspid Annuloplasty
YK Tse, HL Li, SY Yu, MZ Wu, QW Ren, Y Chen, SY Yu, PF Wong,
LY Lam, KY Li, KL Leung, HF Tse, KH Yiu
The University of Hong Kong, Queen Mary Hospital, Hong Kong SAR
Background: Management of tricuspid regurgitation (TR) has evolved
from conservative approaches to direct surgical correction of the
tricuspid valve. The durability of tricuspid annuloplasty is, however,
limited and recurrent TR occurs frequently. Nonetheless, risk factors
and the prognostic impact of repair failure remain underexplored. The
purpose of this study was to describe the prevalence, predictors, and
prognostic implications of residual TR after tricuspid annuloplasty.
Methods: Between 2012 and 2019, 290 consecutive patients (age 639
years, 63% female) underwent transthoracic echocardiography preoperatively, early post-operatively (8 days, interquartile range [IQR] 6
to 8 days), and >1 year (584 days, IQR 450 to 829 days) after tricuspid
annuloplasty. Echocardiographic determinants of residual TR (deﬁned
as moderate or greater severity by echocardiography) were identiﬁed
using logistic regression, and residual TR was correlated with adverse
events (composite of all-cause mortality and heart failure hospitalization) using Cox proportional hazards analysis.
Results: At 1 week and >1 year after tricuspid annuloplasty, residual
TR was present in 44 (15%) and 47 (16%) patients respectively. During
this period, 19 (7%) patients experienced TR progression by 31 grade.
Independent risk factors for residual TR were pre-operative right atrial
pressure (Odds Ratio [OR] 1.08, 95% Conﬁdence Interval [CI] 1.01-1.14;
p¼0.02), tricuspid annulus diameter (OR 1.08, 95% CI 1.03- 1.14;
p<0.01), and right ventricular end-diastolic and end-systolic areas (OR
1.08, 95% CI 1.03-1.13; p<0.01 for both). TR progression was predicted
by pre-operative tricuspid valve regurgitant volume (OR 1.01, 95% CI
1.00-1.02; p<0.01) and right ventricular diastolic area (OR 1.07, 95% CI
1.01-1.14; p¼0.02).
Over a median follow-up of 4.4 years (IQR: 2.7 to 6.3 years), 63 adverse
events (40 heart failure hospitalization and 23 deaths) occurred.
Compared to patients without residual TR, those with residual TR 1
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Swan-Ganz Catheter Assessment of Aortic Stenosis:
Comparison With Echocardiography
HC Lin, WH Yin, TP Tsao
Cheng Hsin General Hospital, Taipei City, Taiwan
Background: Hemodynamic assessment of aortic stenosis in the
catheterization laboratory accurate determined by the transvalvular
gradient. The most widely used invasive technique for more than a
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estimated glomerular ﬁltration rate, acute kidney injury, doubling of
serum creatinine and renal failure. Cox proportional hazard regression
was performed to compare the three drugs.
Results: Rivaroxaban was associated with increased risk of combined
primary endpoint compared to dabigatran (Hazard ratio 1.401, 95%
conﬁdence interval 1.17 to 1.67, p-value <0.001). There were no statistically signiﬁcant differences between rivaroxaban and apixaban, as
well as between dabigatran and apixaban.
Conclusion: Renal function decline is common among patients taking
NOACs for stroke prophylaxis. Intra-novel oral anticoagulant differences exist in terms of adverse renal outcomes.

week or >1 year after tricuspid annuloplasty incurred an excess risk of
adverse outcomes (Hazard Ratio [HR] 1.98, 95% CI 1.07-3.67 and HR
1.86, 95% CI 1.05-3.29 respectively; p¼0.03 for both). Nonetheless, TR
progression was not signiﬁcantly associated with adverse events at
long-term follow-up (p¼0.391).
Conclusions: TR persists in a signiﬁcant proportion of patients after
tricuspid annuloplasty. Right atrial pressures and right ventricular
dimensions identify patients at high risk of residual TR which confers a
heightened risk of adverse outcomes following surgery.
ABSTRACTS: OTHERS
9

EGCG Prevents Pressure Overload-induced Myocardial
Remodeling
Through
Downregulating
HDAC5
Overexpression in Mice

22

Q Mao, X Han, C Peng, L Huang, X Luo, S Wu, H Zhang
Department of Pediatrics, Afﬁliated Hospital of Zunyi Medical University,
China

YC Hung
Department of Medicine and Geriatrics, Tuen Mun Hospital, Hong Kong
SAR

We investigated whether epigallocatechin gallate (EGCG) could prevent myocardial remodeling by regulating histone acetylation and
explored the mechanisms underlying this effect in the hearts of a
mouse model of transverse aortic constriction (TAC). A TAC mouse
model was created by partial thoracic aortic banding (TAB). Subsequently, TAC mice were injected with EGCG at a dose of 50 mg kg1day-1 for 12 weeks. In TAC mice of 4 weeks, 8 weeks and 12 weeks,
acetylation level of histone acetylated lysine 27 on histone H3
(H3K27ac) ﬁrst increases and then decreases, and the expression levels
of genes related to pathological myocardial remodeling, Atrial natriuretic peptide (ANP) and Brain natriuretic peptide (BNP), also increase
ﬁrst and then decrease. The expression of histone deacetylase 5
(HDAC5) gradually increased in TAC mice. More importantly, this
study showed that EGCG increased acetylation of H3K27ac by inhibiting HDAC5 in TAC mice. Meanwhile, EGCG normalized the transcriptional activity of heart nuclear transcription factor MEF2A in TAC
mice. The low expression of myocardial remodeling-related genes
(ANP and BNP) was reversed through EGCG treatment in TAC mice.
In addition, we found that EGCG can reverse cardiac enlargement, and
improve cardiac function nd survival rate in TAC mice. HDAC5mediated histone H3K27ac imbalance plays a critical role in pathological myocardial remodeling, and EGCG can prevent and postpone
myocardial remodeling through inhibiting HDAC5 in TAC mice.

Background: Novel oral anticoagulants (NOACs) are effective in
reducing risk of thromboembolic stroke among high risk patients with
atrial ﬁbrillation. Evidence showed that NOACs, especially dabigatran,
might be associated with higher risk of myocardial infarction. It is not
known whether the available NOACs are different in terms of cardiovascular safety proﬁle.
Methods: Using a database of Hospital Authority of Hong Kong, 1161
patients with nonvalvular atrial ﬁbrillation taking either one of the
NOACs (dabigatran, rivaroxaban and apixaban) before 31st December,
2017 were identiﬁed. Inverse probability of treatment weighting was
used to balance the baseline characteristics. Combined primary endpoint
included risk of myocardial infarction and sudden cardiac death. Secondary endpoints included the risk of major adverse cardiovascular
outcomes, myocardial infarction, cardiovascular death, hospitalization
for heart failure, stroke and fatal bleeding. Cox proportional hazard
regression analyses were performed to compare the three NOACs and
direct thrombin inhibitor versus factor Xa inhibitors collectively.
Results: Rivaroxaban, apixaban and factor Xa inhibitors were associated with trend of lower incidence of combined primary endpoint of
myocardial infarction plus sudden death compared to dabigatran (HR
0.72, 0.58 and 0.67, p-value 0.195, 0.242 and 0.082 respectively). There
were no statistically signiﬁcant differences between rivaroxaban and
apixaban.
Conclusion: Intra-NOACs differences could exist in terms of cardiovascular safety proﬁle among patients with atrial ﬁbrillation.

Cardiovascular Safety of Novel Oral Anticoagulants
Among Patients With Atrial Fibrillation
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Renal Outcomes of Novel Oral Anticoagulants Among
Patients With Atrial Fibrillation
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The Impact of Hyperhomocysteinemia, MTHFR
Genotype and Air Pollution (PM2.5) on Atherogenesis
in Modernizing China

YC Hung
Department of Medicine and Geriatrics, Tuen Mun Hospital, Hong Kong
SAR

TCY Kwok 1, P Poon 1, P Chook 1, DS Guo 2, K Woo 1
1
The Chinese University of Hong Kong, Hong Kong SAR
2
Yu County Provincial Hospital, Shanxi, China

Background: Chronic oral anticoagulation is needed for thromboembolic stroke prophylaxis for patients with atrial ﬁbrillation. Evidence
showed novel oral anticoagulants (NOACs) have better renal outcome
compared to warfarin. It is not known if this is a class effect or if intraclass differences exist.
Methods: Using a database of Hospital Authority of Hong Kong, 1164
patients with nonvalvular atrial ﬁbrillation taking either one of the
NOACs (dabigatran, rivaroxaban and apixaban) before 31st December,
2017 were identiﬁed. Inverse probability of treatment weighting was
used to balance the baseline characteristics. Combined primary
endpoint included renal outcomes, including thirty percent decline in

Background: Atherosclerosis is one of the most important global
health hazards in 21st century, in modernizing China in particular, and
air pollution (AP) has been implicated. Hyperhomocysteinemia (HC)
and MTHFR CT polymorphism have been recognized in many parts of
China.
Methods: To evaluate the prevalence of HC (fasting HC >14 mmol/l)
and impact on atherogenic process, 756 asymptomatic subjects (mean
age 45.311.7 years, male 54%) in Southern China (Hong Kong,
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Conclusions: Our study for the ﬁrst time demonstrates genetic mutations in the ISL1 gene promoter in the Han Chinese population and the
role of these mutations in the development of VSD, providing new
insights into the etiology of congenital heart defect.
This work was supported by the Fundamental Research Funds for the
Central Universities [3332020108] and TEDA International Cardiovascular Hospital Internal Grant [2019-TD-013];Tianjin Science and
Technology Project [18PTZWHZ00060].

Macau, Pan Yu) and Northern China (Yu County of Shanxi, and 3
Gorges Territories) were studied in 1998-2007. Blood were taken for
fasting HC (immunoassay), folate and vitamin B12, and MTHFR CT
genotyping. PM2.5 exposure (satellite remote sensor and modeling)
and metabolic syndrome (IFD criteria) were noted. Brachial ﬂowmediated dilation (FMD) and carotid intima-media thickness (IMT),
both predictive atherosclerotic surrogates, were evaluated by
ultrasound.
Results: Overall homocysteine level was 17.2 16.5 mol/l, lower tertile
7.4 1.2 mol/l and top tertile 32.6 21.3 mol/l, being higher (24.5 20.3mol/l)
in northern Chinese than southern Chinese (9.6 4.3 mol/l, p<0.0015).
The northern Chinese were characterized by lower folate and vitamin
B12 levels, higher MTHFR TT genotype, higher PM2.5 exposure,
higher metabolic syndrome (MS), lower FMD but higher carotid IMT
(p<0.01).
On multivariate regression, HC was related to MTHFR (beta¼0.370,
p<0.0001), folate (beta¼-0.117, p¼0.018) and Vitamin B12 (beta¼- 0.093,
p¼0.048), but not to PM2.5 levels. Brachial FMD was related to PM2.5
(beta¼-1.0, p¼0.028), but not to HC or MTHFR independent of age and
gender, while carotid IMT was related to HC (beta¼0.125, p¼0.004),
PM2.5 (beta¼0.389, p<0.0001) but not to MTHFR, independent of age,
gender, MS, LDL-cholesterol and location.
Conclusions: Hyperhomocysteinemia and MTHFR-TT are more
common in Northern China, associated with lower blood folate and
vitamin B12, but higher PM2.5 levels. Hyperhomocysteinemia and
PM2.5 but not MTHFR genotype are related to carotid IMT, independent of other traditional risk factors, with implications in dietary
and AP strategies for atherosclerosis prevention.
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The Correlations Between Biomarkers of Cardiometabolic
Diseases in Hong Kong Chinese
YC Sung, RYH Leung, BMY Cheung
Department of Medicine, The University of Hong Kong, Queen Mary
Hospital, Hong Kong SAR
Background: Besides adiponectin, novel biomarkers of cardiometabolic syndrome now include growth differentiation factor-15
(GDF-15) and galectin-3. We investigated their relationship with
obesity, C-reactive protein (CRP) and beta-2 microglobulin (B2M).
Methods: 25 healthy subjects (12 male, 13 female; 20.41.29 years) were
recruited. Anthropometric measurements including body weight and
waist circumference were made. Serum samples were collected and
serum biomarker levels were measured by enzyme-linked immunoassay (Antibody and Immunoassay Services, The University of Hong
Kong). Pearson's correlation coefﬁcients were determined, after logarithmic transformation where appropriate.
Results: Mean serum levels of GDF-15, adiponectin, galectin-3, B2M
and CRP were 107.763.7 ng/mL, 175678327.8 ng/mL, 30.518.0 ng/
mL, 1277.8301.8 ng/mL and 753.61190.1 ng/mL respectively. Serum
B2M correlated signiﬁcantly with CRP (r2¼0.61, p¼0.001). Serum GDF15 correlated signiﬁcantly with waist circumference (r2¼0.49, p¼0.013).
In men, serum adiponectin (mean¼16564.37043.1 ng/mL) correlated
inversely with weight (mean¼66.48.02 kg) (r2¼-0.70, p¼0.012). In
women, serum galectin-3 (mean¼31.521.1 ng/mL) correlated
inversely with weight (mean¼ 50.72.90 kg) (r2¼-0.71, p¼0.007).
Conclusions: Our preliminary ﬁndings suggest that GDF-15 and
galectin-3, like adiponectin, are also biomarkers related to obesity.
There appears to be some sex differences that warrant further investigation. Besides being biomarkers, they may also be potential therapeutic targets for cardiometabolic diseases.
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Genetic Analysis of the ISL1 Gene Promoter in Isolated
And Sporadic Congenital Ventricular Septal Defects
SQ Zheng 1, 2, HX Chen 1, 2, XC Liu 1, 2, Q Yang 1, 2, GW He 1, 2, 3, 4
1
Center for Basic Medical Research & Department of Cardiovascular
Surgery, TEDA International Cardiovascular Hospital, Chinese Academy of
Medical Sciences & Peking Union Medical College, Tianjin, China
2
The Institute of Cardiovascular Diseases, Tianjin University, Tianjin,
China
3
Drug Research and Development Center, Wannan Medical College, Wuhu,
Anhui, China
4
Department of Surgery, Oregon Health and Science University, Portland,
United States
Purpose: Ventricular septal defect (VSD) is the most common
congenital heart defect, resulting from interaction and correlation
between genetic and environmental factors. Previous studies have
reported ISL1 gene is highly associated with cardiac malformation, but
the impact of the ISL1 gene promoter mutation on VSD patients has
not yet been explored.
Methods: A total of 400 subjects (VSD patients: healthy controls¼200:
200) were recruited. The mutation of ISL1 gene promoter and related
cellular functional experiments were investigated. Electrophoretic
mobility shift assay (EMSA) experiments were performed to conﬁrm
the impact on gene expression
Results: There were 8 signiﬁcant mutations identiﬁed by Sanger
sequencing in the ISL1 gene promoter region. Using dual-luciferase
reporter assay, three of the 8 mutations signiﬁcantly decreased the
transcriptional activity of the ISL1 gene promoter in HEK-293 cells
(P<0.05). EMSA revealed that these three signiﬁcant mutations
affected the binding afﬁnity of transcription factors. Further, bioinformatic analysis with the JASPAR databases showed that a cluster of
putative binding sites for transcription factors was disrupted by these
mutations. Subsequently, this likely causes low expression of ISL1
protein and development of VSD.
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Outcomes of Percutaneous VA-ECMO Decannulation
Using ProGlide and Manta Devices in Queen Elizabeth
Hospital
SY Au
Queen Elizabeth Hospital, Hong Kong SAR
Background: When veno-arterial extracorporeal membrane oxygenation (VA-ECMO) support can be terminated, arteriotomy wounds
closure by percutaneous devices was shown to have comparable outcomes to traditional surgical open repair. Moreover, transport of the
critically- ill, man-power and timeslots of operating theaters could be
saved if percutaneous decannulation is performed at bedside.
Methods: In the Intensive Care Unit of Queen Elizabeth Hospital,
bedside decannulation was the default VA-ECMO decannulation
method since November 2018. Ultrasound guided ProGlide post-close
technique was ﬁrst employed with the ECMO arterial wound closed by
2 to 3 ProGlide stitches applied at different angles. Since March 2010,
Manta, a collagen- based closure device was also employed. The success rate, procedural details and the immediate complications were
39
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by these mutations, likely causing low or over expression of MEF2C
protein and development of VSD.
Conclusion: Our study for the ﬁrst time demonstrates genetic variations in the MEF2C gene promoter in the Han Chinese population and
the role of these variations in the development of VSD. Further studies
are warranted to reveal the exact role of these ﬁndings in the development of congenital VSD.
This work was supported by the Fundamental Research Funds for the
Central Universities [3332020108] and TEDA International Cardiovascular Hospital Internal Grant [2020-YJSJJ-01 & 2019-TD- 013];
Tianjin Binhai New Area Health Commission [2019BWKY010]; Tianjin
Science and Technology Project [18PTZWHZ00060].

compared between the 2 techniques.
Results: Between November 2018 and March 2021, Eighty-two patients
received VA-ECMO and 48 survived to decannulation. All were decannulated percutaneously by bedside. Forty were decannulated using
ProGlide and 8 were by Manta. Overall, forty-three (89.6%%) had
successful bedside decannulation, with success rate of 87.5% with
ProGlide and 100% for Manta respectively. For the ProGlide group, the
arteriotomy wounds were of 19Fr for 1; 17Fr for 21 and 15Fr for 18
patients. For the Manta group, one patient had 17Fr catheter and the
rest were of 15Fr. In the ProGlide group, two ProGlide devices were
used in 22 (55%) patients, three were used in 17 (42.5%) patients and 4
were used in one patient, while one Manta was used in each patient in
the Manta group. There was no statistically signiﬁcant difference in
clinical outcomes including mortality, ventilator days and length of
stay. The procedure time (49 (15-67) min vs 40 (26-52) min) and the
blood loss (150 (122-320) mL vs 40 (20-200) mL) were similar between
the ProGlide group and the Manta group. Minor complications were
found in 4 (19.1%) patients in the ProGlide group, including two
arterial clot formation, one pseudoaneurysm and one wound infection.
There were no other major complications.
Conclusions: The 2 bedside percutaneous techniques resulted in
similar clinical outcomes and complications rate. Larger studies can
further investigate the difference between the 2 techniques. Other
factors which could affect the choice of devices include cost, learning
curve, case load of the center, the vascular conditions, presence of
septicemia, ultrasound image quality and possibility of rewiring in
case of failed hemostasis. Plan B and standby support by vascular
surgeon were paramount.
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Genetic Analysis of the MEF2C Gene Promoter in Isolated
Congenital Ventricular Septal Defects

Background: Cardiovascular disease (CVD) is the leading cause of
premature death and inﬂicted huge ﬁnancial burden for noncommunicable diseases (NCDs). Five cardiovascular risk factors
involving lifestyle have been identiﬁed as physical activity, diet,
smoking, alcohol consumption and stress. Identifying the underlying
risk of disease is important to manage CVD, subsequently reducing
the burden in the developing countries. This study evaluated the
impact on various lifestyle factors determining CVD risk among the
medical students.
Methods: We conducted a cross-sectional study among medical students in a public university in Malaysia. Simple Lifestyle Indicator
Questionnaire (SLIQ) was administered to all students and their
anthropometric measurements were collected by using calibrated
standardized digital weighing scales. Basic demographic data were
also collected, and all data were analyzed by using the Statistical
Package for Social Sciences (SPSS) version 16.0 with statistical significant set at p<0.05.
Results: A total 319 medical students participated with majority of
female students (74.6%) and mean age of 21 years (standard deviation,
SD¼1.58). None of them have any predisposing chronic medical illness
associated with CVD risk. We found out that almost a quarter of them
with high body mass index (BMI) with overweight and obese reported
to be 17.9% and 4.7% respectively. From our analysis of SLIQ scoring,
55.8% were classiﬁed as intermediate risk for CVD (mean score¼6.33,
SD¼0.76) and the remaining students with healthy scoring (mean
score¼8.33, SD¼0.54), with p<0.001. Majority consumed moderate
healthy diet (55.2%), engaged in vigorous physical activities (57.1%),
had intermediate stress level (70.5%) and did not consume alcohol
(mean¼0.07, SD¼0.46) or smoke (96.9%). From our analysis by using
Logistic regression, the odds ratio (OR) for overweight group showed
4.3 times healthier lifestyle compared with obese group (p¼0.04).
Conclusion: SLIQ correlates with healthy lifestyle and can be used as
screening tool for CVD risk assessment. The majority of medical students from our study had moderate risk for CVD based on SLIQ
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Purpose: Ventricular septal defect (VSD) is the most common
congenital heart defect. Previous studies have reported genetic variations in the encoding region of MEF2C highly associated with cardiac
malformation but the role of MEF2C gene promoter variations in VSD
patients has not been genetically analyzed. We investigated the role of
variations of MEF2C gene promoter in pediatric VSD patients.
Methods: This study enrolled 400 Han Chinese subjects (200 VSD
patients and 200 healthy controls). The promoter region of the human
MEF2C gene was generated by PCR and sequenced. The ﬁreﬂy luciferase reporter gene plasmid (pGL3-basic) expression vectors including
variations was constructed and then transfected into HEK-293 cells.
Dual-luciferase reporter assay system measured the luciferase activities. A bioinformatic analysis with the JASPAR databases was also
performed.
Result: A total of six variations were identiﬁed by Sanger sequencing
in the MEF2C gene promoter region. Using dual-luciferase reporter
assay, two of the 6 variations identiﬁed signiﬁcantly decreased and
other two variations signiﬁcantly increased the transcriptional activity
of the MEF2C gene promoter in HEK-293 cells (P<0.05). Further,
bioinformatic analysis with the JASPAR databases showed that a
cluster of putative binding sites for transcription factors was disrupted
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of PAD will help develop strategies for behavioral change communication and health promotion.
Methods: We conducted a cross-sectional study to assess awareness of
PAD in 1,008 adults (mean age 64.011, 53.2% male) attending
outpatient clinics at the Prince of Wales Hospital. Participants'
awareness was classiﬁed as (i) not heard about the disease; (ii) heard
but could not describe the disease; and (iii) heard about and could
describe the disease. Bivariate analysis for awareness of PAD by
selected participant characteristics was performed, and differences
between groups were analyzed with Pearson's chi-square tests.
Multivariate logistic regression analysis was used to assess independent predictors of awareness of PAD.
Results: Awareness of PAD was low (63%) compared with other CVD
and CV risk factors such as hypertension (99.5%), diabetes (98.6%),
hyperlipidemia (99.5%), coronary artery disease (CAD 93.5%) and cerebrovascular disease (CVD 97.8%, p<0.01). Awareness of risk factors
for PAD, CAD and CVD was high (70-93%) in both the PAD aware and
unaware populations (p¼NS). This suggested a generally high
awareness of CV diseases and risk factors but speciﬁcally for PAD.
Among patients who were aware of PAD, most associated the disease
with walking difﬁculties (90%) and blood clots (76%) but much fewer
were aware of more serious CV complications of PAD including death,
heart attack, stroke and limb loss (57-66%).
Conclusion: Overall awareness of CV diseases and risk factors was
high. However, awareness of PAD was signiﬁcantly lower compared to
other CV diseases and risk factors. Education needs to focus on raising
awareness of the seriousness and potential CV complications of PAD
which are comparable to that of CAD and CVD.

scoring and thus, it is important to look into the lifestyle factors that
could possibly contributed to the risk. Primary prevention of CVD
should be carried out by obesity intervention and lifestyle modiﬁcation
in accordance to global target for better control of NCDs.
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Angiotensin-converting Enzyme Gene Polymorphism in
the Prognosis of Cardiovascular Disorders in Patients
with Asthma
T Pasiieshvili, L Pasiyeshvili, N Zhelezniakova
Kharkiv National Medical University, Kharkiv, Ukraine
Damage to the cardiovascular system in the form of dysmetabolic
cardiomyopathy, myocardiosclerosis or pulmonary heart disease is
one of the serious complications of asthma. It was found that the
predictor of such changes is endothelial dysfunction. Polymorphism of
the angiotensin converting enzyme (ACE) gene can be considered as
one of the markers of endothelial dysfunction.
Aim of the study: to assess the diagnostic and prognostic value of
insertion-deletion polymorphism of the ACE gene in the implementation of cardiovascular events in patients with asthma.
Methods: ACE gene polymorphism was studied using the "SNP-express" diagnostic test system ACE Alu Ins/Del I>D. Analysis of
polymorphic DNA loci was carried out by the method of polymerase
chain reaction of DNA synthesis followed by electrophoretic detection.
Results: In 60 patients with asthma the genotypic ratios of the ACE
gene were presented as follows: I/I genotype was registered in 11.7% of
cases, I/D - in 35% and unfavorable mutant D/D genotype - in 53.3% of
patients. Comparison of genotypes with clinical manifestations of the
asthma showed that the fourth stage of the disease was registered in 30
out of 32 patients with the D/D genotype, and in two cases the third. It
was found that in patients with a pathological mutation, the exacerbation of the disease in 90.6% of cases was accompanied by a moderate
increase in blood pressure (systolic up to 155.23.4 mm Hg and
87.33.2 mm Hg), rhythm disturbances (extrasystole in 59.4% of patients and paroxysmal tachycardia in 28.1%) and conduction (12.5%).
Changes in blood pressure in patients with I/D genotype were recorded in 33.3%, rhythm disturbances in 19% and 14.3%, respectively, and
conduction disturbances in 9.5%; patients with normal I/I genotype
had an increase in blood pressure in 14.3% cases, extrasystole - in
14.4%, conduction disturbances were not recorded.
Conclusions: The presence of the mutant genotype D/D of the ACE
gene in patients with asthma makes it possible to predict a severe
course of the disease with frequent exacerbation of bronchopulmonary
pathology and hemodynamic disorders. The determination of the
genotypic structure of the ACE gene can be used to predict cardiovascular disorders in patients with asthma and, therefore, to develop
issues of prevention and treatment of such patients.
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Effect of Sodium-glucose Co-transporter 2 Inhibitors On
Cardiovascular Outcomes in Patients With Chronic
Kidney Disease: Hong Kong-wide, Observational,
Propensity Score Matched Analysis
W Sun, B Yan
The Chinese University of Hong Kong, Hong Kong SAR
Purpose: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are
associated with lower risk of cardiovascular death (CV death) in patients
with chronic kidney disease (CKD). We aimed to compare CV death
between new users of SGLT2i versus non-users in patients with CKD.
Methods: All patients with chronic kidney disease who were prescribed SGLT2i between August 2015 and August 2020 in 16 public
hospitals in Hong Kong were identiﬁed. Patients with baseline estimated glomerular ﬁltration rate (eGFR) ¼30 ml per minute per 1.73 m2
were included in analysis. Propensity-matched cohorts of SGLT2i
users and non-users (n¼4,632 per group) were generated on the basis
of baseline eGFR, etiology of CKD (i.e., diabetic or non-diabetic),
gender and age. Time to CV death was analyzed using COX proportional hazards model. Subgroup analysis was performed to detect any
heterogeneity of effect across stages of CKD.
Results: SGLT2i users and non-users groups were well balanced at
baseline (mean age 65.012.5, female 38.1%), with a median follow-up
of 3.7 (IQR: 1.6- 5.2) years (32,523.5 person-years). Overall, utilization of
SGLT2i was associated with reduced risk of CV death (Hazards Ratio
(HR) 0.60 (95% CI 0.44 to 0.82), compared with non-users. Subgroup
analysis detected heterogeneity of effect, with a numerically lower risk
with SGLT2i users in G3a group and statistically marked lower risk in
G3b group. The effect was not signiﬁcant across other earlier CKD
stages (P for interaction<0.001).
Conclusion: Utilization of SGLT2i was associated with decreased risk
of CV death compared with non-users in a real-world setting and a
population with stage G3b CKD. Our ﬁndings indicated SGLT2i might
improve CV outcomes among patients with moderate to severe CKD.
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Large Gaps in Awareness of Peripheral Arterial Disease
in Hong Kong: A Cross Sectional Study
B Yan, A Lai
The Chinese University of Hong Kong, Hong Kong SAR
Background: Peripheral arterial disease (PAD) is prevalent and associated with signiﬁcant cardiovascular (CV) mortality and morbidity.
However, PAD awareness is low and there is paucity of published
literature on public awareness of PAD in Asian countries.
Purpose: We aimed to assess awareness of PAD among adults in Hong
Kong. The survey is designed to measure knowledge of risk factors for
PAD and consequences of having PAD. Insights into public awareness
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lecture that included information about the risk factors, major symptoms, and prevention of cardiovascular diseases.
Methods: All residents who live in the western region of Saudi Arabia
aged 18 years and above will be invited to participate voluntarily. A
pre-structured questionnaire was designed to collect data on age,
gender, marital status, education level, occupation, lifestyle habits, and
history of heart diseases, with cardiac symptoms, and risk factors
sections. Educational material was provided at the end of the
questionnaire.
Results: The majority of respondents were females (74.8%). Lack of
exercise, stress, and obesity were the most identiﬁed risk factors. Chest
pain recognized as the major Cardiovascular disease symptom (87.6%).
Other symptoms include dyspnea, syncope, and excessive sweating.
The knowledge about cardiovascular disease risk factors was poor.
Only (18.5%) showed excellent responses regarding risk factors
awareness. 60% were successful in identifying preventable factors for
Cardiovascular diseases: smoking cessation (92.2%), cholesterol level
(88.6%), and blood pressure (78.7%) 83.7% of the participants have
attended the awareness lecture in whom 99% of the attendees reported
that the lecture increased their knowledge about cardiovascular
disease.
Conclusion: A lack of knowledge about cardiovascular symptoms and
risk factors is alarming in our population. A call of action is highly
needed. A simple educational material in a basic language is a useful
tool.

118

The First Systematic Athlete Pre-participation Screening
Program in Hong Kong
K Chan, BSF Lau, KT Wong, PS Wong, LC Wu, JTH Wong, GYK Mak,
DCW Lee, RCH So
Hong Kong Sports Institute, Hong Kong SAR
Background: Sudden cardiac death is the leading medical cause of
mortality in young athletes. However, international consensus on the
roles of routine pre-participation electrocardiography (PP-ECG)
screening for athletes is lacking. We aim to study the efﬁcacy of PPECG in professional athletes.
Method: We performed routine PP-ECG for all professional athletes in
Hong Kong Sports Institute (HKSI). Standardized electrocardiograms
(ECGs) interpretation was performed by 3 independent physicians
according to the 2017 International Criteria for Electrocardiographic
Interpretation Consensus.
Result: Between Dec 2020 and April 2021, 848 athletes received PPECG (mean age 22.88.3 years, 485 males). Abnormal ECGs were
identiﬁed in 28 athletes (3.3%), among whom only 23 (2.7%) (mean age
215.6 years, 11 males) fulﬁlled the consensus criteria. The ECGs abnormalities included pre-excitation (N¼7), QTc prolongation (N¼7), T
wave inversion (TWI) (N¼3), frequent ventricular ectopics (VE) (N¼3),
right bundle branch block (BBB) with left axis deviation (LAD) (N¼1),
left BBB (N¼1) and left atrial enlargement (LAE) with LAD (N¼1).
Among the 7 athletes with pre-excitation, 1 received catheter ablation.
One had incomplete suppression of pre-excitation during treadmill
and would require cardiac electrophysiology study. Four had complete
suppression of pre-excitation during treadmill and were allowed to
resume competitive sports. One was pending treadmill. Among the 7
athletes with QTc prolongation, one had clinical diagnosis of
congenital long QT syndrome and was disqualiﬁed from competitive
sports participation. Rest of the 6 athletes had normal QTc upon
reassessment resting or post-stress ECG. Among the 3 athletes with
frequent VE, 1 received catheter ablation and 2 were managed
conservatively. One athlete with LAE and LAD had atrial septal defect
(ASD) requiring closure. One athlete with abnormal TWI had mitral
valve prolapse. Rest of the athletes with BBB and TWI had unremarkable follow-up investigations.
The remaining 5 athletes (mean age 24.68 years, 3 males) (0.6%) were
regarded as having abnormal ECG basing on clinical assessment, new
onset interval ECG changes or discordance between exercise training
intensity and ECG abnormalities. All had unremarkable follow-up
investigations.
Conclusion: We conducted the ﬁrst systematic PP-ECG screening
program for professional athletes in Hong Kong. The screening program yielded an abnormal ECG rate of 2.7%. Cardiac interventional
procedures were indicated in 3 out of the 23 athletes. One athlete was
disqualiﬁed from competitive sports participation. PP-ECG is helpful
in identifying asymptomatic serious cardiac pathologies that might
increase the risk of exercise-related sudden cardiac death in athletes.
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Add-on Therapy With Sodium-glucose Co-transporter 2
Inhibitors to ACEI/ARB Reduced Cardiovascular
Mortality Across the Spectrum of Chronic Kidney
Disease Stage
W Sun, B Yan
The Chinese University of Hong Kong, Hong Kong SAR
Purpose: Sodium-glucose co-transporter 2 inhibitors (SGLT2i)
reduced risk of cardiovascular death (CV death) in patients with
chronic kidney disease (CKD) in randomized controlled trials.
Whether add-on therapy with SGLT2i further lowers residual CV risk
in patients already on ACEI/ARB is unknown. We aimed to compare
CV death between ACEI/ ARB alone versus combination of SGLT2i
and ACEI/ARB in patients across spectrum of CKD.
Methods: Patients with stage 1-3b CKD (deﬁned as baseline estimated
glomerular ﬁltration rate (eGFR) 330 ml per minute per 1.73 m2) on
ACEI/ARB between August 2010 and August 2015 in 16 public hospitals in Hong Kong were identiﬁed from electronic medical records.
Time to CV death was analyzed using COX proportional hazards
model, adjusted for baseline eGFR, gender and age. Add-on therapy
with SGLT2i was handled as time-varying variable. Patients initiating
SGLT2i contributed follow-up time to the ACEI/ARB single regimen
group until SGLT2i initiation and then to the combination treatment
group thereafter. Subgroup analysis was performed to detect effect
heterogeneity between stages of CKD.
Results: Of 16,678 patients, 8.8% (n¼1,467/16,678) were in stage G1,
30.3% (n¼5,056/16,678) stage G2, 32.5% (n¼5,413/16,678) stage G3a and
28.4% (n¼4,742/16,678) stage G3b. SGLT2i was prescribed in 29.4%
(n¼4,901/16,678) of CKD patients on ACE/ARB (mean age 68.312.8,
female 39.4%), with a median follow-up period of 1.5 (IQR: 0.9-2.9)
years. Compared to ACEI/ARB therapy alone, add-on SGLT2i was
associated with reduced risk of CV death in patients with Stage 2
(Hazards Ratio (HR): 0.56, 95%CI: 0.31-1.02), 3a (HR: 0.47, 95%CI: 0.250.87) and 3b (HR: 0.33, 95%CI: 0.14-0.74) but not in Stage 1 CKD patients.
Conclusion: SGLT2i added to ACEI/ARB was associated with
decreased risk of CV mortality in patient with Stage 2 to 3b CKD
irrespective of diabetic status is a real-world setting.
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A
Community-based,
Cross-sectional
Study
on
Knowledge, Attitude, And Awareness of Cardiovascular
Diseases
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Background: To study the level of awareness about cardiovascular
diseases among the general population and provide an awareness
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